Patent Application
20250042886
The present invention relates to Bis(hetero)aryl thioether oxadiazine derivatives and the uses thereof for controlling phytopathogenic microorganisms such as phytopathogenic fungi. It also relates to processes and intermediates for preparing these compounds.
Numerous crop protection agents to combat or prevent microorganisms' infestations have been developed until now. However, the need remains for the development of new compounds as such, in order to provide compounds being effective against a broad spectrum of phytopathogenic microorganisms, such as fungi, having low toxicity, high selectivity or that can be used at low application rate whilst still allowing effective pest control. It may also be desired to have new compounds to prevent the emergence of resistances.
The present invention provides new compounds for controlling phytopathogenic microorganisms such as fungi which have advantages over known compounds and compositions in at least some of these aspects.
Heterocyclyl-substituted Pyridazines as fungicides are disclosed in WO 2020/127780. WO 2021/245083, WO 2021/249995, WO 2021/245087 and WO 2021/255071 claim further heterocyclyl-substituted compounds as fungicides.
The present invention relates to compounds of formula (I):
wherein
The present invention relates furthermore to compositions comprising at least one compound of formula (I) as defined herein and at least one agriculturally suitable auxiliary.
The present invention also relates to the use of a compound of formula (I) as defined herein or a composition as defined herein for controlling phytopathogenic fungi.
The present invention further relates to a method for controlling phytopathogenic fungi which comprises the step of applying at least one compound of formula (I) as defined herein or a composition as defined herein to a plant, plant parts, seeds, fruits or to the soil in which plants in need of treatment grow.
The present invention also relates to processes and intermediates for preparing compounds of formula (I).
Unless otherwise stated, the following definitions apply for the substituents and residues used throughout this specification and claims:
The term “halogen” as used herein refers to fluorine, chlorine, bromine or iodine atom.
The term “methylidene” as used herein refers to a CH2 group connected to a carbon atom via a double bond.
The term “halomethylidene” as used herein refers to a CX2 group connected to a carbon atom via a double bond, wherein X is halogen.
The term “oxo” as used herein refers to an oxygen atom which is bound to a carbon atom or sulfur atom via a double bound.
The term “formyl” as used herein refers to —CH(═O).
The term “C1-C6-alkyl” as used herein refers to a saturated, branched or straight hydrocarbon chain having 1, 2, 3, 4, 5 or 6 carbon atoms. Examples of C1-C6-alkyl include but are not limited to methyl, ethyl, propyl (n-propyl), 1-methylethyl (iso-propyl), butyl (n-butyl), 1-methylpropyl (sec-butyl), 2-methylpropyl (isobutyl), 1,1-dimethylethyl (tert-butyl), pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 2,2-dimethylpropyl, 1-ethylpropyl, 1,1-dimethylpropyl, 1,2-dimethylpropyl, hexyl, 1-methylpentyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl, 2,2-dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl, 1-ethylbutyl, 2-ethylbutyl, 1,1,2-trimethylpropyl, 1,2,2-trimethylpropyl, 1-ethyl-1-methylpropyl and 1-ethyl-2-methylpropyl. Particularly, said hydrocarbon chain has 1, 2, 3 or 4 carbon atoms (“C1-C4-alkyl”), e.g. methyl, ethyl, propyl, iso-propyl, butyl, sec-butyl, isobutyl or tert-butyl.
The term “C1-C6-haloalkyl” as used herein refers to a C1-C6-alkyl group as defined above in which one or more hydrogen atoms are replaced with one or more halogen atoms that may be the same or different. Examples of C1-C6-haloalkyl include but are not limited to chloromethyl, bromomethyl, dichloromethyl, trichloromethyl, fluoromethyl, difluoromethyl, trifluoromethyl, chlorofluoromethyl, dichlorofluoro-methyl, chlorodifluoromethyl, 1-chloroethyl, 1-bromoethyl, 1-fluoroethyl, 2-fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, 2-chloro-2-fluoroethyl, 2-chloro-2,2-difluoroethyl, 2,2-dichloro-2-fluoroethyl, 2,2,2-trichloroethyl, pentafluoroethyl and 1,1,1-trifluoroprop-2-yl. Preferred are fluoromethyl, difluoromethyl, trifluoromethyl, fluoroethyl, 2-fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, pentafluoroethyl and 1,1,1-trifluoroprop-2-yl.
The term “C1-C6-fluoroalkyl” as used herein refers to a C1-C6-alkyl group as defined above in which one or more hydrogen atoms are replaced with one or more fluorine atoms that may be the same or different. Examples of C1-C6-fluoroalkyl include but are not limited to monofluoromethyl, difluoromethyl, trifluoromethyl, 1-fluoroethyl, 1,1-difluoroethyl, 2,2-difluoroethyl and 2,2,2-trifluoroethyl.
The term “C1-C6-alkylene” as used herein refers to a divalent C1-C6-alkyl group as defined herein. Examples of C1-C6-alkylene include but are not limited to methylene, 1,2-ethylene, 1,1-ethylene, 1,3-propylene, 1,2-propylene, 2,2-propylene, 1,4-butylene, 1,3-butylene, 1,2-butylene, 1,5-pentylene and 1,6-hexylene.
The terms “C3-C8-cycloalkyl” and “C3-C8-cycloalkyl-ring” as used herein refers to a saturated, monocyclic hydrocarbon ring containing 3, 4, 5, 6, 7 or 8 carbon atoms. Examples of C3-C8-cycloalkyl include but are not limited to cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl and cyclooctyl. Particularly, said cycloalkyl has 3 to 6 carbon atoms.
The term “C3-C8-halocycloalkyl” as used herein refers to a saturated hydrocarbon ring system in which all of the ring members, which vary from 3 to 8, are carbon atoms and in which which one or more hydrogen atoms are replaced with one or more halogen atoms that may be the same or different.
The term “C2-C6-alkenyl” as used herein refers to an unsaturated, branched or straight hydrocarbon chain having 2, 3, 4, 5 or 6 carbon atoms and comprising at least one double bond. Examples of C2-C6-alkenyl include but are not limited to ethenyl (or “vinyl”), prop-2-en-1-yl (or “allyl”), prop-1-en-1-yl, but-3-enyl, but-2-enyl, but-1-enyl, pent-4-enyl, pent-3-enyl, pent-2-enyl, pent-1-enyl, hex-5-enyl, hex-4-enyl, hex-3-enyl, hex-2-enyl, hex-1-enyl, prop-1-en-2-yl (or “isopropenyl”), 2-methylprop-2-enyl, 1-methylprop-2-enyl, 2-methylprop-1-enyl, 1-methylprop-1-enyl, 3-methylbut-3-enyl, 2-methylbut-3-enyl, 1-methylbut-3-enyl, 3-methylbut-2-enyl, 2-methylbut-2-enyl, 1-methylbut-2-enyl, 3-methylbut-1-enyl, 2-methylbut-1-enyl, 1-methylbut-1-enyl, 1,1-dimethylprop-2-enyl, 1-ethylprop-1-enyl, 1-propylvinyl, 1-isopropylvinyl, 4-methylpent-4-enyl, 3-methylpent-4-enyl, 2-methylpent-4-enyl, 1-methylpent-4-enyl, 4-methylpent-3-enyl, 3-methylpent-3-enyl, 2-methylpent-3-enyl, 1-methylpent-3-enyl, 4-methylpent-2-enyl, 3-methylpent-2-enyl, 2-methylpent-2-enyl, 1-methylpent-2-enyl, 4-methylpent-1-enyl, 3-methylpent-1-enyl, 2-methylpent-1-enyl, 1-methylpent-1-enyl, 3-ethylbut-3-enyl, 2-ethylbut-3-enyl, 1-ethylbut-3-enyl, 3-ethylbut-2-enyl, 2-ethylbut-2-enyl, 1-ethylbut-2-enyl, 3-ethylbut-1-enyl, 2-ethylbut-1-enyl, 1-ethylbut-1-enyl, 2-propylprop-2-enyl, 1-propylprop-2-enyl, 2-isopropylprop-2-enyl, 1-isopropylprop-2-enyl, 2-propylprop-1-enyl, 1-propylprop-1-enyl, 2-isopropylprop-1-enyl, 1-isopropylprop-1-enyl, 3,3-dimethyl-prop-1-enyl, 1-(1,1-dimethylethyl)ethenyl, buta-1,3-dienyl, penta-1,4-dienyl, hexa-1,5-dienyl or methylhexadienyl group.
The term “C2-C6-alkynyl” as used herein refers to a branched or straight hydrocarbon chain having 2, 3, 4, 5 or 6 carbon atoms and comprising at least one triple bond. Examples of C2-C6-alkynyl include but are not limited to ethynyl, prop-1-ynyl, prop-2-ynyl (or “propargyl”), but-1-ynyl, but-2-ynyl, but-3-ynyl, pent-1-ynyl, pent-2-ynyl, pent-3-ynyl, pent-4-ynyl, hex-1-ynyl, hex-2-ynyl, hex-3-ynyl, hex-4-ynyl, hex-5-ynyl, 1-methylprop-2-ynyl, 2-methylbut-3-ynyl, 1-methylbut-3-ynyl, 1-methylbut-2-ynyl, 3-methylbut-1-ynyl, 1-ethylprop-2-ynyl, 3-methylpent-4-ynyl, 2-methylpent-4-ynyl, 1-methyl-pent-4-ynyl, 2-methyl-pent-3-ynyl, 1-methylpent-3-ynyl, 4-methylpent-2-ynyl, 1-methyl-pent-2-ynyl, 4-methylpent-1-ynyl, 3-methylpent-1-ynyl, 2-ethylbut-3-ynyl, 1-ethylbut-3-ynyl, 1-ethylbut-2-ynyl, 1-propylprop-2-ynyl, 1-isopropylprop-2-ynyl, 2,2-dimethylbut-3-ynyl, 1,1-dimethylbut-3-ynyl, 1,1-dimethylbut-2-ynyl or 3,3-dimethylbut-1-ynyl group.
The term “C2-C6-haloalkenyl” as used herein refers to a C2-C6-alkenyl group as defined above in which one or more hydrogen atoms are replaced with one or more halogen atoms that may be the same or different.
The term “C2-C6-haloalkynyl” as used herein refers to a C2-C6-alkynyl group as defined above in which one or more hydrogen atoms are replaced with one or more halogen atoms that may be the same or different.
The term “C2-C6-alkenylene” as used herein refers to a divalent C2-C6-alkenyl group as defined herein. Examples of C2-C6-alkenylene include but are not limited to ethenylene, 1,3-propenylene, butenylene, pentenylene, hexenylene.
The term “C2-C6-alkynylene” as used herein refers to a divalent C2-C6-alkynyl group as defined herein. Examples of C2-C6-alkynylene include but are not limited to ethynylene, 1,3-propynylene, butynylene, pentynylene, hexynylene and the like.
The term “C1-C6-alkoxy” as used herein refers to a group of formula (C1-C6-alkyl)-O—, in which the term “C1-C6-alkyl” is as defined herein. Examples of C1-C6-alkoxy include but are not limited to methoxy, ethoxy, n-propoxy, 1-methylethoxy, n-butoxy, 1-methylpropoxy, 2-methylpropoxy, 1,1-dimethylethoxy, n-pentoxy, 1-methylbutoxy, 2-methylbutoxy, 3-methylbutoxy, 2,2-dimethylpropoxy, 1-ethylpropoxy, 1,1-dimethylpropoxy, 1,2-dimethylpropoxy, n-hexyloxy, 1-methylpentoxy, 2-methylpentoxy, 3-methylpentoxy, 4-methylpentoxy, 1,1-dimethylbutoxy, 1,2-dimethylbutoxy, 1,3-dimethylbutoxy, 2,2-dimethylbutoxy, 2,3-dimethylbutoxy, 3,3-dimethylbutoxy, 1-ethylbutoxy, 2-ethylbutoxy, 1,1,2-trimethylpropoxy, 1,2,2-trimethylpropoxy, 1-ethyl-1-methylpropoxy and 1-ethyl-2-methylpropoxy. This definition also applies to alkoxy as part of a composite substituent, for example alkoxyalkyl, alkoxyalkoxy, unless defined elsewhere.
The term “C1-C6-haloalkoxy” as used herein refers to a C1-C6-alkoxy group as defined above in which one or more hydrogen atoms are replaced with one or more halogen atoms that may be the same or different. Examples of C1-C6-haloalkoxy include but are not limited to chloromethoxy, bromomethoxy, dichloromethoxy, trichloromethoxy, fluoromethoxy, difluoromethoxy, trifluoromethoxy, chlorofluoro-methoxy, dichlorofluoromethoxy, chlorodifluoromethoxy, 1-chloroethoxy, 1-bromoethoxy, 1-fluoroethoxy, 2-fluoroethoxy, 2,2-difluoroethoxy, 2,2,2-trifluoroethoxy, 2-chloro-2-fluoroethoxy, 2-chloro-2,2-difluoroethoxy, 2,2-dichloro-2-fluoroethoxy, 2,2,2-trichloroethoxy, pentafluoroethoxy and 1,1,1-trifluoroprop-2-oxy.
The term “C1-C6-hydroxyalkyl” as used herein refers to a C1-C6-alkyl group as defined above in which at least one hydrogen atom is replaced with a hydroxyl group. Examples of C1-C6-hydroxyalkyl include but are not limited to hydroxymethyl, 1-hydroxyethyl, 2-hydroxyethyl, 1,2-dihydroxyethyl, 3-hydroxypropyl, 2-hydroxypropyl, 1-hydroxypropyl, 1-hydroxypropan-2-yl, 2-hydroxypropan-2-yl, 2,3-dihydroxypropyl and 1,3-dihydroxypropan-2-yl.
The term “C3-C8-cycloalkoxy” as used herein refers to a monocyclic, saturated cycloalkoxy radical having 3 to 8 and preferably 3 to 6 carbon ring members, for example (but not limited to) cyclopropyloxy, cyclobutyloxy, cyclopentyloxy and cyclohexyloxy. This definition also applies to cycloalkoxy as part of a composite substituent, for example cycloalkoxyalkyl, unless defined elsewhere.
The term C2-C6-alkenyloxy as used herein refers to a formula (C2-C6-alkenyl)-O—, in which the term “C1-C6-alkenyl” group is which the as defined herein. Examples of C2-C6-alkenyl include but are not limited to ethenyloxy (or “vinyloxy”), prop-2-en-1-yloxy (or “allyl”), prop-1-en-1-yloxy, but-3-enyloxy, but-2-enyloxy, but-1-enyloxy, pent-4-enyloxy, pent-3-enyloxy, pent-2-enyloxy, pent-1-enyloxy, hex-5-enyloxy, hex-4-enyloxy, hex-3-enyloxy, hex-2-enyloxy, hex-1-enyloxy, prop-1-en-2-yloxy (or “iso-propenyloxy”), 2-methylprop-2-enyloxy, 1-methylprop-2-enyloxy, 2-methylprop-1-enyloxy, 1-methyl-prop-1-enyloxy, 3-methylbut-3-enyloxy, 2-methylbut-3-enyloxy, 1-methylbut-3-enyloxy, 3-methylbut-2-enyloxy, 2-methylbut-2-enyloxy, 1-methylbut-2-enyloxy, 3-methylbut-1-enyloxy, 2-methylbut-1-enyloxy, 1-methylbut-1-enyloxy, 1,1-dimethylprop-2-enyloxy, 1-ethylprop-1-enyloxy, 1-propylvinyloxy, 1-isopropylvinyloxy, 4-methylpent-4-enyloxy, 3-methylpent-4-enyloxy, 2-methylpent-4-enyloxy, 1-methylpent-4-enyloxy, 4-methylpent-3-enyloxy, 3-methylpent-3-enyloxy, 2-methylpent-3-enyloxy, 1-methylpent-3-enyloxy, 4-methylpent-2-enyloxy, 3-methylpent-2-enyloxy, 2-methylpent-2-enyloxy, 1-methylpent-2-enyloxy, 4-methylpent-1-enyloxy, 3-methylpent-1-enyloxy, 2-methylpent-1-enyloxy, 1-methylpent-1-enyloxy, 3-ethylbut-3-enyloxy, 2-ethylbut-3-enyloxy, 1-ethylbut-3-enyloxy, 3-ethylbut-2-enyloxy, 2-ethylbut-2-enyloxy, 1-ethylbut-2-enyloxy, 3-ethylbut-1-enyloxy, 2-ethylbut-1-enyloxy, 1-ethylbut-1-enyloxy, 2-propylprop-2-enyloxy, 1-propylprop-2-enyloxy, 2-isopropylprop-2-enyloxy, 1-iso-propylprop-2-enyloxy, 2-propylprop-1-enyloxy, 1-propylprop-1-enyloxy, 2-isopropylprop-1-enyloxy, 1-isopropylprop-1-enyloxy, 3,3-dimethylprop-1-enyloxy, 1-(1,1-dimethylethyl)ethenyloxy, buta-1,3-dienyloxy, penta-1,4-dienyloxy, hexa-1,5-dienyloxy or methylhexadienyloxy group.
The term “C2-C6-haloalkenyloxy” as used herein refers to a (C2-C6-alkenyl)-O— group as defined above in which one or more hydrogen atoms are replaced with one or more halogen atoms that may be the same or different.
The term “C2-C6-haloalkynyloxy” as used herein refers to a (C2-C6-alkynyl)-O— group as defined above in which one or more hydrogen atoms are replaced with one or more halogen atoms that may be the same or different.
The term “C1-C6-alkylsulfanyl” as used herein refers to a saturated, linear or branched group of formula (C1-C6-alkyl)-S—, in which the term “C1-C6-alkyl” is as defined herein. Examples of C1-C6-alkylsulfanyl include but are not limited to methylsulfanyl, ethylsulfanyl, propylsulfanyl, isopropylsulfanyl, butylsulfanyl, sec-butylsulfanyl, isobutylsulfanyl, tert-butylsulfanyl, pentylsulfanyl, isopentylsulfanyl, hexylsulfanyl group.
The term “C1-C6-haloalkylsulfanyl” as used herein refers to a C1-C6-alkylsulfanyl as defined above in which one or more hydrogen atoms are replaced with one or more halogen atoms that may be the same or different.
The term “C3-C8-cycloalkylsulfanyl” as used herein refers to a saturated, monovalent, monocylic hydrocarbon ring which contains 3, 4, 5, 6, 7 or 8 carbon atoms and which is bound to the skeleton via a sulfur atom. Examples of monocyclic C3-C8-cycloalkylsulfanyls include but are not limited to cyclopropylsulfanyl, cyclobutylsulfanyl, cyclopentylsulfanyl, cyclohexylsulfanyl, cycloheptylsulfanyl, or cyclooctylsulfanyl.
The term “C1-C6-alkylsulfinyl” as used herein refers to a saturated, linear or branched group of formula (C1-C6-alkyl)-S(═O)—, in which the term “C1-C6-alkyl” is as defined herein. Examples of C1-C6-alkylsulfinyl include but are not limited to saturated, straight-chain or branched alkylsulfinyl radicals having 1 to 8, preferably 1 to 6 and more preferably 1 to 4 carbon atoms, for example (but not limited to) C1-C6-alkylsulfinyl such as methylsulfinyl, ethylsulfinyl, propylsulfinyl, 1-methylethylsulfinyl, butylsulfinyl, 1-methylpropylsulfinyl, 2-methylpropylsulfinyl, 1,1-dimethylethylsulfinyl, pentylsulfinyl, 1-methylbutylsulfinyl, 2-methylbutylsulfinyl, 3-methylbutylsulfinyl, 2,2-dimethylpropylsulfinyl, 1-ethyl-propylsulfinyl, 1,1-dimethylpropylsulfinyl, 1,2-dimethylpropylsulfinyl, hexylsulfinyl, 1-methylpentylsulfinyl, 2-methylpentylsulfinyl, 3-methylpentylsulfinyl, 4-methylpentylsulfinyl, 1,1-dimethylbutylsulfinyl, 1,2-dimethylbutylsulfinyl, 1,3-dimethylbutylsulfinyl, 2,2-dimethylbutylsulfinyl, 2,3-dimethylbutylsulfinyl, 3,3-dimethylbutylsulfinyl, 1-ethylbutylsulfinyl, 2-ethylbutylsulfinyl, 1,1,2-trimethylpropylsulfinyl, 1,2,2-trimethylpropylsulfinyl, 1-ethyl-1-methylpropylsulfinyl and 1-ethyl-2-methylpropylsulfinyl.
The term “C1-C6-haloalkylsulfinyl” as used herein refers to a C1-C6-alkylsulfinyl as defined above in which one or more hydrogen atoms are replaced with one or more halogen atoms that may be the same or different.
The term “C3-C8-cycloalkylsulfinyl” as used herein refers to a saturated, monovalent, monocylic hydrocarbon ring which contains 3, 4, 5, 6, 7 or 8 carbon atoms and which is bound to the skeleton via a —S(═O)— group. Examples of monocyclic C3-C8-cycloalkylsulfinyls include but are not limited to cyclopropylsulfinyl, cyclobutylsulfinyl, cyclopentylsulfinyl, cyclohexylsulfinyl, cycloheptylsulfinyl or cyclooctylsulfinyl.
The term “C1-C6-alkylsulfonyl” s used herein refers to a saturated, linear or branched group of formula (C1-C6-alkyl)-S(═O)2—, in which the term “C1-C6-alkyl” is as defined herein. Examples of C1-C6-alkylsulfonyl include but are not limited to methylsulfonyl, ethylsulfonyl, propylsulfonyl, 1-methylethyl-sulfonyl, butylsulfonyl, 1-methylpropylsulfonyl, 2-methylpropylsulfonyl, 1,1-dimethylethylsulfonyl, pentylsulfonyl, 1-methylbutylsulfonyl, 2-methylbutylsulfonyl, 3-methylbutylsulfonyl, 2,2-dimethylpropylsulfonyl, 1-ethylpropylsulfonyl, 1,1-dimethylpropylsulfonyl, 1,2-dimethylpropylsulfonyl, hexyl-sulfonyl, 1-methylpentylsulfonyl, 2-methylpentylsulfonyl, 3-methylpentylsulfonyl, 4-methylpentylsulfonyl, 1,1-dimethylbutylsulfonyl, 1,2-dimethylbutylsulfonyl, 1,3-dimethylbutylsulfonyl, 2,2-dimethylbutylsulfonyl, 2,3-dimethylbutylsulfonyl, 3,3-dimethylbutylsulfonyl, 1-ethylbutysulfonyl, 2-ethylbutyl-sulfonyl, 1,1,2-trimethylpropylsulfonyl, 1,2,2-trimethylpropylsulfonyl, 1-ethyl-1-methylpropylsulfonyl and 1-ethyl-2-methylpropylsulfonyl.
The term “C1-C6-haloalkylsulfonyl” as used herein refers to a C1-C6-alkylsulfonyl as defined above in which one or more hydrogen atoms are replaced with one or more halogen atoms that may be the same or different.
The term “C3-C8-cycloalkylsulfonyl” as used herein refers to a saturated, monovalent, monocylic hydrocarbon ring which contains 3, 4, 5, 6, 7 or 8 carbon atoms and which is bound to the skeleton via a —S(═O)2— group. Examples of monocyclic C3-C8-cycloalkylsulfonyls include but are not limited to cyclopropylsulfonyl, cyclobutylsulfonyl, cyclopentylsulfonyl, cyclohexylsulfonyl, cycloheptylsulfonyl or cyclooctylsulfonyl.
The term “C1-C6-alkylcarbonyl” as used herein refers to a saturated, linear or branched group of formula (C1-C6-alkyl)-C(═O)—, in which the term “C1-C6-alkyl” is as defined herein.
The term “C1-C6-haloalkylcarbonyl” as used herein refers to a C1-C6-alkylcarbonyl as defined above in which one or more hydrogen atoms are replaced with one or more halogen atoms that may be the same or different.
The term “C1-C6-alkylcarbonyloxy” as used herein refers to a saturated, linear or branched group of formula (C1-C6-alkyl)-C(═O)O—, in which the term “C1-C6-alkyl” is as defined herein.
The term “C1-C6-alkoxycarbonyl” as used herein refers to a saturated, linear or branched group of formula (C1-C6-alkoxy)-C(═O)—, in which the term “C1-C6-alkoxy” is as defined herein.
The term “C1-C6-haloalkoxycarbonyl” as used herein refers to a C1-C6-alkoxycarbonyl as defined above in which one or more hydrogen atoms are replaced with one or more halogen atoms that may be the same or different.
The term “mono-(C1-C6-alkyl)amino” as used herein refers to an amino radical having one C1-C6-alkyl group as defined herein. Examples of mono-(C1-C6-alkyl)amino include but are not limited to N-methylamino, N-ethylamino, N-isopropylamino, N-n-propylamino, N-isopropylamino and N-tert-butylamino.
The term “di-(C1-C6)-alkylamino” as used herein refers to an amino radical having two independently selected C1-C6-alkyl groups as defined herein. Examples of C1-C6-dialkylamino include but are not limited to N,N-dimethylamino, N,N-diethylamino, N,N-diisopropylamino, N-ethyl-N-methylamino, N-methyl-N-n-propylamino, N-isopropyl-N-n-propylamino and N-tert-butyl-N-methylamino.
The term “C3-C12-carbocyclyl” as used herein refers to a saturated or partially unsaturated hydrocarbon ring system in which all of the ring members, which vary from 3 to 12, are carbon atoms. The ring system may be monocyclic or polycyclic (fused, spiro or bridged). C3-C12-carbocyclyls include but are not limited to C3-C12-cycloalkyl (mono or bicyclic), C3-C12-cycloalkenyl (mono or bicyclic), bicylic system comprising an aryl (e.g. phenyl) fused to a monocyclic C3-C8-cycloalkyl (e.g. tetrahydronaphthalenyl, indanyl, 3-bicyclo[4.2.0]octa-1,3,5-trienyl), bicylic system comprising an aryl (e.g. phenyl) fused to a monocyclic C3-C8-cycloalkenyl (e.g. indenyl, dihydronaphthalenyl) and tricyclic system comprising a cyclopropyl connected through one carbon atom to a bicylic system comprising an aryl (e.g. phenyl) fused to a C3-C8-cycloalkyl or to a C3-C8-cycloalkenyl. The C3-C12-carbocyclyl can be attached to the parent molecular moiety through any carbon atom.
The term “C3-C12-cycloalkenyl” as used herein refers to an unsaturated, monovalent, mono- or bicylic hydrocarbon ring which contains 3, 4, 5, 6, 7, 8, 9, 10, 11 or 12 carbon atoms and one or two double bonds. Examples of monocyclic C3-C8-cycloalkenyl group include but are not limited to cyclobutenyl, cyclopentenyl, cyclohexenyl, cycloheptenyl and cyclooctenyl group. Examples of bicyclic C6-C12-cycloalkenyl group include but are not limited to 3-bicyclo[4.2.0]octa-1,3,5-trienyl, bicyclo[2.2.1]hept-2-enyl or bicyclo[2.2.2]oct-2-enyl.
The term “C6-C14-aryl” as used herein refers to an aromatic hydrocarbon ring system in which all of the ring members, which vary from 6 to 14, preferably from 6 to 10, are carbon atoms. The ring system may be monocyclic or fused polycyclic (e.g. bicyclic or tricyclic). Examples of aryl include but are not limited to phenyl, azulenyl and naphthyl.
The term “3- to 14-membered heterocyclyl” as used herein refers to a saturated or partially unsaturated 3-, 4-, 5-, 6-, 7-, 8-, 9-, 10-, 11-, 12-, 13- or 14-membered membered ring system comprising 1 to 4 heteroatoms independently selected from the group consisting of oxygen, nitrogen and sulfur. If the ring system contains more than one oxygen atoms, they are not directly adjacent. Heterocycles include but are not limited to 3- to 7-membered monocyclic heterocycles and 8- to 14-membered polycyclic (e.g. bicyclic or tricyclic) heterocycles. The 3- to 14-membered heterocycle can be connected to the parent molecular moiety through any carbon atom or nitrogen atom contained within the heterocycle. Examples of saturated heterocycles include but are not limited to 3-membered ring such as oxiranyl, aziridinyl, 4-membered ring such as azetidinyl, oxetanyl, thietanyl, 5-membered ring such as tetrahydrofuranyl, 1,3-dioxolanyl, tetrahydrothienyl, pyrrolidinyl, pyrazolidinyl, imidazolidinyl, triazolidinyl, isoxazolidinyl, oxazolidinyl, oxadiazolidinyl, thiazolidinyl, isothiazolidinyl, thiadiazolidinyl, 6-membered ring such as piperidinyl, hexahydropyridazinyl, hexahydropyrimidinyl, piperazinyl, triazinanyl, hexahydrotriazinyl, tetrahydropyranyl, dioxanyl, tetrahydrothiopyranyl, dithianyl, morpholinyl, 1,2-oxazinanyl, oxathianyl, thiomorpholinyl or 7-membered ring such as oxepanyl, azepanyl, 1,4-diazepanyl and 1,4-oxazepanyl.
Examples of unsaturated heterocycles include but are not limited to 5-membered ring such as dihydrofuranyl, 1,3-dioxolyl, dihydrothienyl, pyrrolinyl, dihydroimidazolyl, dihydropyrazolyl, isoxazolinyl, dihydrooxazolyl, dihydrothiazolyl or 6-membered ring such as pyranyl, thiopyranyl, thiazinyl and thiadiazinyl. Bicyclic heterocycles may consist of a monocyclic heteroaryl as defined herein fused to a monocyclic C3-C8-cycloalkyl, a monocyclic C3-C8-cycloalkenyl or a monocyclic heterocycle or may consist of a monocyclic heterocycle fused either to an aryl (e.g. phenyl), a C3-C8-cycloalkyl, a C3-C8-cycloalkenyl or a monocyclic heterocycle. When two monocyclic heterocycles or one monocyclic heterocycle and one monocyclic heteroaryl comprising nitrogen atoms are fused, nitrogen atom may be at the bridgehead (e.g. 4,5,6,7-tetrahydropyrazolo[1,5-a]pyridinyl, 5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridinyl, 5,6,7,8-tetrahydroimidazo[1,2-a]pyridinyl). Tricyclic heterocycles may consist of a monocyclic cycloalkyl connected through one common atom to a bicyclic heterocycle.
The terms “3- to 7-membered heterocyclyl” and “3- to 7-membered heterocyclyl-ring” as used herein refers to a saturated 3—, 4-, 5-, 6- or 7-membered ring system comprising 1, 2 or 3 heteroatoms independently selected from the group consisting of oxygen, nitrogen and sulfur. Examples include but are not limited to oxiranyl, aziridinyl, azetidinyl, oxetanyl, thietanyl, tetrahydrofuranyl, 1,3-dioxolanyl, tetrahydrothienyl, pyrrolidinyl, pyrazolidinyl, imidazolidinyl, triazolidinyl, isoxazolidinyl, oxazolidinyl, oxadiazolidinyl, thiazolidinyl, isothiazolidinyl, thiadiazolidinyl, piperidinyl, hexahydropyridazinyl, hexahydropyrimidinyl, piperazinyl, triazinanyl, hexahydrotriazinyl, tetrahydropyranyl, dioxanyl, tetrahydrothiopyranyl, dithianyl, morpholinyl, 1,2-oxazinanyl, oxathianyl, thiomorpholinyl, oxepanyl, azepanyl, 1,4-diazepanyl and 1,4-oxazepanyl. Preferred 3- to 7-membered heterocyclyl are oxiranyl, aziridinyl, azetidinyl, oxetanyl, tetrahydrofuranyl, 1,3-dioxolanyl, pyrrolidinyl, piperidinyl, piperazinyl, tetrahydropyranyl, dioxanyl, morpholinyl and thiomorpholinyl.
The term “5- to 14-membered heteroaryl” as used herein refers to an aromatic ring system comprising 1 to 4 heteroatoms independently selected from the group consisting of oxygen, nitrogen and sulfur. If the ring system contains more than one oxygen atom, they are not directly adjacent. Aromatic heterocycles include 5- or 6-membered monocyclic heteroaryls and 7- to 14-membered polycyclic (e.g. bicyclic or tricyclic) heteroaryls. The 5- to 14-membered heteroaryl can be connected to the parent molecular moiety through any carbon atom or nitrogen atom contained within the heterocycle.
The term “5- or 6-membered heteroaryl” as used herein refers to a 5- or 6-membered aromatic monocyclic ring system containing 1, 2, 3 or 4 heteroatoms independently selected from the group consisting of oxygen, nitrogen and sulfur. Examples of 5-membered monocyclic heteroaryl include but are not limited to furyl (furanyl), thienyl, pyrrolyl, pyrazolyl, imidazolyl, triazolyl, tetrazolyl, isoxazolyl, oxazolyl, oxadiazolyl, oxatriazolyl, isothiazolyl, thiazolyl, thiadiazolyl and thiatriazolyl. Examples of 6-membered monocyclic heteroaryl include but are not limited to pyridinyl, pyridazinyl, pyrimidinyl, pyrazinyl, triazinyl, tetrazinyl.
The term “7- to 14-membered heteroaryl” as used herein refers to a 7-, 8-, 9-, 10-, 11-, 12-, 13- or 14-membered aromatic polycyclic (e.g. bicyclic or tricyclic) ring system containing 1, 2 or 3 heteroatoms independently selected from the group consisting of oxygen, nitrogen and sulfur. Bicyclic heteroaryls may consist of a monocyclic heteroaryl as defined herein fused to an aryl (e.g. phenyl) or to a monocyclic heteroaryl. Examples of bicyclic heteroaryls include but are not limited to 9-membered ring such as indolyl, indolizinyl, isoindolyl, benzimadozolyl, imidazopyridinyl, indazolyl, benzotriazolyl, purinyl, benzofuranyl, benzothiophenyl, benzothiazolyl, benzoxazolyl and benzisoxazolyl or 10-membered ring such as quinolinyl, isoquinolinyl, cinnolinyl, quinazolinyl, quinoxalinyl, phthalazinyl, naphthyridinyl, pteridinal and benzodioxinyl. In 9- or 10-membered bicyclic heteroaryls comprising two fused 5- or 6-membered monocyclic heteroaryls, nitrogen atom may be at the bridgehead (e.g. imidazo[1,2-a]pyridinyl, [1,2,4]triazolo[4,3-a]pyridinyl, imidazo[1,2-a]pyridinyl, imidazo[2,1-b]oxazolyl, furo[2,3-d]isoxazolyl). Examples of tricyclic aromatic heterocyle include but are not limited to carbazolyl, acridinyl and phenazinyl.
The terms “C3-C12-carbocyclyloxy”, “C3-C8-cycloalkoxy”, “C6-C14-aryloxy”, “5- to 14-membered heteroaryloxy”, “3- to 14-membered heterocyclyloxy” as used herein designate a group of formula —O—R wherein R is respectively a C3-C12-carbocyclyl, a C3-C8-cycloalkyl, a C6-C14-aryl, a 5- to 14-membered heteroaryl or a 3- to 14-membered heterocyclyl group as defined herein.
The terms “C3-C12-carbocyclylsulfanyl”, “C6-C14-arylsulfanyl”, “5- to 14-membered heteroarylsulfanyl”, “3- to 14-membered heterocyclylsulfanyl” as used herein designate a group of formula —S—R wherein R is respectively a C3-C12-carbocyclyl, a C6-C14-aryl, a 5- to 14-membered heteroaryl or a 3- to 14-membered heterocyclyl group as defined herein.
The terms “C3-C12-carbocyclylsulfinyl”, “C6-C14-arylsulfinyl”, “5- to 14-membered heteroarylsulfinyl”, “3- to 14-membered heterocyclylsulfinyl” as used herein designate a group of formula —(S═O)—R wherein R is respectively a C3-C12-carbocyclyl, a C6-C14-aryl, a 5- to 14-membered heteroaryl or a 3- to 14-membered heterocyclyl group as defined herein.
The terms “C3-C12-carbocyclylsulfonyl”, “C6-C14-arylsulfonyl”, “5- to 14-membered heteroarylsulfonyl”, “3- to 14-membered heterocyclylsulfonyl” as used herein designate a group of formula —(S═O)2—R wherein R is respectively a C3-C12-carbocyclyl, a C6-C14-aryl, a 5- to 14-membered heteroaryl or a 3- to 14-membered heterocyclyl group as defined herein.
The term “leaving group” as used herein is to be understood as meaning a group which is displaced from a compound in a substitution or an elimination reaction, for example a halogen atom, a trifluoromethanesulphonate (“triflate”) group, alkoxy, methanesulphonate or p-toluenesulphonate.
Not encompassed herein are compounds resulting from combinations which are against natural laws and which the person skilled in the art would therefore exclude based on his/her expert knowledge. For instance, ring structures having three or more adjacent oxygen atoms are excluded.
The compounds of fomula (I) can suitably be in their free form, salt form, N-oxide form or solvate form (e.g. hydrate).
Depending on the nature of the substituents, the compound of fomula (I) may be present in the form of different stereoisomers. These stereoisomers are, for example, enantiomers, diastereomers, atropisomers or geometric isomers. Accordingly, the invention encompasses both pure stereoisomers and any mixture of these isomers. Where a compound can be present in two or more tautomer forms in equilibrium, reference to the compound by means of one tautomeric description is to be considered to include all tautomer forms.
Any of the compounds of the present invention can also exist in one or more geometric isomer forms depending on the number of double bonds in the compound. Geometric isomers by nature of substituents about a double bond or a ring may be present in cis (═Z—) or trans (=E-) form. The invention thus relates equally to all geometric isomers and to all possible mixtures, in all proportions.
Depending on the nature of the substituents, the compound of fomula (I) may be present in the form of the free compound and/or a salt thereof, such as an agrochemically active salt.
Agrochemically active salts include acid addition salts of inorganic and organic acids well as salts of customary bases. Examples of inorganic acids are hydrohalic acids, such as hydrogen fluoride, hydrogen chloride, hydrogen bromide and hydrogen iodide, sulfuric acid, phosphoric acid and nitric acid, and acidic salts, such as sodium bisulfate and potassium bisulfate. Useful organic acids include, for example, formic acid, carbonic acid and alkanoic acids such as acetic acid, trifluoroacetic acid, trichloroacetic acid and propionic acid, and also glycolic acid, thiocyanic acid, lactic acid, succinic acid, citric acid, benzoic acid, cinnamic acid, oxalic acid, saturated or mono- or diunsaturated fatty acids having 6 to 20 carbon atoms, alkylsulphuric monoesters, alkylsulphonic acids (sulphonic acids having straight-chain or branched alkyl radicals having 1 to 20 carbon atoms), arylsulphonic acids or aryldisulphonic acids (aromatic radicals, such as phenyl and naphthyl, which bear one or two sulphonic acid groups), alkylphosphonic acids (phosphonic acids having straight-chain or branched alkyl radicals having 1 to 20 carbon atoms), arylphosphonic acids or aryldiphosphonic acids (aromatic radicals, such as phenyl and naphthyl, which bear one or two phosphonic acid radicals), where the alkyl and aryl radicals may bear further substituents, for example p-toluenesulphonic acid, salicylic acid, p-aminosalicylic acid, 2-phenoxybenzoic acid, 2-acetoxybenzoic acid, etc.
Solvates of the compounds of the invention or their salts are stoichiometric compositions of the compounds with solvents.
The compounds of the invention may exist in multiple crystalline and/or amorphous forms. Crystalline forms include unsolvated crystalline forms, solvates and hydrates.
Preferably the present invention relates to compounds of formula (I), wherein
More preferably the present invention relates to compounds of formula (I), wherein
Likewise more preferably the present invention relates to compounds of formula (I), wherein
A2 is preferably O, S, C(═O), S(═O)2, NR1 or CR2AR2B, wherein R1, R2A and R2B are independently from each other hydrogen, methyl, ethyl, n-propyl, iso-propyl, cyclopropyl or cyclobutyl.
More preferably, A2 is O, NR1 or CR2AR2B, wherein R1, R2A and R2B are independently from each other hydrogen, methyl, ethyl, cyclopropyl or cyclobutyl.
Even more preferably, A2 is O.
m is preferably 0 or 1, more preferably 1.
T is preferably hydrogen or C1-C4-alkyl, more preferably hydrogen, methyl, ethyl, n-propyl or iso-propyl, even more preferably hydrogen.
More preferably, R3 and R4 are independently selected from the group consisting of hydrogen, fluoro, chloro, C1-C4-alkyl, C2-C4-alkenyl, C2-C4-alkynyl and C3-C6-cycloalkyl, even more preferably from the group consisting of hydrogen, fluoro and C1-C4-alkyl, even more preferably from the group consisting of hydrogen, fluoro, methyl, ethyl, n-propyl and iso-propyl.
Even more preferably, both, R3 and R4 are each hydrogen.
R5 is preferably hydrogen, hydroxyl, C1-C4-alkyl, C1-C4-alkoxy or C1-C4-alkylsulfanyl,
R5 is more preferably hydrogen, hydroxyl, C1-C4-alkyl, C1-C4-alkoxy or C1-C4-alkylsulfanyl, even more preferably hydrogen, hydroxyl or C1-C4-alkyl, even more preferably hydrogen, methyl, ethyl, n-propyl or iso-propyl, Even more preferably hydrogen.
More preferably, A2 is O, NH or CH2, m is 0 or 1, T is hydrogen, and each of R3, R4 and R5 is hydrogen.
Even more preferably, A2 is O, m is 1, T is hydrogen, and each of R3, R4 and R5 is hydrogen.
L is preferably a direct bond, C1-C6-alkylene or a group of formula
L is more preferably a direct bond or C1-C6-alkylene, wherein said C1-C6-alkylene is optionally substituted with one to three substituents LSA, wherein LSA is independently fluoro, chloro, hydroxyl, C1-C4-alkoxy, C1-C4-haloalkoxy, C3-C6-cycloalkyl and C3-C6-halocycloalkyl.
L is even more preferably methylene, wherein said methylene is optionally substituted with one or two substituents fluoro.
L is likewise even more preferably a direct bond or methylene, wherein said methylene is optionally substituted with one or two substituents fluoro.
Preferably, R6 is indanyl, 1,2,3,4-tetrahydronaphthalenyl, bicyclo[4.2.0]octa-1,3,5-trienyl, bicyclo[4.2.0]octa-1(6),2,4-trienyl, indenyl, 1,2-dihydronaphthalenyl, spiro[cyclopropane-2,1′-indane]-1-yl, spiro[cyclopropane-2,1′-tetralin]-1-yl, phenyl, naphthyl, phenoxy, benzyloxy, OCF2-phenyl, phenylsulfanyl, 3-dihydrobenzofuranyl, 2,3-dihydrobenzothiophenyl, indolinyl, 1,3-benzodioxolyl, 1,2,3,4-tetrahydroquinolinyl, chromanyl, isochromanyl, thiochromanyl, 2,3-dihydro-1,4-benzodioxinyl, 6,7-dihydro-5H-cyclopenta[b]pyridinyl, 5,6,7,8-tetrahydroquinolinyl, 4,5,6,7-tetrahydrobenzothiophenyl, 4,5,6,7-tetrahydrobenzofuranyl, 4,5,6,7-tetrahydro-1,3-benzoxazolyl, 4,5,6,7-tetrahydro-1,3-benzothiazolyl, 4,5,6,7-tetrahydro-1H-benzimidazolyl, 4,5,6,7-tetrahydro-1H-indazolyl, 4,5,6,7-tetrahydro-2H-isoindolyl, 4,5,6,7-tetrahydro-2-benzothiophenyl, 5,6-dihydro-4H-cyclopenta[b]thiophenyl, 5,6-dihydro-4H-cyclopenta[d]thiazolyl, 4,5,6,7-tetrahydropyrazolo[1,5-a]pyridinyl, 5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridinyl, 5,6,7,8-tetrahydroimidazo[1,2-a]pyridinyl, 6,7-dihydro-5H-thieno[3,2-b]pyranyl, spiro[chromane-3,1′-cyclopropane]-yl, spiro[7,8-dihydro-5H-quinoline-6,1′-cyclopropane]-yl, furanyl, thienyl, pyrazolyl, imidazolyl, triazolyl, oxazolyl, oxadiazolyl, thiazolyl, thiadiazolyl, pyridinyl, pyridazinyl, pyrimidinyl, indolyl, benzimadazolyl, indazolyl, benzofuranyl, benzothiophenyl, benzothiazolyl, benzoxazolyl, quinolinyl, isoquinolinyl, quinoxalinyl, pyrrolo[2,3-b]pyridin-3-yl, imidazo[1,2-a]pyridinyl, [1,2,4]triazolo[4,3-a]pyridinyl, thieno[3,2-b]pyrrol-6-yl, thieno[3,2-b]thiophenyl, imidazo[2,1-b]oxazolyl, furo[2,3-d]isoxazolyl or thieno[2,3-d]isothiazolyl, wherein indanyl, 1,2,3,4-tetrahydronaphthalenyl, bicyclo[4.2.0]octa-1,3,5-trienyl, bicyclo[4.2.0]octa-1(6),2,4-trienyl, indenyl, 1,2-dihydronaphthalenyl, spiro[cyclopropane-2,1′-indane]-1-yl, spiro[cyclopropane-2,1′-tetralin]-1-yl, phenyl, naphthyl, phenoxy, benzyloxy, OCF2-phenyl, phenylsulfanyl, 3-dihydrobenzofuranyl, 2,3-dihydrobenzothiophenyl, indolinyl, 1,3-benzodioxolyl, 1,2,3,4-tetrahydroquinolinyl, chromanyl, isochromanyl, thiochromanyl, 2,3-dihydro-1,4-benzodioxinyl, 6,7-dihydro-5H-cyclopenta[b]pyridinyl, 5,6,7,8-tetrahydroquinolinyl, 4,5,6,7-tetrahydrobenzothiophenyl, 4,5,6,7-tetrahydrobenzofuranyl, 4,5,6,7-tetrahydro-1,3-benzoxazolyl, 4,5,6,7-tetrahydro-1,3-benzothiazolyl, 4,5,6,7-tetrahydro-1H-benzimidazolyl, 4,5,6,7-tetrahydro-1H-indazolyl, 4,5,6,7-tetrahydro-2H-isoindolyl, 4,5,6,7-tetrahydro-2-benzothiophenyl, 5,6-dihydro-4H-cyclopenta[b]thiophenyl, 5,6-dihydro-4H-cyclopenta[d]thiazolyl, 4,5,6,7-tetrahydropyrazolo[1,5-a]pyridinyl, 5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridinyl, 5,6,7,8-tetrahydroimidazo[1,2-a]pyridinyl, 6,7-dihydro-5H-thieno[3,2-b]pyranyl, spiro[chromane-3,1′-cyclopropane]-yl, spiro[7,8-dihydro-5H-quinoline-6,1′-cyclopropane]-yl, furanyl, thienyl, pyrazolyl, imidazolyl, triazolyl, oxazolyl, oxadiazolyl, thiazolyl, thiadiazolyl, pyridinyl, pyridazinyl and pyrimidinyl, indolyl, benzimadazolyl, indazolyl, benzofuranyl, benzothiophenyl, benzothiazolyl, benzoxazolyl, quinolinyl, isoquinolinyl, quinoxalinyl, pyrrolo[2,3-b]pyridin-3-yl, imidazo[1,2-a]pyridinyl, [1,2,4]triazolo[4,3-a]pyridinyl, thieno[3,2-b]pyrrol-6-yl, thieno[3,2-b]thiophenyl, imidazo[2,1-b]oxazolyl, furo[2,3-d]isoxazolyl and thieno[2,3-d]isothiazolyl are optionally substituted with one to three substituents R6S, wherein
More preferably, R6 is indanyl, 1,2,3,4-tetrahydronaphthalenyl, phenyl, naphthyl, dihydrobenzofuranyl or dihydrobenzodioxinyl, wherein indanyl, 1,2,3,4-tetrahydronaphthalenyl, phenyl, naphthyl, dihydrobenzofuranyl and dihydrobenzodioxinyl are optionally substituted with one or two R6S substituents, wherein
Likewise more preferably, R6 is phenyl or thienyl, wherein phenyl and thienyl are substituted with one or two R6S substituents, wherein R6S is independently selected from the group consisting of chloro, bromo or methyl.
Even more preferably, R6 is phenyl, substituted with one or two R6S substituents, wherein
Still even more preferably, R6 is
wherein
Even more preferably, L is a direct bond or methylene and R6 is phenyl, wherein phenyl is optionally substituted with one or two R6S substituents, wherein R6S is independently selected from the group consisting of fluoro, chloro, C1-C4-alkyl, difluoromethyl, trifluoromethyl, C1-C4-alkoxy, difluoromethoxy or trifluoromethoxy.
Likewise even more preferably, L is a direct bond or methylene and R6 is phenyl or thienyl, wherein phenyl and thienyl are optionally substituted with one or two R6S substituents, wherein R6S is independently selected from the group consisting of fluoro, chloro, bromo and C1-C4-alkyl.
Even more preferably, A2 is O, m is 1, T is hydrogen, each of R3, R4 and R5 is hydrogen, L is methylene and R6 is phenyl, substituted with one or two R6S substituents, wherein R6S is independently selected from the group consisting of chloro, bromo or methyl.
Q is preferably phenyl, naphthyl, bicyclo[4.2.0]octa-1(6),2,4-trienyl, indanyl, tetrahydronaphthalenyl, indenyl, dihydronaphthalenyl, bicyclo[4.2.0]octa-1(6),2,4-trienyl, dihydrobenzofuranyl, 1,3-dihydroisobenzofuranyl, indolinyl, 1,3-benzodioxolyl, chromanyl, dihydro-1,4-benzodioxinyl, [1,3]dioxolo[4,5-b]pyridinyl, tetrahydroquinolinyl, 6,7-dihydro-5H-cyclopenta[b]pyridinyl, pyrrolyl, furanyl, thienyl, imidazolyl, triazolyl, oxazolyl, thiazolyl, pyridinyl, pyridazinyl, pyrimidinyl, indolyl, benzimidazolyl, indazolyl, benzofuranyl, benzothiophenyl, benzothiazolyl, benzoxazolyl, quinolinyl, furo[3,2-b]pyridinyl, thieno[3,2-b]thiophenyl or thieno[2,3-d]thiazolyl, wherein phenyl, naphthyl, bicyclo[4.2.0]octa-1(6),2,4-trienyl, indanyl, tetrahydronaphthalenyl, indenyl, dihydronaphthalenyl, bicyclo[4.2.0]octa-1(6),2,4-trienyl, dihydrobenzofuranyl, 1,3-dihydroisobenzofuranyl, indolinyl, 1,3-benzodioxolyl, chromanyl, dihydro-1,4-benzodioxinyl, [1,3]dioxolo[4,5-b]pyridinyl, tetrahydroquinolinyl, 6,7-dihydro-5H-cyclopenta[b]pyridinyl, pyrrolyl, furanyl, thienyl, imidazolyl, triazolyl, oxazolyl, thiazolyl, pyridinyl, pyridazinyl, pyrimidinyl, indolyl, benzimidazolyl, indazolyl, benzofuranyl, benzothiophenyl, benzothiazolyl, benzoxazolyl, quinolinyl, furo[3,2-b]pyridinyl, thieno[3,2-b]thiophenyl and thieno[2,3-d]thiazolyl are optionally substituted with one to three substituents QS, wherein
More preferably Q is phenyl, naphthyl, bicyclo[4.2.0]octa-1(6),2,4-trienyl, benzodioxolyl, 2,3-dihydrobenzofuranyl, pyridinyl, thienyl or indolyl, wherein phenyl, naphthyl, bicyclo[4.2.0]octa-1(6),2,4-trienyl, benzodioxolyl, 2,3-dihydrobenzofuranyl, pyridinyl, thienyl and indolyl are optionally substituted with one to three substituents Qs, wherein
Even more preferably, Q is phenyl, wherein phenyl is substituted with one or two substituents Qs independently selected from the group consisting of halogen, cyano, nitro, formyl, C1-C4-alkyl, difluoromethyl, trifluoromethyl, C1-C4-alkoxy, difluoromethoxy or trifluoromethoxy.
Most preferably Q is
wherein
More preferably, the ring Y is a group of formula (II-a), (II-ab) or (II-ac)
Even more preferably, the ring Y is a group of formula (II-a), (II-ab-1) or (II-ac)
Likewise even more preferably, the ring Y is a group of formula (II-a), (II-ab-1) or (II-ac-1)
The above specified definitions of A1, A2, R1, R2A, R2B, R3, R4, R5, R6, L, m, p, T, Q and Y (broad definition as well as preferred, more preferred, even more preferred and most preferred definitions) can be combined in various manners. These combinations of definitions thus provide sub-classes of compounds according to the invention, such as for instance the ones disclosed below.
Preference is given to those compounds of formula (I) in which each of the definitions (substituents and variables) have the abovementioned preferred meanings.
Particular preference is given to those compounds of formula (I) in which each of the definitions (substituents and variables) have the abovementioned more, even more and/or most preferred meanings.
The present invention also relates to any compound of formula (I) disclosed in Table 1.
The compounds of formula (I) may be used as fungicides (for controlling phytopathogenic fungi), in particular in methods for controlling phytopathogenic fungi which comprises the step of applying one or more compounds of formula (I) to the plants, plant parts, seeds, fruits or to the soil in which the plants grow.
The present invention also relates to processes for the preparation of compounds of formula (I) and their intermediates. Unless indicated otherwise, the variables A1, A2, R1, R2A, R2B, R3, R4, R5, R6, L, m, p, T, Q and Y as used below have the meanings given above for the compounds of formula (I). These definitions apply not only to the end products of formula (I) but also to all intermediates comprising the respective variables.
Compounds of formula (I-a) are various subsets of formula (I). Compounds of formula (I-a-1) to (I-a-3) are various subsets of formula (I-a). All variables in formulae (I-a) and (I-a-1) to (I-a-3) are as defined above for formula (I) unless otherwise noted.
A compound of formula (I-a-1), wherein Q, Y, A1, L, R3, R4, R5 and R6 are defined as above and wherein
The compound of formula (I-a-1) may be obtained by treating a compound of formula (I-a-2) with an oxydizing agent such as a peracid, preferably m-chloroperbenzoic acid, in a halogenated solvent such as dichloromethane.
Such methods to form sulfones or sulfoxides are known and have been described in the literature (Catalysis Communications (2018), 111, 52-58; CS Omega (2018), 3(5), 4860-4870).
A compound of formula (I-a-2), wherein Q, Y, A1, L, R3, R4, R5 and R6 are defined as above and wherein
The compound of formula (I-a-2) may be obtained by treating a compound of formula (4) with a dehydrating agent such as POCl3, P2O5 or triflic anhydride, optionally in the presence of a base. Such methods to form oxadiazine rings are known and have been described in the literature (J. Med. Chem. 2017, 60, 2383-2400 or WO 2020/127780). The reaction may be performed in any customary inert organic solvents. Preference is given to using optionally halogenated aliphatic, alicyclic or aromatic hydrocarbons, such as petroleum ether, hexane, heptane, cyclohexane, methylcyclohexane, benzene, toluene, xylene or decalin, chlorobenzene, dichlorobenzene, dichloromethane, chloroform, carbon tetrachloride, dichloro-ethane or trichlorethane, ethers, such as diisopropyl ether, methyl t-butyl ether, methyl t-amyl ether, dioxane, tetrahydrofuran, 1,2-dimethoxyethane, 1,2-diethoxyethane or anisole, nitriles, such as acetonitrile, propionitrile, n- or i-butyronitrile or benzonitrile; alcohols, such as ethanol or isopropanol.
When T represents an amino protecting group, step 3 is followed by an additional deprotection step using reaction conditions described in the literature (Greene's Protective Groups in organic Synthesis; Peter G. M. Wuts; Wiley; Fifth Edition; 2014; 895-1194). For example a tert-butoxycarbonyl group can be removed in acidic medium such as hydrochloric acid or trifluoroacetic acid.
Compound of formula (4), wherein m, p, Q, Y, A1, A2, L, R1, R2, R3, R4, R5 and R6 are defined as above, may be obtained by first reacting a compound of formula (1), wherein p, A1, Q and Y are defined as above and
Reaction conditions to remove a phtalimide group are well known and have been reported in the literature (Greene's Protective Groups in organic Synthesis; Peter G. M. Wuts; Wiley; Fifth Edition; 2014; 1012-1014).
Compounds of formula (1) can be prepared by one or more processes described herein (see processes H, I and J).
Amines of formula (2) may be prepared by process described in WO 2020/127780.
Compounds of formula (1) wherein U1 is a hydroxyl group can be reacted with an amine of formula (2) in the presence of a condensing reagent by means of methods described in the literature (e.g. Tetrahedron 2005, 61, 10827-10852). Examples of suitable condensing reagents include, but are not limited to, halogenating reagents (e.g. phosgene, phosphorous tribromide, phosphorous trichloride, phosphorous pentachloride, phosphorous trichloride oxide, oxalyl chloride or thionyl chloride), dehydrating reagents (e.g. ethyl chloroformate, methyl chloroformate, isopropyl chloroformate, isobutyl chloroformate or methanesulfonyl chloride), carbodiimides (e.g. N,N′-dicyclohexylcarbodiimide (DCC)) or other customary condensing (or peptide coupling) reagents (e.g. phosphorous pentoxide, polyphosphoric acid, bis(2-oxo-3-oxazolidinyl)phosphinic chloride, 1-[Bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxid hexafluorophosphate (HATU), N,N′-carbonyl-diimidazole, 2-ethoxy-N-ethoxy-carbonyl-1,2-dihydroquinoline (EEDQ), triphenylphosphine/tetrachloro-methane, 4-(4,6-dimethoxy[1.3.5]-triazin-2-yl)-4-methylmorpholinium chloride hydrate, bromo-tripyrrolidinophos-phoniumhexafluorophosphate or propanephosphonic anhydride (T3P).
Compounds of formula (1) wherein U1 is a halogen atom can be reacted with an amine of formula (2) in the presence of an acid scavenger by means of well-known methods. Suitable acid scavengers include any inorganic and organic bases, as described herein, which are customary for such reactions. Preference is given to alkali metal carbonates, alkaline earth metal acetates, tertiary amines or aromatic bases.
Compounds of formula (1) wherein U1 is a C1-C6-alkoxy group can be reacted with an excess of amine of formula (2), optionally in the presence of a Lewis acid such as trimethylaluminum.
A compound of formula (I-a-2), wherein Q, Y, A1, L, R3, R4, R5 and R6 are defined as above and wherein
Compounds of formula (5), wherein m, Y, A1, A2, L, T, X1, R3, R4, R5 and R6 are defined as above, may be prepared according to procedure described in WO 2020/127780.
Compounds of formula (6) are commercially available or may be obtained by conversion or derivatization of another compound of formula (6) in accordance to well-known methods.
A compound of formula (I-a-1), wherein p, Q, Y, A1, L, R3, R4 and R6 are defined as above and wherein
Compounds of formula (10) may be cyclized under acidic conditions in the presence of a reducing agent such as sodium cyanoborohydride to provide a compound of formula (I-a-1). Reaction conditions to form oxadiazine rings with this methodology are known and have been described in the literature (Heterocycles 2016, 92, 2166-2200).
Compound of formula (10), wherein m, p, Q, Y, A1, T, L, R3, R4, R5 and R6 are defined as above, may be obtained by reacting a compound of formula (8), wherein p, Q, Y, A1 and T are defined as above, with a compound of formula (9), wherein m, L, R3, R4 and R6 are defined as above, in the presence of a base. Suitable bases are alkali metal hydrides such as sodium hydride, alkali metal carbonates such as potassium carbonate, alkali metal hydroxides such as potassium hydroxide, or phosphazene bases such as BEMP as described in the literature (Heterocycles 2016, 92, 2166-2200).
Compound of formula (8), wherein p, Q, Y, A1, and T are defined as above, may be obtained by reacting a compound of formula (7), wherein p, Q, Y and A1 are defined as above, with hydroxylamine or a salt thereof. Reaction conditions to perform such transformations are known and have been reported in the literature (WO 2010/138600).
Compounds of formula (7) may be prepared by process K described herein.
Compounds of formula (9) are either commercially available or may be prepared by processes described in the literature (Eur. J. Med. Chem. 2014, 84, 302, Eur. J. Med. Chem. 2015, 100, 18-23, WO2017/031325).
A compound of formula (I-a-1), wherein p, Q, Y, A1, L, R3, R4, R5 and R6 are defined as above and
When E1 is hydroxyl a compound of formula (14) is converted into a compound of formula (I-a-1) using Mitsunobu reaction conditions known by the skilled person of the art (Strategic Applications of Named Reactions in Organic Synthesis; Laszlo Kürti, Barbara Czako; Elsevier; 2005; 294-295 and reference herein). When E1 is halogen a compound of formula (14) is converted into a compound of formula (I-a-1) in the presence of a base.
When W represents an amino protecting group, Step 3 is followed by an additional deprotection step using reaction conditions described in the literature (Greene's Protective Groups in organic Synthesis; Peter G. M. Wuts; Wiley; Fifth Edition; 2014; 895-1194) to provide a compound of formula (I-a-1).
Aminoalcohols of formula (11-a, E1=hydroxyl) are commercially available or may be producible by methods described in the literature (Molecules, 9 (6), 405-426; 2004; WO2017203474). Compounds of formula (11-b, E1=halogen) can be obtained from the corresponding aminoalcohol by well-known methods.
A compound of formula (I-a-3), wherein p, Q, Y, A1, R3, R4 and R5 are defined as above and
Reagents of formula (15) are either commercially available or producible by processes described in the literature (WO 2010/099279).
Reagents of formula (17) are commercially available or can be prepared by known processes. Compounds of formula (7) may be prepared by process K described herein.
A compound of formula (I-a), wherein m, p, L, A2, Q, R3, R4, R5 and R6 are defined as above and
Non-limiting examples of conversions performed in accordance with scheme 7 are provided below.
A compound of formula (I-a), wherein R7L1 or R7B1 or R7F1 is halogen, can be converted in a compound of formula (I-b), wherein R7L2 or R7B2 or R7F2 is cyano, amino, mercapto, hydroxyl, C1-C6-alkyl, C1-C6-haloalkyl, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl, C2-C6-haloalkynyl, C3-C8-cycloalkyl, C3-C8-halocycloalkyl, C3-C6-cycloalkenyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C2-C6-alkenyloxy, C2-C6-haloalkenyloxy, C2-C6-alkynyloxy, C2-C6-haloalkynyloxy, C3-C8-cycloalkyloxy, C6-C14-aryloxy, 3- to 14-membered heterocyclyloxy, 5- to 14-membered heteroaryloxy, C6-C14-aryl, 5- to 14-membered heteroaryl, 3- to 14-membered heterocyclyl, —N(R30)2 or —SR31, in the presence of a base and optionally in the presence of a transition metal catalyst such as a metal salt or complex described herein, and if appropriate in the presence of a ligand, or metallo-photoredox catalyzed processes in analogy to processes described in the literature (WO 2008/151211; WO 2000/050401; J. Org. Chem. 2005, 70, 1432-1437).
A compound of formula (I-b), wherein R7L2 is —SR31, can be further converted into a compound of formula (I-a-4), wherein R7L2 is —S(═O)R31 or —S(═O)2R31, by reacting the starting compound of formula (I-a-4) with an oxidant such as hydrogen peroxide.
A compound of formula (I-b), wherein R7L2 is C2-C6-alkenyl substituted by a C1-C3-alkoxy, can be converted into a compound of formula (I-c), wherein R7L3 is C1-C6-alkylcarbonyl, by means of methods described in the literature (e.g. J. Org. Chem. 1993, 55, 3114).
The compound of formula (I-c), wherein R7L2a is C1-C6-alkylcarbonyl, can be further converted into a compound of formula (I-c), wherein R7L3 is —C(═NR21)R22, wherein R21 is defined as above and R22 is C1-C6-alkyl, by methods described in the literature (e.g. Greene's Protective Groups in organic Synthesis; Peter G. M. Wuts; Wiley; Fifth Edition; 2014; 655, 661, 667).
A compound of formula (I-c), wherein R7L3 is C1-C6-alkylcarbonyl, can be further converted into a compound of formula (I-c), wherein R7L3 is C1-C6-hydroxyalkyl, by classical functional group interconversion such as reductions of ketones to alcohols in the presence of NaBH4 in methanol.
A compound of formula (I-c), wherein R7L3 is C1-C6-hydroxyalkyl, can be further converted into a compound (I-c), wherein R7L3 is C1-C6-fluoroalkyl, in the presence of a fluorinating agent. Non-limitative examples of fluorinating agents include sulfur fluorides such as sulfur tetrafluoride, diethyl-aminosulfurtrifluoride, morpholinosulfur trifluoride, bis(2-methoxyethyl)aminosulfur trifluoride, 2,2-difluoro-1,3-dimethylimidazolidine or 4-tert-butyl-2,6-dimethylphenylsulfur trifluoride.
A compound of formula (I-a) can be prepared by one or more of the processes herein described.
A compound of formula (1) may be directly obtained by performing process H described below or may be obtained by conversion or derivatization of another compound of formula (1) prepared in accordance with the processes described herein. Compounds of formula (1-a)-(1-e) are various subsets of formula (1).
A compound of formula (1-a), wherein p, Q and A1 are as defined above and
A compound of formula (1-b) may be prepared by reacting a compound of formula (20), wherein U1 and A1 are as defined above and
Compounds of formula (20) can be prepared by treating compounds of formula (18), wherein X1 and A1 are as defined above, with a base (e.g. nBuLi or LDA) and carbon dioxide or a reagent of formula (19), wherein
Compounds of formula (1-b), wherein U1 is hydroxyl, can be converted to compounds of formula (1-b), wherein U1 is C1-C6-alkoxy, by well-known esterification methods.
Compounds of formula (1-b), wherein U1 is C1-C6-alkoxy, can be converted to compounds of formula (1-a), by well-known oxydation methods of the thioether in presence of a peracid reagent such m-chloroperbenzoic acid as described in Catalysis Communications (2018), 111, 52-58.
Compounds of formula (1-a), wherein U1 is C1-C6-alkoxy, can be converted to compounds of formula (1-a), wherein U1 is hydroxyl, by well-known functional group interconversion methods, for example by hydrolysis of an ester group with LiOH in THF/water.
Compounds of formula (1-a), wherein U1 is hydroxyl, can be converted to compounds of formula (1-a), wherein U1 is halogen, in the presence of halogenating agents by well-known methods. Suitable halogenating reagents include, but are not limited to, phosphorous tribromide, phosphorous trichloride, phosphorous pentachloride, phosphorous trichloride oxide, oxalyl chloride or thionyl chloride.
Compounds of formula (6) and (19) are commercially available.
Compounds of formula (18) are commercially available or may be obtained by conversion or derivatization of another compound of formula (18) in accordance to well-known methods for example WO2020/109391 or WO2020/127780.
A compound of formula (1-c), wherein p, Q and A1 are defined as above and
Non-limiting examples of conversion may be performed in accordance the description provided in process G.
The obtained compound of formula (1-d) and (1-e), wherein U1 is C1-C6-alkoxy, can then be converted into compounds of formula (1-d) and (1-e), wherein U1 is hydroxyl or halogen.
Examples of such conversion are described below.
Compounds of formula (1-c), (1-d) and (1-e), wherein U1 is C1-C6-alkoxy, can be converted to compounds of formula (1-c), (1-d) and (1-e), wherein U1 is hydroxyl, by well-known functional group interconversion methods, for example by hydrolysis of an ester group with LiOH in THF/water.
Compounds of formula (1-c), (1-d) and (1-e), wherein U1 is hydroxyl, can then be further converted to compounds of formula (1-c), (1-d) and (1-e), wherein U1 is halogen, in the presence of halogenating agents by well-known methods. Suitable halogenating reagents include, but are not limited to, phosphorous tribromide, phosphorous trichloride, phosphorous pentachloride, phosphorous trichloride oxide, oxalyl chloride or thionyl chloride.
Compounds of formula (1-c) can be prepared by one or more of the processes described herein.
A compound of formula (1-b), wherein Y, Q and A1 is defined as above and
Compounds of formula (23) may be prepared by reacting compounds of formula (21), wherein Y and A1 is defined as above, with a reagent of formula (22), wherein
The compounds of formula (1-b), wherein U1 is C1-C6-alkoxy may be converted into compound of formula (1-b), wherein U1 is hydroxyl or halogen, using the same conditions as described in process I.
Starting materials of formula (19), (21) and (22) are commercially available.
A compound of formula (7) may be obtained by performing process N described below or may be obtained by conversion or derivatization of another compound of formula (7-a) prepared in accordance with the processes described herein. Compounds of formula (7-a) and (7-b) are various subsets of formula (7).
A compound of formula (7-a), wherein Y, Q and A1 are defined as above may be converted by means of methods described in the literature to the corresponding compounds (9-b), wherein Y, Q and A1 are defined as above and
In process K, R20 is defined as above.
Compounds of formula (24), wherein X3 is halogen, are commercially available or producible by processes described in the literature (WO 2019/087129).
A compound of formula (24), wherein X3 is halogen, may be converted according to step 1 of Process K into a compound of formula (7-a) in the presence of a reagent of formula (6), wherein Q is defined as above, and a base (e.g organic or inorganic base) as described herein.
A compound of formula (7-a) can be further converted in a compound of formula (7-b), by oxidation of the sulfur atom as shown in procedure H.
Compounds of formula (8) are commercially available or may be obtained by conversion or derivatization of another compound of formula (8) in accordance to well-known methods.
Compounds of formula (5) may be also prepared according to procedures described herein.
Compounds of formula (5), wherein Y, A1, R3, R4, and R5 are defined as above and wherein
Compounds of formula (26) may be prepared by reacting a compound of formula (27), wherein m, Y, X1, A1, R3, R4 and R5 are defined as above under oxidative condition as shown in scheme 12.
The compound of formula (26) can be reacted with a compound of formula (25), wherein R6 is C6-C14-aryl, C7-C14-carbocyclyl, 7- to 14-membered heterocycle or 5- to 14-membered heteroaryl, wherein C6-C14-aryl, C7-C14-carbocyclyl, 7- to 14-membered heterocycle and 5- to 14-membered heteroaryl are optionally substituted as defined above, under acidic conditions to provide a compound of formula (5). Reaction conditions to form oxadiazine rings with this methodology are known and have been described in the literature (WO 2017/031325).
Compounds of formula (25) are commercially available.
Compounds of formula (26) can be obtained from a compound of formula (27) under oxidative conditions, for example in the presence of osmium tetraoxide and sodium periodate.
Compounds of formula (27) may be prepared by process M described herein.
Compound of formula (27), wherein Y, X1, A1, R3, R4 and R5 are defined as above and wherein
Compound of formula (27) may be prepared by reacting a compound of formula (29) with hydroxyl amine as shown in scheme 13.
Compound of formula (27) can be obtained by reacting a compound of formula (29) with a compound of formula (28) in the presence of a base. Suitable bases can be alkali metal hydrides such as sodium hydride, alkali metal carbonates such as potassium carbonate, alkali metal hydroxides such as potassium hydroxide, or phosphazene bases such as BEMP as described in the literature (Heterocycles 2016, 92, 2166-2200).
Compound of formula (29) can be obtained by reacting a compound of formula (24) with hydroxylamine or one of its salt. Reaction conditions to perform such transformations are known and have been reported in the literature (WO 2010/138600).
Compounds of formula (24) are commercially available or producible by processes described in the literature (WO 2019/087129).
Compounds of formula (28) are either commercially available or available or can be prepared by processes described in the literature (Eur. J. Med. Chem. 2014, 84, 302, Eur. J. Med. Chem. 2015, 100, 18-23; WO 2017/031325).
The present invention also relates to intermediates for the preparation of compounds of formula (I).
Thus, the present invention relates to compounds of formula (1):
wherein p, A1, Y, and Q are defined as in formula (I) and
The preferred, more preferred, even more preferred and most preferred definitions of A1, Y, p and Q given with regard to formula (I) apply mutatis mutandis.
The present invention also relates to compounds of formula (3):
wherein p, L, Q, Y, R3, R4, R5 and R6 are defined as in formula (I) and
The preferred, more preferred, even more preferred and most preferred definitions of m, R3, R4, R5, L, R6, Y, T, p and Q given with regard to formula (I) apply mutatis mutandis.
The present invention also relates to compounds of formula (4):
wherein L, Q, Y, R3, R4, R5 and R6 are defined as in formula (I) and
The preferred, more preferred, even more preferred and most preferred definitions of m, R3, R4, R5, R6, L, Y, T and Q given with regard to formula (I) apply mutatis mutandis.
The present invention also relates to compounds of formula (7):
wherein p, Q and Y are defined as in formula (I) and
The preferred, more preferred, even more preferred and most preferred definitions of p, Y and Q given with regard to formula (I) apply mutatis mutandis.
The present invention also relates to compounds of formula (7):
wherein p, Q and Y are defined as in formula (I) and
The preferred, more preferred, even more preferred and most preferred definitions of p, Y and Q given with regard to formula (I) apply mutatis mutandis.
The present invention also relates to compounds of formula (8):
wherein p, Y and Q are defined as in formula (I) and
The preferred, more preferred, even more preferred and most preferred definitions of p, Y and Q given with regard to formula (I) apply mutatis mutandis.
The present invention also relates to compounds of formula (8):
wherein p, Y and Q are defined as in formula (I) and
The preferred, more preferred, even more preferred and most preferred definitions of p, Y and Q given with regard to formula (I) apply mutatis mutandis.
The present invention also relates to compounds of formula (10):
wherein p, L, Q, T, Y, R3, R4 and R6 are defined as in formula (I) and
The preferred, more preferred, even more preferred and most preferred definitions of m, p, L, Q, T, Y, R3, R4 and R6 given with regard to formula (I) apply mutatis mutandis.
The present invention also relates to compounds of formula (12):
wherein p, L, Q, T, Y, R3, R4, R5 and R6 are defined as in formula (I) and
The preferred, more preferred, even more preferred and most preferred definitions of m, p, L, Q, T, Y, R3, R4, R5, and R6 given with regard to formula (I) apply mutatis mutandis.
The present invention also relates to compounds of formula (14):
wherein p, L, Q, T, Y, R3, R4, R5 and R6 are defined as in formula (I) and
The preferred, more preferred, even more preferred and most preferred definitions of m, p, L, Q, T, Y, R3, R4, R5 and R6 given with regard to formula (I) apply mutatis mutandis.
The present invention also relates to compounds of formula (16):
wherein p, Q, T, Y, R3, R4 and R5 are defined as in formula (I) and
The preferred, more preferred, even more preferred and most preferred definitions of p, Q, Y, R3, R4 and R5 given with regard to formula (I) apply mutatis mutandis.
The present invention also relates to compounds of formula (18):
wherein p, Q, T, Y, R3, R4, R5 and R6 are defined as in formula (I) and
The preferred, more preferred, even more preferred and most preferred definitions of p, Q, T, Y, R3, R4, R5 and R6 given with regard to formula (I) apply mutatis mutandis.
The present invention also relates to intermediates of formula (6):
Q-SH (6),
wherein
wherein
Thus, the present invention relates to compounds of formula (26):
wherein Y is defined as in formula (I) and
The preferred, more preferred, even more preferred and most preferred definitions of Y, R3, R4 and R5 given with regard to formula (I) apply mutatis mutandis.
The present invention also relates to compounds of formula (27)
wherein Y is defined as in formula (I) and
The preferred, more preferred, even more preferred and most preferred definitions of Y, R3, R4 and R5 given with regard to formula (I) apply mutatis mutandis.
The present invention also relates to compounds of formula (29)
wherein Y is defined as in formula (I) and
The present invention further relates to compositions, in particular compositions for controlling unwanted microorganisms. The composition may be applied to the microorganisms and/or in their habitat.
The composition comprises at least one compound of formula (I) and at least one agriculturally suitable auxiliary, e.g. carrier(s) and/or surfactant(s).
A carrier is a solid or liquid, natural or synthetic, organic or inorganic substance that is generally inert. The carrier generally improves the application of the compounds, for instance, to plants, plants parts or seeds. Examples of suitable solid carriers include, but are not limited to, ammonium salts, in particular ammonium sulfates, ammonium phosphates and ammonium nitrates, natural rock flours, such as kaolins, clays, talc, chalk, quartz, attapulgite, montmorillonite and diatomaceous earth, silica gel and synthetic rock flours, such as finely divided silica, alumina and silicates. Examples of typically useful solid carriers for preparing granules include, but are not limited to crushed and fractionated natural rocks such as calcite, marble, pumice, sepiolite and dolomite, synthetic granules of inorganic and organic flours and granules of organic material such as paper, sawdust, coconut shells, maize cobs and tobacco stalks. Examples of suitable liquid carriers include, but are not limited to, water, organic solvents and combinations thereof. Examples of suitable solvents include polar and nonpolar organic chemical liquids, for example from the classes of aromatic and nonaromatic hydrocarbons (such as cyclohexane, paraffins, alkylbenzenes, xylene, toluene, tetrahydronaphthalene, alkylnaphthalenes, chlorinated aromatics or chlorinated aliphatic hydrocarbons such as chlorobenzenes, chloroethylenes or methylene chloride), alcohols and polyols (which may optionally also be substituted, etherified and/or esterified, such as ethanol, propanol, butanol, benzylalcohol, cyclohexanol or glycol), ketones (such as acetone, methyl ethyl ketone, methyl isobutyl ketone or cyclohexanone), esters (including fats and oils) and (poly)ethers, unsubstituted and substituted amines, amides (such as dimethylformamide or fatty acid amides) and esters thereof, lactams (such as N-alkylpyrrolidones, in particular N-methylpyrrolidone) and lactones, sulfones and sulfoxides (such as dimethyl sulfoxide), oils of vegetable or animal origin. The carrier may also be a liquefied gaseous extender, i.e. liquid which is gaseous at standard temperature and under standard pressure, for example aerosol propellants such as halohydrocarbons, butane, propane, nitrogen and carbon dioxide.
Preferred solid carriers are selected from clays, talc and silica.
Preferred liquid carriers are selected from water, fatty acid amides and esters thereof, aromatic and nonaromatic hydrocarbons, lactams and carbonic acid esters.
The amount of carrier typically ranges from 1 to 99.99%, preferably from 5 to 99.9%, more preferably from 10 to 99.5%, and most preferably from 20 to 99% by weight of the composition.
Liquid carriers are typically present in a range of from 20 to 90%, for example 30 to 80% by weight of the composition.
Solid carriers are typically present in a range of from 0 to 50%, preferably 5 to 45%, for example 10 to 30% by weight of the composition.
If the composition comprises two or more carriers, the outlined ranges refer to the total amount of carriers.
The surfactant can be an ionic (cationic or anionic), amphoteric or non-ionic surfactant, such as ionic or non-ionic emulsifier(s), foam former(s), dispersant(s), wetting agent(s), penetration enhancer(s) and any mixtures thereof. Examples of suitable surfactants include, but are not limited to, salts of polyacrylic acid, salts of lignosulfonic acid (such as sodium lignosulfonate), salts of phenolsulfonic acid or naphthalenesulfonic acid, polycondensates of ethylene oxide and/or propylene oxide with fatty alcohols, fatty acids or fatty amines (for example, polyoxyethylene fatty acid esters such as castor oil ethoxylate, polyoxyethylene fatty alcohol ethers, for example alkylaryl polyglycol ethers), substituted phenols (preferably alkylphenols or arylphenols) and ethoxylates thereof (such as tristyrylphenol ethoxylate), salts of sulfosuccinic esters, taurine derivatives (preferably alkyl taurates), phosphoric esters of polyethoxylated alcohols or phenols, fatty esters of polyols (such a fatty acid esters of glycerol, sorbitol or sucrose), sulfates (such as alkyl sulfates and alkyl ether sulfates), sulfonates (for example, alkylsulfonates, arylsulfonates and alkylbenzene sulfonates), phosphate esters, protein hydrolysates, lignosulfite waste liquors and methylcellulose. Any reference to salts in this paragraph refers preferably to the respective alkali, alkaline earth and ammonium salts.
Preferred surfactants are selected from polyoxyethylene fatty alcohol ethers, polyoxyethylene fatty acid esters, alkylbenzene sulfonates, such as calcium dodecylbenzenesulfonate, castor oil ethoxylate, sodium lignosulfonate and arylphenol ethoxylates, such as tristyrylphenol ethoxylate.
The amount of surfactants typically ranges from 5 to 40%, for example 10 to 20%, by weight of the composition.
Further examples of suitable auxiliaries include water repellents, siccatives, binders (adhesive, tackifier, fixing agent, such as carboxymethylcellulose, natural and synthetic polymers in the form of powders, granules or latices, such as gum arabic, polyvinyl alcohol and polyvinyl acetate, natural phospholipids such as cephalins and lecithins and synthetic phospholipids, polyvinylpyrrolidone and tylose), thickeners and secondary thickeners (such as cellulose ethers, acrylic acid derivatives, xanthan gum, modified clays, e.g. the products available under the name Bentone, and finely divided silica), stabilizers (e.g. cold stabilizers, preservatives (e.g. dichlorophene and benzyl alcohol hemiformal), antioxidants, light stabilizers, in particular UV stabilizers, or other agents which improve chemical and/or physical stability), dyes or pigments (such as inorganic pigments, e.g. iron oxide, titanium oxide and Prussian Blue; organic dyes, e.g. alizarin, azo and metal phthalocyanine dyes), antifoams (e.g. silicone antifoams and magnesium stearate), antifreezes, stickers, gibberellins and processing auxiliaries, mineral and vegetable oils, perfumes, waxes, nutrients (including trace nutrients, such as salts of iron, manganese, boron, copper, cobalt, molybdenum and zinc), protective colloids, thixotropic substances, penetrants, sequestering agents and complex formers.
The choice of the auxiliaries depends on the intended mode of application of compounds of formula (I) and/or on the physical properties of the compound(s). Furthermore, the auxiliaries may be chosen to impart particular properties (technical, physical and/or biological properties) to the compositions or use forms prepared therefrom. The choice of auxiliaries may allow customizing the compositions to specific needs.
The composition of the invention may be provided to the end user as ready-for-use formulation, i.e. the compositions may be directly applied to the plants or seeds by a suitable device, such as a spraying or dusting device. Alternatively, the compositions may be provided to the end user in the form of concentrates which have to be diluted, preferably with water, prior to use.
The composition of the invention can be prepared in conventional manners, for example by mixing the compound(s) of formula (I) with one or more suitable auxiliaries, such as disclosed herein above.
The composition comprises a fungicidally effective amount of the compound(s) of formula (I). The term “effective amount” is an amount, which is sufficient for controlling harmful fungi on cultivated plants or in the protection of materials and which does not result in a substantial damage to the treated plants. Such an amount can vary in a broad range and is dependent on various factors, such as the fungal species to be controlled, the treated cultivated plant or material, the climatic conditions and the specific compound of formula (I) used. Usually, the composition according to the invention contains from 0.01 to 99% by weight, preferably from 0.05 to 98% by weight, more preferred from 0.1 to 95% by weight, even more preferably from 0.5 to 90% by weight, most preferably from 1 to 80% by weight of the compound of formula (I). It is possible that a composition comprises two or more compounds of the invention. In such case the outlined ranges refer to the total amount of compounds of the present invention.
The composition of the invention may be in any customary composition type, such as solutions (e.g aqueous solutions), emulsions, water- and oil-based suspensions, powders (e.g. wettable powders, soluble powders), dusts, pastes, granules (e.g. soluble granules, granules for broadcasting), suspoemulsion concentrates, natural or synthetic products impregnated with the compound of formula (I), fertilizers and also microencapsulations in polymeric substances. The compounds of formula (I) may be present in a suspended, emulsified or dissolved form. Examples of particular suitable composition types are solutions, watersoluble concentrates (e.g. SL, LS), dispersible concentrates (DC), suspensions and suspension concentrates (e.g. SC, OD, OF, FS), emulsifiable concentrates (e.g. EC), emulsions (e.g. EW, EO, ES, ME, SE), capsules (e.g. CS, ZC), pastes, pastilles, wettable powders or dusts (e.g. WP, SP, WS, DP, DS), pressings (e.g. BR, TB, DT), granules (e.g. WG, SG, GR, FG, GG, MG), insecticidal articles (e.g. LN), as well as gel formulations for the treatment of plant propagation materials such as seeds (e.g. GW, GF). These and further compositions types are defined by the Food and Agriculture Organization of the United Nations (FAO). An overview is given in the “Catalogue of pesticide formulation types and international coding system”, Technical Monograph No. 2, 6th Ed. May 2008, Croplife International.
Preferably, the composition of the invention is in form of one of the following types: EC, SC, FS, SE, OD and WG, more preferred EC, SC, OD and WG.
Further details about examples of composition types and their preparation are given below. If two or more compounds of the invention are present, the outlined amount of compound of the invention refers to the total amount of compounds of the present invention. This applies mutatis mutandis for any further component of the composition, if two or more representatives of such component, e.g. wetting agent, binder, are present.
10-60% by weight of at least one compound of formula (I) and 5-15% by weight surfactant (e.g. polyoxyethylene fatty alcohol ether) are dissolved in such amount of water and/or water-soluble solvent (e.g. alcohols such as propylene glycol or carbonates such as propylene carbonate) to result in a total amount of 100% by weight. Before application the concentrate is diluted with water.
5-25% by weight of at least one compound of formula (I) and 1-10% by weight surfactant and/or binder (e.g. polyvinylpyrrolidone) are dissolved in such amount of organic solvent (e.g. cyclohexanone) to result in a total amount of 100% by weight. Dilution with water gives a dispersion.
iii) Emulsifiable Concentrates (EC)
15-70% by weight of at least one compound of formula (I) and 5-10% by weight surfactant (e.g. a mixture of calcium dodecylbenzenesulfonate and castor oil ethoxylate) are dissolved in such amount of water-insoluble organic solvent (e.g. aromatic hydrocarbon or fatty acid amide) and if needed additional water-soluble solvent to result in a total amount of 100% by weight. Dilution with water gives an emulsion.
5-40% by weight of at least one compound of formula (I) and 1-10% by weight surfactant (e.g. a mixture of calcium dodecylbenzenesulfonate and castor oil ethoxylate) are dissolved in 20-40% by weight water-insoluble organic solvent (e.g. aromatic hydrocarbon). This mixture is added to such amount of water by means of an emulsifying machine to result in a total amount of 100% by weight. The resulting composition is a homogeneous emulsion. Before application the emulsion may be further diluted with water.
v-1) Water-Based (SC, FS)
In a suitable grinding equipment, e.g. an agitated ball mill, 20-60% by weight of at least one compound of formula (I) are comminuted with addition of 2-10% by weight surfactant (e.g. sodium lignosulfonate and polyoxyethylene fatty alcohol ether), 0.1-2% by weight thickener (e.g. xanthan gum) and water to give a fine active substance suspension. The water is added in such amount to result in a total amount of 100% by weight. Dilution with water gives a stable suspension of the active substance. For FS type compositions up to 40% by weight binder (e.g. polyvinylalcohol) is added.
v-2) Oil-Based (OD, OF)
In a suitable grinding equipment, e.g. an agitated ball mill, 20-60% by weight of at least one compound of formula (I) are comminuted with addition of 2-10% by weight surfactant (e.g. sodium lignosulfonate and polyoxyethylene fatty alcohol ether), 0.1-2% by weight thickener (e.g. modified clay, in particular Bentone, or silica) and an organic carrier to give a fine active substance oil suspension. The organic carrier is added in such amount to result in a total amount of 100% by weight. Dilution with water gives a stable dispersion of the active substance.
50-80% by weight of at least one compound of formula (I) are ground finely with addition of surfactant (e.g. sodium lignosulfonate and polyoxyethylene fatty alcohol ether) and converted to water-dispersible or water-soluble granules by means of technical appliances (e. g. extrusion, spray tower, fluidized bed). The surfactant is used in such amount to result in a total amount of 100% by weight. Dilution with water gives a stable dispersion or solution of the active substance.
vii) Water-Dispersible Powders and Water-Soluble Powders (WP, SP, WS)
50-80% by weight of at least one compound of formula (I) are ground in a rotor-stator mill with addition of 1-8% by weight surfactant (e.g. sodium lignosulfonate, polyoxyethylene fatty alcohol ether) and such amount of solid carrier, e.g. silica gel, to result in a total amount of 100% by weight. Dilution with water gives a stable dispersion or solution of the active substance.
viii) Gel (GW, GF)
In an agitated ball mill, 5-25% by weight of at least one compound of formula (I) are comminuted with addition of 3-10% by weight surfactant (e.g. sodium lignosulfonate), 1-5% by weight binder (e.g. carboxymethylcellulose) and such amount of water to result in a total amount of 100% by weight. This results in a fine suspension of the active substance. Dilution with water gives a stable suspension of the active substance.
5-20% by weight of at least one compound of formula (I) are added to 5-30% by weight organic solvent blend (e.g. fatty acid dimethylamide and cyclohexanone), 10-25% by weight surfactant blend (e.g. polyoxyethylene fatty alcohol ether and arylphenol ethoxylate), and such amount of water to result in a total amount of 100% by weight. This mixture is stirred for 1 h to produce spontaneously a thermodynamically stable microemulsion.
An oil phase comprising 5-50% by weight of at least one compound of formula (I), 0-40% by weight water-insoluble organic solvent (e.g. aromatic hydrocarbon), 2-15% by weight acrylic monomers (e.g. methylmethacrylate, methacrylic acid and a di- or triacrylate) are dispersed into an aqueous solution of a protective colloid (e.g. polyvinyl alcohol). Radical polymerization initiated by a radical initiator results in the formation of poly(meth)acrylate microcapsules. Alternatively, an oil phase comprising 5-50% by weight of at least one compound of formula (I), 0-40% by weight water-insoluble organic solvent (e.g. aromatic hydrocarbon), and an isocyanate monomer (e.g. diphenylmethene-4,4′-diisocyanatae) are dispersed into an aqueous solution of a protective colloid (e.g. polyvinyl alcohol). The addition of a polyamine (e.g. hexamethylenediamine) results in the formation of polyurea microcapsules. The monomers amount to 1-10% by weight of the total CS composition.
1-10% by weight of at least one compound of formula (I) are ground finely and mixed intimately with such amount of solid carrier, e.g. finely divided kaolin, to result in a total amount of 100% by weight.
xii) Granules (GR, FG)
0.5-30% by weight of at least one compound of formula (I) are ground finely and associated with such amount of solid carrier (e.g. silicate) to result in a total amount of 100% by weight. Granulation is achieved by extrusion, spray-drying or the fluidized bed.
xiii) Ultra-low volume liquids (UL)
1-50% by weight of at least one compound of formula (I) are dissolved in such amount of organic solvent, e.g. aromatic hydrocarbon, to result in a total amount of 100% by weight.
The compositions types i) to xiii) may optionally comprise further auxiliaries, such as 0.1-1% by weight preservatives, 0.1-1% by weight antifoams, 0.1-1% by weight dyes and/or pigments, and 5-10% by weight antifreezes.
The compound of formula (I) and the composition of the invention can be mixed with other active ingredients like fungicides, bactericides, acaricides, nematicides, insecticides, biological control agents or herbicides. Mixtures with fertilizers, growth regulators, safeners, nitrification inhibitors, semiochemicals and/or other agriculturally beneficial agents are also possible. This may allow to broaden the activity spectrum or to prevent development of resistance. Examples of known fungicides, insecticides, acaricides, nematicides and bactericides are disclosed in the Pesticide Manual, 17th Edition.
Examples of fungicides which could be mixed with the compound of formula (I) and the composition of the invention are:
All named mixing partners of the classes (1) to (15) as described here above can be present in the form of the free compound or, if their functional groups enable this, an agrochemically active salt thereof.
The compound of formula (I) and the composition of the invention may also be combined with one or more biological control agents.
As used herein, the term “biological control” is defined as control of harmful organisms such as a phytopathogenic fungi and/or insects and/or acarids and/or nematodes by the use or employment of a biological control agent.
As used herein, the term “biological control agent” is defined as an organism other than the harmful organisms and/or proteins or secondary metabolites produced by such an organism for the purpose of biological control. Mutants of the second organism shall be included within the definition of the biological control agent. The term “mutant” refers to a variant of the parental strain as well as methods for obtaining a mutant or variant in which the pesticidal activity is greater than that expressed by the parental strain. The “parent strain” is defined herein as the original strain before mutagenesis. To obtain such mutants the parental strain may be treated with a chemical such as N-methyl-N′-nitro-N-nitrosoguanidine, ethylmethanesulfone, or by irradiation using gamma, x-ray, or UV-irradiation, or by other means well known to those skilled in the art. Known mechanisms of biological control agents comprise enteric bacteria that control root rot by out-competing fungi for space on the surface of the root. Bacterial toxins, such as antibiotics, have been used to control pathogens. The toxin can be isolated and applied directly to the plant or the bacterial species may be administered so it produces the toxin in situ.
A “variant” is a strain having all the identifying characteristics of the NRRL or ATCC Accession Numbers as indicated in this text and can be identified as having a genome that hybridizes under conditions of high stringency to the genome of the NRRL or ATCC Accession Numbers.
“Hybridization” refers to a reaction in which one or more polynucleotides react to form a complex that is stabilized via hydrogen bonding between the bases of the nucleotide residues. The hydrogen bonding may occur by Watson-Crick base pairing, Hoogstein binding, or in any other sequence-specific manner. The complex may comprise two strands forming a duplex structure, three or more strands forming a multi-stranded complex, a single self-hybridizing strand, or any combination of these. Hybridization reactions can be performed under conditions of different “stringency”. In general, a low stringency hybridization reaction is carried out at about 40° C. in 10×SSC or a solution of equivalent ionic strength/temperature. A moderate stringency hybridization is typically performed at about 50° C. in 6×SSC, and a high stringency hybridization reaction is generally performed at about 60° C. in 1×SSC.
A variant of the indicated NRRL or ATCC Accession Number may also be defined as a strain having a genomic sequence that is greater than 85%, more preferably greater than 90% or more preferably greater than 95% sequence identity to the genome of the indicated NRRL or ATCC Accession Number. A polynucleotide or polynucleotide region (or a polypeptide or polypeptide region) has a certain percentage (for example, 80%, 85%, 90%, or 95%) of “sequence identity” to another sequence means that, when aligned, that percentage of bases (or amino acids) are the same in comparing the two sequences. This alignment and the percent homology or sequence identity can be determined using software programs known in the art, for example, those described in Current Protocols in Molecular Biology (F. M. Ausubel et al., eds., 1987).
NRRL is the abbreviation for the Agricultural Research Service Culture Collection, an international depositary authority for the purposes of deposing microorganism strains under the Budapest treaty on the international recognition of the deposit of microorganisms for the purposes of patent procedure, having the address National Center for Agricultural Utilization Research, Agricultural Research service, U.S. Department of Agriculture, 1815 North university Street, Peoria, Illinois 61604 USA.
ATCC is the abbreviation for the American Type Culture Collection, an international depositary authority for the purposes of deposing microorganism strains under the Budapest treaty on the international recognition of the deposit of microorganisms for the purposes of patent procedure, having the address ATCC Patent Depository, 10801 University Blvd., Manassas, VA 10110 USA.
Examples of biological control agents which may be combined with the compound of formula (I) and the composition of the invention are:
The compound of formula (I) and the composition of the invention may be combined with one or more active ingredients selected from insecticides, acaricides and nematicides.
“Insecticides” as well as the term “insecticidal” refers to the ability of a substance to increase mortality or inhibit growth rate of insects. As used herein, the term “insects” comprises all organisms in the class “Insecta”.
“Nematicide” and “nematicidal” refers to the ability of a substance to increase mortality or inhibit the growth rate of nematodes. In general, the term “nematode” comprises eggs, larvae, juvenile and mature forms of said organism.
“Acaricide” and “acaricidal” refers to the ability of a substance to increase mortality or inhibit growth rate of ectoparasites belonging to the class Arachnida, sub-class Acari.
Examples of insecticides, acaricides and nematicides, respectively, which could be mixed with the compound of formula (I) and the composition of the invention are:
Further active ingredients with unknown or uncertain mode of action, for example Afidopyropen, Afoxolaner, Azadirachtin, Benclothiaz, Benzoximate, Bifenazate, Broflanilide, Bromopropylate, Chinomethionat, Cryolite, Cyclaniliprole, Cycloxaprid, Cyhalodiamide Dicloromezotiaz, Dicofol, Diflovidazin, Flometoquin, Fluazaindolizine, Fluensulfone, Flufenerim, Flufenoxystrobin, Flufiprole, Fluhexafon, Fluopyram, Fluralaner, Fluxametamide, Fufenozide, Guadipyr, Heptafluthrin, Imidaclothiz, Iprodione, Lotilaner, Meperfluthrin, Paichongding, Pyflubumide, Pyridalyl, Pyrifluquinazon, Pyriminostrobin, Sarolaner, Tetramethylfluthrin, Tetraniliprole, Tetrachlorantraniliprole, Tioxazafen, Thiofluoximate, Triflumezopyrim and Iodomethane; furthermore products based on Bacillus firmus (including but not limited to strain CNCM I-1582, such as, for example, VOTiVO™, BioNem) or one of the following known active compounds: 1-{2-fluoro-4-methyl-5-[(2,2,2-trifluoro-ethyl)sulfinyl]phenyl}-3-(trifluoromethyl)-1H-1,2,4-triazol-5-amine (known from WO2006/043635), {1′-[(2E)-3-(4-chlorophenyl)prop-2-en-1-yl]-5-fluorospiro[indole-3,4′-piperidin]-1(2H)-yl}(2-chloro-pyridin-4-yl)methanone (known from WO2003/106457), 2-chloro-N-[2-{1-[(2E)-3-(4-chlorophenyl)prop-2-en-1-yl]piperidin-4-yl}-4-(trifluoromethyl)phenyl]isonicotinamide (known from WO2006/003494), 3-(2,5-dimethylphenyl)-4-hydroxy-8-methoxy-1,8-diazaspiro[4.5]dec-3-en-2-one (known from WO2009/049851), 3-(2,5-dimethylphenyl)-8-methoxy-2-oxo-1,8-diazaspiro[4.5]dec-3-en-4-yl ethyl carbonate (known from WO2009/049851), 4-(but-2-yn-1-yloxy)-6-(3,5-dimethylpiperidin-1-yl)-5-fluoropyrimidine (known from WO2004/099160), 4-(but-2-yn-1-yloxy)-6-(3-chlorophenyl)pyrimidine (known from WO2003/076415), PF1364 (CAS-Reg. No. 1204776-60-2), methyl 2-[2-({[3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl]carbonyl}amino)-5-chloro-3-methylbenzoyl]-2-methylhydrazinecarboxylate (known from WO2005/085216), methyl 2-[2-({[3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl]carbonyl}amino)-5-cyano-3-methylbenzoyl]-2-ethylhydrazinecarboxylate (known from WO2005/085216), methyl 2-[2-({[3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl]carbonyl}amino)-5-cyano-3-methylbenzoyl]-2-methylhydrazinecarboxylate (known from WO2005/085216), methyl 2-[3,5-dibromo-2-({[3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl]carbonyl}amino)benzoyl]-2-ethylhydrazinecarboxylate (known from WO2005/085216), N-[2-(5-amino-1,3,4-thiadiazol-2-yl)-4-chloro-6-methylphenyl]-3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazole-5-carboxamide (known from CN102057925), 8-chloro-N-[(2-chloro-5-methoxyphenyl)sulfonyl]-6-(trifluoromethyl)imidazo[1,2-a]pyridine-2-carboxamide (known from WO2009/080250), N-[(2E)-1-[(6-chloropyridin-3-yl)methyl]pyridin-2(1H)-ylidene]-2,2,2-trifluoroacetamide (known from WO2012/029672), 1-[(2-chloro-1,3-thiazol-5-yl)methyl]-4-oxo-3-phenyl-4H-pyrido[1,2-a]pyrimidin-1-ium-2-olate (known from WO2009/099929), 1-[(6-chloropyridin-3-yl)methyl]-4-oxo-3-phenyl-4H-pyrido[1,2-a]pyrimidin-1-ium-2-olate (known from WO2009/099929), 4-(3-{2,6-dichloro-4-[(3,3-dichloroprop-2-en-1-yl)oxy]phenoxy}propoxy)-2-methoxy-6-(trifluoromethyl)pyrimidine (known from CN101337940), N-[2-(tert-butylcarbamoyl)-4-chloro-6-methylphenyl]-1-(3-chloropyridin-2-yl)-3-(fluoromethoxy)-1H-pyrazole-5-carboxamide (known from WO2008/134969), butyl [2-(2,4-dichlorophenyl)-3-oxo-4-oxaspiro[4.5]dec-1-en-1-yl]carbonate (known from CN 102060818), 3E)-3-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-1,1,1-trifluoro-propan-2-one (known from WO2013/144213), N-(methylsulfonyl)-6-[2-(pyridin-3-yl)-1,3-thiazol-5-yl]pyridine-2-carboxamide (known from WO2012/000896), N-[3-(benzylcarbamoyl)-4-chlorophenyl]-1-methyl-3-(pentafluoroethyl)-4-(trifluoromethyl)-1H-pyrazole-5-carboxamide (known from WO2010/051926), 5-bromo-4-chloro-N-[4-chloro-2-methyl-6-(methylcarbamoyl)phenyl]-2-(3-chloro-2-pyridyl)pyrazole-3-carboxamido (known from CN103232431), ), Tioxazafen, 4-[5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-2-methyl-N-(cis-1-oxido-3-thietanyl)-benzamide, 4-[5-(3,5-dichloro-phenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-2-methyl-N-(trans-1-oxido-3-thietanyl)-benzamide and 4-[(5S)-5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-2-methyl-N-(cis-1-oxido-3-thietanyl)benzamide (known from WO 2013050317 A1), N-[3-chloro-1-(3-pyridinyl)-1H-pyrazol-4-yl]-N-ethyl-3-[(3,3,3-trifluoropropyl)sulfinyl]-propanamide, (+)—N-[3-chloro-1-(3-pyridinyl)-1H-pyrazol-4-yl]-N-ethyl-3-[(3,3,3-trifluoropropyl)sulfinyl]-propanamide and (−)—N-[3-chloro-1-(3-pyridinyl)-1H-pyrazol-4-yl]-N-ethyl-3-[(3,3,3-trifluoropropyl)sulfinyl]-propanamide (known from WO 2013162715 A2, WO 2013162716 A2, US 20140213448 A1), 5-[[(2E)-3-chloro-2-propen-1-yl]amino]-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-[(trifluoromethyl)sulfinyl]-1H-pyrazole-3-carbonitrile (known from CN 101337937 A), 3-bromo-N-[4-chloro-2-methyl-6-[(methylamino)thioxomethyl]phenyl]-1-(3-chloro-2-pyridinyl)-1H-pyrazole-5-carboxamide, (Liudaibenjiaxuanan, known from CN 103109816 A); N-[4-chloro-2-[[(1,1-dimethyl-ethyl)amino]carbonyl]-6-methylphenyl]-1-(3-chloro-2-pyridinyl)-3-(fluoromethoxy)-1H-Pyrazole-5-carboxamide (known from WO 2012034403 A1), N-[2-(5-amino-1,3,4-thiadiazol-2-yl)-4-chloro-6-methylphenyl]-3-bromo-1-(3-chloro-2-pyridinyl)-1H-pyrazole-5-carboxamide (known from WO 2011085575 A1), 4-[3-[2,6-dichloro-4-[(3,3-dichloro-2-propen-1-yl)oxy]phenoxy]propoxy]-2-methoxy-6-(trifluoromethyl)-pyrimidine (known from CN 101337940 A); (2E)- and 2(Z)-2-[2-(4-cyanophenyl)-1-[3-(trifluoromethyl)phenyl]ethylidene]-N-[4-(difluoromethoxy)phenyl]-hydrazinecarboxamide (known from CN 101715774 A); 3-(2,2-dichloroethenyl)-2,2-dimethyl-4-(1H-benzimidazol-2-yl)phenyl-cyclopropanecarboxylic acid ester (known from CN 103524422 A); (4aS)-7-chloro-2,5-dihydro-2-[[(methoxycarbonyl)[4-[(trifluoromethyl)thio]phenyl]amino]carbonyl]-indeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylic acid methyl ester (known from CN 102391261 A).
Examples of herbicides which could be mixed with the compound of formula (I) and the composition of the invention are:
Acetochlor, acifluorfen, acifluorfen-sodium, aclonifen, alachlor, allidochlor, alloxydim, alloxydim-sodium, ametryn, amicarbazone, amidochlor, amidosulfuron, 4-amino-3-chloro-5-fluoro-6-(7-fluoro-1H-indol-6-yl)pyridine-2-carboxylic acid, aminocyclopyrachlor, aminocyclopyrachlor-potassium, aminocyclopyrachlor-methyl, aminopyralid, amitrole, ammoniumsulfamate, anilofos, asulam, atrazine, azafenidin, azimsulfuron, beflubutamid, benazolin, benazolin-ethyl, benfluralin, benfuresate, bensulfuron, bensulfuron-methyl, bensulide, bentazone, benzobicyclon, benzofenap, bicyclopyron, bifenox, bilanafos, bilanafos-sodium, bispyribac, bispyribac-sodium, bixlozone, bromacil, bromobutide, bromofenoxim, bromoxynil, bromoxynil-butyrate, -potassium, -heptanoate, and -octanoate, busoxinone, butachlor, butafenacil, butamifos, butenachlor, butralin, butroxydim, butylate, cafenstrole, carbetamide, carfentrazone, carfentrazone-ethyl, chloramben, chlorbromuron, 1-{2-chloro-3-[(3-cyclopropyl-5-hydroxy-1-methyl-1H-pyrazol-4-yl)carbonyl]-6-(trifluormethyl)phenyl}piperidin-2-on, 4-{2-chloro-3-[(3,5-dimethyl-1H-pyrazol-1-yl)methyl]-4-(methylsulfonyl)benzoyl}-1,3-dimethyl-1H-pyrazol-5-yl-1,3-dimethyl-1H-pyrazol-4-carboxylat, chlorfenac, chlorfenac-sodium, chlorfenprop, chlorflurenol, chlorflurenol-methyl, chloridazon, chlorimuron, chlorimuron-ethyl, 2-[2-chloro-4-(methylsulfonyl)-3-(morpholin-4-ylmethyl)benzoyl]-3-hydroxycyclohex-2-en-1-on, 4-{2-chloro-4-(methylsulfonyl)-3-[(2,2,2-trifluoroethoxy)methyl]benzoyl}-1-ethyl-1H-pyrazol-5-yl-1,3-dimethyl-1H-pyrazol-4-carboxylat, chlorophthalim, chlorotoluron, chlorthal-dimethyl, 3-[5-chloro-4-(trifluormethyl)pyridine-2-yl]-4-hydroxy-1-methylimidazolidine-2-on, chlorsulfuron, cinidon, cinidon-ethyl, cinmethylin, cinosulfuron, clacyfos, clethodim, clodinafop, clodinafop-propargyl, clomazone, clomeprop, clopyralid, cloransulam, cloransulam-methyl, cumyluron, cyanamide, cyanazine, cycloate, cyclopyranil, cyclopyrimorate, cyclosulfamuron, cycloxydim, cyhalofop, cyhalofop-butyl, cyprazine, 2,4-D, 2,4-D-butotyl, -butyl, -dimethylammonium, -diolamin, -ethyl, -2-ethylhexyl, -isobutyl, -isooctyl, -isopropylammonium, -potassium, -triisopropanolammonium, and -trolamine, 2,4-DB, 2,4-DB-butyl, -dimethylammonium, -isooctyl, -potassium, and -sodium, daimuron (dymron), dalapon, dazomet, n-decanol, desmedipham, detosyl-pyrazolate (DTP), dicamba, dichlobenil, dichlorprop, dichlorprop-P, diclofop, diclofop-methyl, diclofop-P-methyl, diclosulam, difenzoquat, diflufenican, diflufenzopyr, diflufenzopyr-sodium, dimefuron, dimepiperate, dimethachlor, dimethametryn, dimethenamid, dimethenamid-P, 3-(2,6-dimethylphenyl)-6-[(2-hydroxy-6-oxocyclohex-1-en-1-yl)carbonyl]-1-methylchinazolin-2,4(1H,3H)-dion, 1,3-dimethyl-4-[2-(methylsulfonyl)-4-(trifluormethyl)benzoyl]-1H-pyrazol-5-yl-1,3-dimethyl-1H-pyrazol-4-carboxylat, dimetrasulfuron, dinitramine, dinoterb, diphenamid, diquat, diquat-dibromid, dithiopyr, diuron, DMPA, DNOC, endothal, EPTC, esprocarb, ethalfluralin, ethametsulfuron, etha-metsulfuron-methyl, ethiozin, ethofumesate, ethoxyfen, ethoxyfen-ethyl, ethoxysulfuron, etobenzanid, ethyl-[(3-{2-chloro-4-fluoro-5-[3-methyl-2,6-dioxo-4-(trifluormethyl)-3,6-dihydropyrimidin-1(2H)-yl]phenoxy}pyridin-2-yl)oxy]acetat, F-9960, F-5231, i.e. N-{2-chloro-4-fluoro-5-[4-(3-fluoropropyl)-5-oxo-4,5-dihydro-1H-tetrazol-1-yl]phenyl}ethanesulfonamide, F-7967, i. e. 3-[7-chloro-5-fluoro-2-(trifluoromethyl)-1H-benzimidazol-4-yl]-1-methyl-6-(trifluoromethyl)pyrimidine-2,4(1H,3H)-dione, fenoxaprop, fenoxaprop-P, fenoxaprop-ethyl, fenoxaprop-P-ethyl, fenoxasulfone, fenquinotrione, fentrazamide, flamprop, flamprop-M-isopropyl, flamprop-M-methyl, flazasulfuron, florasulam, fluazifop, fluazifop-P, fluazifop-butyl, fluazifop-P-butyl, flucarbazone, flucarbazone-sodium, flucetosulfuron, fluchloralin, flufenacet, flufenpyr, flufenpyr-ethyl, flumetsulam, flumiclorac, flumiclorac-pentyl, flumioxazin, fluometuron, flurenol, flurenol-butyl, -dimethylammonium and -methyl, fluoroglycofen, fluoroglycofen-ethyl, flupropanate, flupyrsulfuron, flupyrsulfuron-methyl-sodium, fluridone, flurochloridone, fluroxypyr, fluroxypyr-meptyl, flurtamone, fluthiacet, fluthiacet-methyl, fomesafen, fomesafen-sodium, foramsulfuron, fosamine, glufosinate, glufosinate-ammonium, glufosinate-P-sodium, glufosinate-P-ammonium, glufosinate-P-sodium, glyphosate, glyphosate-ammonium, -isopropylammonium, -diammonium, -dimethylammonium, -potassium, -sodium, and -trimesium, H-9201, i.e. O-(2,4-dimethyl-6-nitrophenyl)O-ethyl isopropylphosphoramidothioate, halauxifen, halauxifen-methyl, halosafen, halosulfuron, halosulfuron-methyl, haloxyfop, haloxyfop-P, haloxyfop-ethoxyethyl, haloxyfop-P-ethoxyethyl, haloxyfop-methyl, haloxyfop-P-methyl, hexazinone, HW-02, i.e. 1-(dimethoxyphosphoryl) ethyl-(2,4-dichlorophenoxy)acetate, 4-hydroxy-1-methoxy-5-methyl-3-[4-(trifluormethyl)pyridine-2-yl]imidazolidine-2-on, 4-hydroxy-1-methyl-3-[4-(trifluormethyl)pyridine-2-yl]imidazolidine-2-on, (5-hydroxy-1-methyl-1H-pyrazol-4-yl)(3,3,4-trimethyl-1,1-dioxido-2,3-dihydro-1-benzothiophen-5-yl)methanon, 6-[(2-hydroxy-6-oxocyclohex-1-en-1-yl)carbonyl]-1,5-dimethyl-3-(2-methylphenyl)chinazolin-2,4(1H,3H)-dion, imazamethabenz, imazamethabenz-methyl, imazamox, imazamox-ammonium, imazapic, imazapic-ammonium, imazapyr, imazapyr-isopropylammonium, imazaquin, imazaquin-ammonium, imazethapyr, imazethapyr-immonium, imazosulfuron, indanofan, indaziflam, iodosulfuron, iodosulfuron-methyl-sodium, ioxynil, ioxynil-octanoate, -potassium and -sodium, ipfencarbazone, isoproturon, isouron, isoxaben, isoxaflutole, karbutilate, KUH-043, i.e. 3-({[5-(difluoromethyl)-1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]methyl}sulfonyl)-5,5-dimethyl-4,5-dihydro-1,2-oxazole, ketospiradox, lactofen, lenacil, linuron, MCPA, MCPA-butotyl, -dimethylammonium, -2-ethylhexyl, -isopropylammonium, -potassium, and -sodium, MCPB, MCPB-methyl, -ethyl, and -sodium, mecoprop, mecoprop-sodium, and -butotyl, mecoprop-P, mecoprop-P-butotyl, -dimethylammonium, -2-ethylhexyl, and -potassium, mefenacet, mefluidide, mesosulfuron, mesosulfuron-methyl, mesotrione, methabenzthiazuron, metam, metamifop, metamitron, metazachlor, metazosulfuron, methabenzthiazuron, methiopyrsulfuron, methiozolin, 2-({2-[(2-methoxy-ethoxy)methyl]-6-(trifluormethyl)pyridin-3-yl}carbonyl)cyclohexan-1,3-dion, methyl isothiocyanate, 1-methyl-4-[(3,3,4-trimethyl-1,1-dioxido-2,3-dihydro-1-benzothiophen-5-yl)carbonyl]-1H-pyrazol-5-ylpropan-1-sulfonat, metobromuron, metolachlor, S-metolachlor, metosulam, metoxuron, metribuzin, metsulfuron, metsulfuron-methyl, molinat, monolinuron, monosulfuron, monosulfuron-ester, MT-5950, i.e. N-(3-chloro-4-isopropylphenyl)-2-methylpentan amide, NGGC-011, napropamide, NC-310, i.e. [5-(benzyloxy)-1-methyl-1H-pyrazol-4-yl](2,4-dichlorophenyl)methanone, neburon, nicosulfuron, nonanoic acid (pelargonic acid), norflurazon, oleic acid (fatty acids), orbencarb, orthosulfamuron, oryzalin, oxadiargyl, oxadiazon, oxasulfuron, oxaziclomefon, oxyfluorfen, paraquat, paraquat dichloride, pebulate, pendimethalin, penoxsulam, pentachlorphenol, pentoxazone, pethoxamid, petroleum oils, phenmedipham, picloram, picolinafen, pinoxaden, piperophos, pretilachlor, primisulfuron, primisulfuron-methyl, prodiamine, profoxydim, prometon, prometryn, propachlor, propanil, propaquizafop, propazine, propham, propisochlor, propoxycarbazone, propoxycarbazone-sodium, propyrisulfuron, propyzamide, prosulfocarb, prosulfuron, pyraclonil, pyraflufen, pyraflufen-ethyl, pyrasulfotole, pyrazolynate (pyrazolate), pyrazosulfuron, pyrazosulfuron-ethyl, pyrazoxyfen, pyribambenz, pyribambenz-isopropyl, pyribambenz-propyl, pyribenzoxim, pyributicarb, pyridafol, pyridate, pyriftalid, pyriminobac, pyriminobac-methyl, pyrimisulfan, pyrithiobac, pyrithiobac-sodium, pyroxasulfone, pyroxsulam, quinclorac, quinmerac, quinoclamine, quizalofop, quizalofop-ethyl, quizalofop-P, quizalofop-P-ethyl, quizalofop-P-tefuryl, QYM-201, QYR-301, rimsulfuron, saflufenacil, sethoxydim, siduron, simazine, simetryn, SL-261, sulcotrion, sulfentrazone, sulfometuron, sulfometuron-methyl, sulfosulfuron, SYN-523, SYP-249, i.e. 1-ethoxy-3-methyl-1-oxobut-3-en-2-yl 5-[2-chloro-4-(trifluoromethyl)phenoxy]-2-nitrobenzoate, SYP-300, i.e. 1-[7-fluoro-3-oxo-4-(prop-2-yn-1-yl)-3,4-dihydro-2H-1,4-benzoxazin-6-yl]-3-propyl-2-thioxoimidazolidine-4,5-dione, 2,3,6-TBA, TCA (trichloroacetic acid), TCA-sodium, tebuthiuron, tefuryltrione, tembotrione, tepraloxydim, terbacil, terbucarb, terbumeton, terbuthylazin, terbutryn, tetflupyrolimet, thenylchlor, thiazopyr, thiencarbazone, thiencarbazone-methyl, thifensulfuron, thifensulfuron-methyl, thiobencarb, tiafenacil, tolpyralate, topramezone, tralkoxydim, triafamone, tri-allate, triasulfuron, triaziflam, tribenuron, tribenuron-methyl, triclopyr, trietazine, trifloxysulfuron, trifloxysulfuron-sodium, trifludimoxazin, trifluralin, triflusulfuron, triflusulfuron-methyl, tritosulfuron, urea sulfate, vernolate, ZJ-0862, i.e. 3,4-dichloro-N-{2-[(4,6-dimethoxypyrimidin-2-yl)oxy]benzyl}aniline.
Examples for plant growth regulators are:
Acibenzolar, acibenzolar-S-methyl, 5-aminolevulinic acid, ancymidol, 6-benzylaminopurine, Brassinolid, catechine, chlormequat chloride, cloprop, cyclanilide, 3-(cycloprop-1-enyl) propionic acid, daminozide, dazomet, n-decanol, dikegulac, dikegulac-sodium, endothal, endothal-dipotassium, -disodium, and -mono(N,N-dimethylalkylammonium), ethephon, flumetralin, flurenol, flurenol-butyl, flurprimidol, forchlorfenuron, gibberellic acid, inabenfide, indol-3-acetic acid (IAA), 4-indol-3-ylbutyric acid, isoprothiolane, probenazole, jasmonic acid, maleic hydrazide, mepiquat chloride, 1-methylcyclopropene, methyl jasmonate, 2-(1-naphthyl)acetamide, 1-naphthylacetic acid, 2-naphthyloxyacetic acid, nitrophenolate-mixture, paclobutrazol, N-(2-phenylethyl)-beta-alanine, N-phenylphthalamic acid, prohexadione, prohexadione-calcium, prohydrojasmone, salicylic acid, strigolactone, tecnazene, thidiazuron, triacontanol, trinexapac, trinexapac-ethyl, tsitodef, uniconazole, uniconazole-P.
Examples of safeners which could be mixed with the compound of formula (I) and the composition of the invention are, for example, benoxacor, cloquintocet (-mexyl), cyometrinil, cyprosulfamide, dichlormid, fenchlorazole (-ethyl), fenclorim, flurazole, fluxofenim, furilazole, isoxadifen (-ethyl), mefenpyr (-diethyl), naphthalic anhydride, oxabetrinil, 2-methoxy-N-({4-[(methylcarbamoyl)amino]phenyl}-sulphonyl)benzamide (CAS 129531-12-0), 4-(dichloroacetyl)-1-oxa-4-azaspiro[4.5]decane (CAS 71526-07-3), 2,2,5-trimethyl-3-(dichloroacetyl)-1,3-oxazolidine (CAS 52836-31-4).
Examples of nitrification inhibitors which can be mixed with the compound of formula (I) and the composition of the invention are selected from the group consisting of 2-(3,4-dimethyl-1H-pyrazol-1-yl)succinic acid, 2-(4,5-dimethyl-1H-pyrazol-1-yl)succinic acid, 3,4-dimethyl pyrazolium glycolate, 3,4-dimethyl pyrazolium citrate, 3,4-dimethyl pyrazolium lactate, 3,4-dimethyl pyrazolium mandelate, 1,2,4-triazole, 4-Chloro-3-methylpyrazole, N-((3(5)-methyl-1H-pyrazole-1-yl)methyl)acetamide, N-((3(5)-methyl-1H-pyrazole-1-yl)methyl)formamide, N-((3(5),4-dimethylpyrazole-1-yl)methyl)formamide, N-((4-chloro-3(5)-methyl-pyrazole-1-yl)methyl)formamide; reaction adducts of dicyandiamide, urea and formaldehyde, triazonyl-formaldehyde-dicyandiamide adducts, 2-cyano-1-((4-oxo-1,3,5-triazinan-1-yl)methyl)guanidine, 1-((2-cyanoguanidino)methyl)urea, 2-cyano-1-((2-cyanoguanidino)methyl)-guanidine, 2-chloro-6-(trichloromethyl)-pyridine (nitrapyrin or N-serve), dicyandiamide, 3,4-dimethyl pyrazole phosphate, 4,5-dimethyl pyrazole phosphate, 3,4-dimethylpyrazole, 4,5-dimethyl pyrazole, ammoniumthiosulfate, neem, products based on ingredients of neem, linoleic acid, alpha-linolenic acid, methyl p-coumarate, methyl ferulate, methyl 3-(4-hydroxyphenyl) propionate, karanjin, brachialacton, p-benzoquinone sorgoleone, 4-amino-1,2,4-triazole hydrochloride, 1-amido-2-thiourea, 2-amino-4-chloro-6-methylpyrimidine, 2-mercapto-benzothiazole, 5-ethoxy-3-trichloromethyl-1,2,4-thiodiazole (terrazole, etridiazole), 2-sulfanilamidothiazole, 3-methylpyrazol, 1,2,4-triazol thiourea, cyan amide, melamine, zeolite powder, catechol, benzoquinone, sodium tetraborate, allylthiourea, chlorate salts, and zinc sulfate.
The compound of formula (I) and the composition of the invention may be combined with one or more agriculturally beneficial agents.
Examples of agriculturally beneficial agents include biostimulants, plant growth regulators, plant signal molecules, growth enhancers, microbial stimulating molecules, biomolecules, soil amendments, nutrients, plant nutrient enhancers, etc., such as lipo-chitooligosaccharides (LCO), chitooligosaccharides (CO), chitinous compounds, flavonoids, jasmonic acid or derivatives thereof (e.g., jasmonates), cytokinins, auxins, gibberellins, absiscic acid, ethylene, brassinosteroids, salicylates, macro- and micro-nutrients, linoleic acid or derivatives thereof, linolenic acid or derivatives thereof, karrikins, and beneficial microorganisms (e.g., Rhizobium spp., Bradyrhizobium spp., Sinorhizobium spp., Azorhizobium spp., Glomus spp., Gigaspora spp., Hymenoscyphous spp., Oidiodendron spp., Laccaria spp., Pisolithus spp., Rhizopogon spp., Scleroderma spp., Rhizoctonia spp., Acinetobacter spp., Arthrobacter spp., Arthrobotrys spp., Aspergillus spp., Azospirillum spp., Bacillus spp., Burkholderia spp., Candida spp., Chryseomonas spp., Enterobacter spp., Eupenicillium spp., Exiguobacterium spp., Klebsiella spp., Kluyvera spp., Microbacterium spp., Mucor spp., Paecilomyces spp., Paenibacillus spp., Penicillium spp., Pseudomonas spp., Serratia spp., Stenotrophomonas spp., Streptomyces spp., Streptosporangium spp., Swaminathania spp., Thiobacillus spp., Torulospora spp., Vibrio spp., Xanthobacter spp., Xanthomonas spp., etc.), and combinations thereof.
The compounds of formula (I) and the compositions of the invention have potent microbicidal activity and/or plant defense modulating potential. They can be used for controlling unwanted microorganisms, such as unwanted fungi and bacteria, on plants. They can be particularly useful in crop protection (they control microorganisms that cause plants diseases) or for protecting materials (e.g. industrial materials, timber, storage goods) as described in more details herein below. More specifically, the compound of formula (I) and the composition of the invention can be used to protect seeds, germinating seeds, emerged seedlings, plants, plant parts, fruits, harvest goods and/or the soil in which the plants grow from unwanted microorganisms.
Control or controlling as used herein encompasses protective, curative and eradicative treatment of unwanted microorganisms. Unwanted microorganisms may be pathogenic bacteria, pathogenic virus, pathogenic oomycetes or pathogenic fungi, more specifically phytopathogenic bacteria, phytopathogenic virus, phytopathogenic oomycetes or phytopathogenic fungi. As detailed herein below, these phytopathogenic microorganims are the causal agents of a broad spectrum of plants diseases.
More specifically, the compound of formula (I) and the composition of the invention can be used as fungicides. For the purpose of the specification, the term “fungicide” refers to a compound or composition that can be used in crop protection for the control of unwanted fungi, such as Plasmodiophoromycetes, Chytridiomycetes, Zygomycetes, Ascomycetes, Basidiomycetes and Deuteromycetes and/or for the control of Oomycetes.
The compound of formula (I) and the composition of the invention may also be used as antibacterial agent. In particular, they may be used in crop protection, for example for the control of unwanted bacteria, such as Pseudomonadaceae, Rhizobiaceae, Xanthomonadaceae, Enterobacteriaceae, Corynebacteriaceae and Streptomycetaceae.
The compound of formula (I) and the composition of the invention may also be used as antiviral agent in crop protection. For example the compound of formula (I) and the composition of the invention may have effects on diseases from plant viruses, such as the tobacco mosaic virus (TMV), tobacco rattle virus, tobacco stunt virus (TStuV), tobacco leaf curl virus (VLCV), tobacco nervilia mosaic virus (TVBMV), tobacco necrotic dwarf virus (TNDV), tobacco streak virus (TSV), potato virus X (PVX), potato viruses Y, S, M, and A, potato acuba mosaic virus (PAMV), potato mop-top virus (PMTV), potato leaf-roll virus (PLRV), alfalfa mosaic virus (AMV), cucumber mosaic virus (CMV), cucumber green mottlemosaic virus (CGMMV), cucumber yellows virus (CuYV), watermelon mosaic virus (WMV), tomato spotted wilt virus (TSWV), tomato ringspot virus (TomRSV), sugarcane mosaic virus (SCMV), rice drawf virus, rice stripe virus, rice black-streaked drawf virus, strawberry mottle virus (SMoV), strawberry vein banding virus (SVBV), strawberry mild yellow edge virus (SMYEV), strawberry crinkle virus (SCrV), broad beanwilt virus (BBWV), and melon necrotic spot virus (MNSV).
The present invention also relates to a method for controlling unwanted microorganisms, such as unwanted fungi, oomycetes and bacteria, on plants comprising the step of applying at least one compound of formula (I) or at least one composition of the invention to the microorganisms and/or their habitat (to the plants, plant parts, seeds, fruits or to the soil in which the plants grow).
Typically, when the compound of formula (I) and the composition of the invention are used in curative or protective methods for controlling phytopathogenic fungi and/or phytopathogenic oomycetes, an effective and plant-compatible amount thereof is applied to the plants, plant parts, fruits, seeds or to the soil or substrates in which the plants grow. Suitable substrates that may be used for cultivating plants include inorganic based substrates, such as mineral wool, in particular stone wool, perlite, sand or gravel; organic substrates, such as peat, pine bark or sawdust; and petroleum-based substrates such as polymeric foams or plastic beads. Effective and plant-compatible amount means an amount that is sufficient to control or destroy the fungi present or liable to appear on the cropland and that does not entail any appreciable symptom of phytotoxicity for said crops. Such an amount can vary within a wide range depending on the fungus to be controlled, the type of crop, the crop growth stage, the climatic conditions and the respective compound or composition of the invention used. This amount can be determined by systematic field trials that are within the capabilities of a person skilled in the art.
The compound of formula (I) and the composition of the invention may be applied to any plants or plant parts.
Plants mean all plants and plant populations, such as desired and undesired wild plants or crop plants (including naturally occurring crop plants). Crop plants may be plants which can be obtained by conventional breeding and optimization methods or by biotechnological and genetic engineering methods or combinations of these methods, including the genetically modified plants (GMO or transgenic plants) and the plant cultivars which are protectable and non-protectable by plant breeders' rights.
Plant cultivars are understood to mean plants which have new properties (“traits”) and have been obtained by conventional breeding, by mutagenesis or by recombinant DNA techniques. They can be cultivars, varieties, bio- or genotypes.
Plant parts are understood to mean all parts and organs of plants above and below the ground, such as shoots, leaves, needles, stalks, stems, flowers, fruit bodies, fruits, seeds, roots, tubers and rhizomes. The plant parts also include harvested material and vegetative and generative propagation material, for example cuttings, tubers, rhizomes, slips and seeds.
Plants which may be treated in accordance with the methods of the invention include the following: cotton, flax, grapevine, fruit, vegetables, such as Rosaceae sp. (for example pome fruits such as apples and pears, but also stone fruits such as apricots, cherries, almonds and peaches, and soft fruits such as strawberries), Ribesioidae sp., Juglandaceae sp., Betulaceae sp., Anacardiaceae sp., Fagaceae sp., Moraceae sp., Oleaceae sp., Actinidaceae sp., Lauraceae sp., Musaceae sp. (for example banana trees and plantations), Rubiaceae sp. (for example coffee), Theaceae sp., Sterculiceae sp., Rutaceae sp. (for example lemons, oranges and grapefruit); Solanaceae sp. (for example tomatoes), Liliaceae sp., Asteraceae sp. (for example lettuce), Umbelliferae sp., Cruciferae sp., Chenopodiaceae sp., Cucurbitaceae sp. (for example cucumber), Alliaceae sp. (for example leek, onion), Papilionaceae sp. (for example peas); major crop plants, such as Gramineae sp. (for example maize, turf, cereals such as wheat, rye, rice, barley, oats, millet and triticale), Asteraceae sp. (for example sunflower), Brassicaceae sp. (for example white cabbage, red cabbage, broccoli, cauliflower, Brussels sprouts, pak choi, kohlrabi, radishes, and oilseed rape, mustard, horseradish and cress), Fabacae sp. (for example bean, peanuts), Papilionaceae sp. (for example soya bean), Solanaceae sp. (for example potatoes), Chenopodiaceae sp. (for example sugar beet, fodder beet, swiss chard, beetroot); useful plants and ornamental plants for gardens and wooded areas; and genetically modified varieties of each of these plants.
Plants and plant cultivars which may be treated by the above disclosed methods include plants and plant cultivars which are resistant against one or more biotic stresses, i.e. said plants show a better defense against animal and microbial pests, such as against nematodes, insects, mites, phytopathogenic fungi, bacteria, viruses and/or viroids.
Plants and plant cultivars which may be treated by the above disclosed methods include those plants which are resistant to one or more abiotic stresses. Abiotic stress conditions may include, for example, drought, cold temperature exposure, heat exposure, osmotic stress, flooding, increased soil salinity, increased mineral exposure, ozone exposure, high light exposure, limited availability of nitrogen nutrients, limited availability of phosphorus nutrients, shade avoidance.
Plants and plant cultivars which may be treated by the above disclosed methods include those plants characterized by enhanced yield characteristics. Increased yield in said plants may be the result of, for example, improved plant physiology, growth and development, such as water use efficiency, water retention efficiency, improved nitrogen use, enhanced carbon assimilation, improved photosynthesis, increased germination efficiency and accelerated maturation. Yield may furthermore be affected by improved plant architecture (under stress and non-stress conditions), including but not limited to, early flowering, flowering control for hybrid seed production, seedling vigor, plant size, internode number and distance, root growth, seed size, fruit size, pod size, pod or ear number, seed number per pod or ear, seed mass, enhanced seed filling, reduced seed dispersal, reduced pod dehiscence and lodging resistance. Further yield traits include seed composition, such as carbohydrate content and composition for example cotton or starch, protein content, oil content and composition, nutritional value, reduction in anti-nutritional compounds, improved processability and better storage stability.
Plants and plant cultivars which may be treated by the above disclosed methods include plants and plant cultivars which are hybrid plants that already express the characteristic of heterosis or hybrid vigor which results in generally higher yield, vigor, health and resistance towards biotic and abiotic stresses.
The compound of formula (I) can be advantageously used to treat transgenic plants, plant cultivars or plant parts that received genetic material which imparts advantageous and/or useful properties (traits) to these plants, plant cultivars or plant parts. Therefore, it is contemplated that the present invention may be combined with one or more recombinant traits or transgenic event(s) or a combination thereof. For the purposes of this application, a transgenic event is created by the insertion of a specific recombinant DNA molecule into a specific position (locus) within the chromosome of the plant genome. The insertion creates a novel DNA sequence referred to as an “event” and is characterized by the inserted recombinant DNA molecule and some amount of genomic DNA immediately adjacent to/flanking both ends of the inserted DNA. Such trait(s) or transgenic event(s) include, but are not limited to, pest resistance, water use efficiency, yield performance, drought tolerance, seed quality, improved nutritional quality, hybrid seed production, and herbicide tolerance, in which the trait is measured with respect to a plant lacking such trait or transgenic event. Concrete examples of such advantageous and/or useful properties (traits) are better plant growth, vigor, stress tolerance, standability, lodging resistance, nutrient uptake, plant nutrition, and/or yield, in particular improved growth, increased tolerance to high or low temperatures, increased tolerance to drought or to levels of water or soil salinity, enhanced flowering performance, easier harvesting, accelerated ripening, higher yields, higher quality and/or a higher nutritional value of the harvested products, better storage life and/or processability of the harvested products, and increased resistance against animal and microbial pests, such as against insects, arachnids, nematodes, mites, slugs and snails.
Among DNA sequences encoding proteins which confer properties of tolerance to such animal and microbial pests, in particular insects, mention will particularly be made of the genetic material from Bacillus thuringiensis encoding the Bt proteins widely described in the literature and well known to those skilled in the art. Mention will also be made of proteins extracted from bacteria such as Photorhabdus (WO97/17432 and WO98/08932). In particular, mention will be made of the Bt Cry or VIP proteins which include the Cry1A, Cry1Ab, CryIAc, CryIIA, CryIIIA, CryIIIB2, Cry9c Cry2Ab, Cry3Bb and CryIF proteins or toxic fragments thereof and also hybrids or combinations thereof, especially the Cry1F protein or hybrids derived from a Cry1F protein (e.g. hybrid Cry1A-Cry1F proteins or toxic fragments thereof), the Cry1A-type proteins or toxic fragments thereof, preferably the Cry1Ac protein or hybrids derived from the Cry1Ac protein (e.g. hybrid Cry1Ab-Cry1Ac proteins) or the Cry1Ab or Bt2 protein or toxic fragments thereof, the Cry2Ae, Cry2Af or Cry2Ag proteins or toxic fragments thereof, the Cry1A.105 protein or a toxic fragment thereof, the VIP3Aa19 protein, the VIP3Aa20 protein, the VIP3A proteins produced in the COT202 or COT203 cotton events, the VIP3Aa protein or a toxic fragment thereof as described in Estruch et al. (1996), Proc Natl Acad Sci USA. 28; 93(11):5389-94, the Cry proteins as described in WO2001/47952, the insecticidal proteins from Xenorhabdus (as described in WO98/50427), Serratia (particularly from S. entomophila) or Photorhabdus species strains, such as Tc-proteins from Photorhabdus as described in WO98/08932. Also any variants or mutants of any one of these proteins differing in some amino acids (1-10, preferably 1-5) from any of the above named sequences, particularly the sequence of their toxic fragment, or which are fused to a transit peptide, such as a plastid transit peptide, or another protein or peptide, is included herein.
Another and particularly emphasized example of such properties is conferred tolerance to one or more herbicides, for example imidazolinones, sulphonylureas, glyphosate or phosphinothricin. Among DNA sequences encoding proteins which confer properties of tolerance to certain herbicides on the transformed plant cells and plants, mention will be particularly be made to the bar or PAT gene or the Streptomyces coelicolor gene described in WO2009/152359 which confers tolerance to glufosinate herbicides, a gene encoding a suitable EPSPS (5-Enolpyruvylshikimat-3-phosphat-synthase) which confers tolerance to herbicides having EPSPS as a target, especially herbicides such as glyphosate and its salts, a gene encoding glyphosate-n-acetyltransferase, or a gene encoding glyphosate oxidoreductase. Further suitable herbicide tolerance traits include at least one ALS (acetolactate synthase) inhibitor (e.g. WO2007/024782), a mutated Arabidopsis ALS/AHAS gene (e.g. U.S. Pat. No. 6,855,533), genes encoding 2,4-D-monooxygenases conferring tolerance to 2,4-D (2,4-dichlorophenoxyacetic acid) and genes encoding Dicamba monooxygenases conferring tolerance to dicamba (3,6-dichloro-2-methoxybenzoic acid).
Yet another example of such properties is resistance to one or more phytopathogenic fungi, for example Asian Soybean Rust. Among DNA sequences encoding proteins which confer properties of resistance to such diseases, mention will particularly be made of the genetic material from glycine tomentella, for example from any one of publically available accession lines PI441001, PI483224, PI583970, PI446958, PI499939, PI505220, PI499933, PI441008, PI505256 or PI446961 as described in WO2019/103918.
Further and particularly emphasized examples of such properties are increased resistance against bacteria and/or viruses owing, for example, to systemic acquired resistance (SAR), systemin, phytoalexins, elicitors and also resistance genes and correspondingly expressed proteins and toxins.
Particularly useful transgenic events in transgenic plants or plant cultivars which can be treated with preference in accordance with the invention include Event 531/PV-GHBK04 (cotton, insect control, described in WO2002/040677), Event 1143-14A (cotton, insect control, not deposited, described in WO2006/128569); Event 1143-51B (cotton, insect control, not deposited, described in WO2006/128570); Event 1445 (cotton, herbicide tolerance, not deposited, described in US-A 2002-120964 or WO2002/034946); Event 17053 (rice, herbicide tolerance, deposited as PTA-9843, described in WO2010/117737); Event 17314 (rice, herbicide tolerance, deposited as PTA-9844, described in WO2010/117735); Event 281-24-236 (cotton, insect control—herbicide tolerance, deposited as PTA-6233, described in WO2005/103266 or US-A 2005-216969); Event 3006-210-23 (cotton, insect control—herbicide tolerance, deposited as PTA-6233, described in US-A 2007-143876 or WO2005/103266); Event 3272 (corn, quality trait, deposited as PTA-9972, described in WO2006/098952 or US-A 2006-230473); Event 33391 (wheat, herbicide tolerance, deposited as PTA-2347, described in WO2002/027004), Event 40416 (corn, insect control—herbicide tolerance, deposited as ATCC PTA-11508, described in WO 11/075593); Event 43A47 (corn, insect control -herbicide tolerance, deposited as ATCC PTA-11509, described in WO2011/075595); Event 5307 (corn, insect control, deposited as ATCC PTA-9561, described in WO2010/077816); Event ASR-368 (bent grass, herbicide tolerance, deposited as ATCC PTA-4816, described in US-A 2006-162007 or WO2004/053062); Event B16 (corn, herbicide tolerance, not deposited, described in US-A 2003-126634); Event BPS-CV127-9 (soybean, herbicide tolerance, deposited as NCIMB No. 41603, described in WO2010/080829); Event BLR1 (oilseed rape, restoration of male sterility, deposited as NCIMB 41193, described in WO2005/074671), Event CE43-67B (cotton, insect control, deposited as DSM ACC2724, described in US-A 2009-217423 or WO2006/128573); Event CE44-69D (cotton, insect control, not deposited, described in US-A 2010-0024077); Event CE44-69D (cotton, insect control, not deposited, described in WO2006/128571); Event CE46-02A (cotton, insect control, not deposited, described in WO2006/128572); Event COT102 (cotton, insect control, not deposited, described in US-A 2006-130175 or WO2004/039986); Event COT202 (cotton, insect control, not deposited, described in US-A 2007-067868 or WO2005/054479); Event COT203 (cotton, insect control, not deposited, described in WO2005/054480); ); Event DAS21606-3/1606 (soybean, herbicide tolerance, deposited as PTA-11028, described in WO2012/033794), Event DAS40278 (corn, herbicide tolerance, deposited as ATCC PTA-10244, described in WO2011/022469); Event DAS-44406-6/pDAB8264.44.06.1 (soybean, herbicide tolerance, deposited as PTA-11336, described in WO2012/075426), Event DAS-14536-7/pDAB8291.45.36.2 (soybean, herbicide tolerance, deposited as PTA-11335, described in WO2012/075429), Event DAS-59122-7 (corn, insect control—herbicide tolerance, deposited as ATCC PTA 11384, described in US-A 2006-070139); Event DAS-59132 (corn, insect control—herbicide tolerance, not deposited, described in WO2009/100188); Event DAS68416 (soybean, herbicide tolerance, deposited as ATCC PTA-10442, described in WO2011/066384 or WO2011/066360); Event DP-098140-6 (corn, herbicide tolerance, deposited as ATCC PTA-8296, described in US-A 2009-137395 or WO 08/112019); Event DP-305423-1 (soybean, quality trait, not deposited, described in US-A 2008-312082 or WO2008/054747); Event DP-32138-1 (corn, hybridization system, deposited as ATCC PTA-9158, described in US-A 2009-0210970 or WO2009/103049); Event DP-356043-5 (soybean, herbicide tolerance, deposited as ATCC PTA-8287, described in US-A 2010-0184079 or WO2008/002872); EventEE-I (brinjal, insect control, not deposited, described in WO 07/091277); Event Fil 17 (corn, herbicide tolerance, deposited as ATCC 209031, described in US-A 2006-059581 or WO 98/044140); Event FG72 (soybean, herbicide tolerance, deposited as PTA-11041, described in WO2011/063413), Event GA21 (corn, herbicide tolerance, deposited as ATCC 209033, described in US-A 2005-086719 or WO 98/044140); Event GG25 (corn, herbicide tolerance, deposited as ATCC 209032, described in US-A 2005-188434 or WO98/044140); Event GHB119 (cotton, insect control—herbicide tolerance, deposited as ATCC PTA-8398, described in WO2008/151780); Event GHB614 (cotton, herbicide tolerance, deposited as ATCC PTA-6878, described in US-A 2010-050282 or WO2007/017186); Event GJ11 (corn, herbicide tolerance, deposited as ATCC 209030, described in US-A 2005-188434 or WO98/044140); Event GM RZ13 (sugar beet, virus resistance, deposited as NCIMB-41601, described in WO2010/076212); Event H7-1 (sugar beet, herbicide tolerance, deposited as NCIMB 41158 or NCIMB 41159, described in US-A 2004-172669 or WO 2004/074492); Event JOPLIN1 (wheat, disease tolerance, not deposited, described in US-A 2008-064032); Event LL27 (soybean, herbicide tolerance, deposited as NCIMB41658, described in WO2006/108674 or US-A 2008-320616); Event LL55 (soybean, herbicide tolerance, deposited as NCIMB 41660, described in WO 2006/108675 or US-A 2008-196127); Event LLcotton25 (cotton, herbicide tolerance, deposited as ATCC PTA-3343, described in WO2003/013224 or US-A 2003-097687); Event LLRICE06 (rice, herbicide tolerance, deposited as ATCC 203353, described in U.S. Pat. No. 6,468,747 or WO2000/026345); Event LLRice62 (rice, herbicide tolerance, deposited as ATCC 203352, described in WO2000/026345), Event LLRICE601 (rice, herbicide tolerance, deposited as ATCC PTA-2600, described in US-A 2008-2289060 or WO2000/026356); Event LY038 (corn, quality trait, deposited as ATCC PTA-5623, described in US-A 2007-028322 or WO2005/061720); Event MIR162 (corn, insect control, deposited as PTA-8166, described in US-A 2009-300784 or WO2007/142840); Event MIR604 (corn, insect control, not deposited, described in US-A 2008-167456 or WO2005/103301); Event MON15985 (cotton, insect control, deposited as ATCC PTA-2516, described in US-A 2004-250317 or WO2002/100163); Event MON810 (corn, insect control, not deposited, described in US-A 2002-102582); Event MON863 (corn, insect control, deposited as ATCC PTA-2605, described in WO2004/011601 or US-A 2006-095986); Event MON87427 (corn, pollination control, deposited as ATCC PTA-7899, described in WO2011/062904); Event MON87460 (corn, stress tolerance, deposited as ATCC PTA-8910, described in WO2009/111263 or US-A 2011-0138504); Event MON87701 (soybean, insect control, deposited as ATCC PTA-8194, described in US-A 2009-130071 or WO2009/064652); Event MON87705 (soybean, quality trait—herbicide tolerance, deposited as ATCC PTA-9241, described in US-A 2010-0080887 or WO2010/037016); Event MON87708 (soybean, herbicide tolerance, deposited as ATCC PTA-9670, described in WO2011/034704); Event MON87712 (soybean, yield, deposited as PTA-10296, described in WO2012/051199), Event MON87754 (soybean, quality trait, deposited as ATCC PTA-9385, described in WO2010/024976); Event MON87769 (soybean, quality trait, deposited as ATCC PTA-8911, described in US-A 2011-0067141 or WO2009/102873); Event MON88017 (corn, insect control—herbicide tolerance, deposited as ATCC PTA-5582, described in US-A 2008-028482 or WO2005/059103); Event MON88913 (cotton, herbicide tolerance, deposited as ATCC PTA-4854, described in WO2004/072235 or US-A 2006-059590); Event MON88302 (oilseed rape, herbicide tolerance, deposited as PTA-10955, described in WO2011/153186), Event MON88701 (cotton, herbicide tolerance, deposited as PTA-11754, described in WO2012/134808), Event MON89034 (corn, insect control, deposited as ATCC PTA-7455, described in WO 07/140256 or US-A 2008-260932); Event MON89788 (soybean, herbicide tolerance, deposited as ATCC PTA-6708, described in US-A 2006-282915 or WO2006/130436); Event MSl 1 (oilseed rape, pollination control—herbicide tolerance, deposited as ATCC PTA-850 or PTA-2485, described in WO2001/031042); Event MS8 (oilseed rape, pollination control—herbicide tolerance, deposited as ATCC PTA-730, described in WO2001/041558 or US-A 2003-188347); Event NK603 (corn, herbicide tolerance, deposited as ATCC PTA-2478, described in US-A 2007-292854); Event PE-7 (rice, insect control, not deposited, described in WO2008/114282); Event RF3 (oilseed rape, pollination control—herbicide tolerance, deposited as ATCC PTA-730, described in WO2001/041558 or US-A 2003-188347); Event RT73 (oilseed rape, herbicide tolerance, not deposited, described in WO2002/036831 or US-A 2008-070260); Event SYHT0H2/SYN-000H2-5 (soybean, herbicide tolerance, deposited as PTA-11226, described in WO2012/082548), Event T227-1 (sugar beet, herbicide tolerance, not deposited, described in WO2002/44407 or US-A 2009-265817); Event T25 (corn, herbicide tolerance, not deposited, described in US-A 2001-029014 or WO2001/051654); Event T304-40 (cotton, insect control—herbicide tolerance, deposited as ATCC PTA-8171, described in US-A 2010-077501 or WO2008/122406); Event T342-142 (cotton, insect control, not deposited, described in WO2006/128568); Event TC1507 (corn, insect control—herbicide tolerance, not deposited, described in US-A 2005-039226 or WO2004/099447); Event VTP1034 (corn, insect control—herbicide tolerance, deposited as ATCC PTA-3925, described in WO2003/052073), Event 32316 (corn, insect control-herbicide tolerance, deposited as PTA-11507, described in WO2011/084632), Event 4114 (corn, insect control-herbicide tolerance, deposited as PTA-11506, described in WO2011/084621), event EE-GM3/FG72 (soybean, herbicide tolerance, ATCC Accession No PTA-11041) optionally stacked with event EE-GM1/LL27 or event EE-GM2/LL55 (WO2011/063413A2), event DAS-68416-4 (soybean, herbicide tolerance, ATCC Accession No PTA-10442, WO2011/066360A1), event DAS-68416-4 (soybean, herbicide tolerance, ATCC Accession No PTA-10442, WO2011/066384A1), event DP-040416-8 (corn, insect control, ATCC Accession No PTA-11508, WO2011/075593A1), event DP-043A47-3 (corn, insect control, ATCC Accession No PTA-11509, WO2011/075595A1), event DP-004114-3 (corn, insect control, ATCC Accession No PTA-11506, WO2011/084621A1), event DP-032316-8 (corn, insect control, ATCC Accession No PTA-11507, WO2011/084632A1), event MON-88302-9 (oilseed rape, herbicide tolerance, ATCC Accession N° PTA-10955, WO2011/153186A1), event DAS-21606-3 (soybean, herbicide tolerance, ATCC Accession No. PTA-11028, WO2012/033794A2), event MON-87712-4 (soybean, quality trait, ATCC Accession No. PTA-10296, WO2012/051199A2), event DAS-44406-6 (soybean, stacked herbicide tolerance, ATCC Accession No. PTA-11336, WO2012/075426A1), event DAS-14536-7 (soybean, stacked herbicide tolerance, ATCC Accession No. PTA-11335, WO2012/075429A1), event SYN-000H2-5 (soybean, herbicide tolerance, ATCC Accession No. PTA-11226, WO2012/082548A2), event DP-061061-7 (oilseed rape, herbicide tolerance, no deposit No available, WO2012071039A1), event DP-073496-4 (oilseed rape, herbicide tolerance, no deposit No available, US2012131692), event 8264.44.06.1 (soybean, stacked herbicide tolerance, Accession No PTA-11336, WO2012075426A2), event 8291.45.36.2 (soybean, stacked herbicide tolerance, Accession No. PTA-11335, WO2012075429A2), event SYHT0H2 (soybean, ATCC Accession No. PTA-11226, WO2012/082548A2), event MON88701 (cotton, ATCC Accession No PTA-11754, WO2012/134808A1), event KK179-2 (alfalfa, ATCC Accession No PTA-11833, WO2013/003558A1), event pDAB8264.42.32.1 (soybean, stacked herbicide tolerance, ATCC Accession No PTA-11993, WO2013/010094A1), event MZDT09Y (corn, ATCC Accession No PTA-13025, WO2013/012775A1).
Further, a list of such transgenic event(s) is provided by the United States Department of Agriculture's (USDA) Animal and Plant Health Inspection Service (APHIS) and can be found on their website on the world wide web at aphis.usda.gov. For this application, the status of such list as it is/was on the filing date of this application, is relevant.
The genes/events which impart the desired traits in question may also be present in combinations with one another in the transgenic plants. Examples of transgenic plants which may be mentioned are the important crop plants, such as cereals (wheat, rice, triticale, barley, rye, oats), maize, soya beans, potatoes, sugar beet, sugar cane, tomatoes, peas and other types of vegetable, cotton, tobacco, oilseed rape and also fruit plants (with the fruits apples, pears, citrus fruits and grapes), with particular emphasis being given to maize, soya beans, wheat, rice, potatoes, cotton, sugar cane, tobacco and oilseed rape. Traits which are particularly emphasized are the increased resistance of the plants to insects, arachnids, nematodes and slugs and snails, as well as the increased resistance of the plants to one or more herbicides.
Commercially available examples of such plants, plant parts or plant seeds that may be treated with preference in accordance with the invention include commercial products, such as plant seeds, sold or distributed under the GENUITY®, DROUGHTGARD®, SMARTSTAX®, RIB COMPLETE®, ROUNDUP READY®, VT DOUBLE PRO®, VT TRIPLE PRO®, BOLLGARD II®, ROUNDUP READY 2 YIELD®, YIELDGARD®, ROUNDUP READY® 2 XTENDTM, INTACTA RR2 PRO®, VISTIVE GOLD®, and/or XTENDFLEX™ trade names.
Non-limiting examples of pathogens of fungal diseases which may be treated in accordance with the invention include:
diseases caused by powdery mildew pathogens, for example Blumeria species, for example Blumeria graminis; Podosphaera species, for example Podosphaera leucotricha; Sphaerotheca species, for example Sphaerotheca fuliginea; Uncinula species, for example Uncinula necator; diseases caused by rust disease pathogens, for example Gymnosporangium species, for example Gymnosporangium sabinae; Hemileia species, for example Hemileia vastatrix; Phakopsora species, for example Phakopsora pachyrhizi or Phakopsora meibomiae; Puccinia species, for example Puccinia recondita, Puccinia graminis oder Puccinia striiformis; Uromyces species, for example Uromyces appendiculatus;
diseases caused by pathogens from the group of the Oomycetes, for example Albugo species, for example Albugo candida; Bremia species, for example Bremia lactucae; Peronospora species, for example Peronospora pisi or P. brassicae; Phytophthora species, for example Phytophthora infestans; Plasmopara species, for example Plasmopara viticola; Pseudoperonospora species, for example Pseudoperonospora humuli or Pseudoperonospora cubensis; Pythium species, for example Pythium ultimum; leaf blotch diseases and leaf wilt diseases caused, for example, by Alternaria species, for example Alternaria solani; Cercospora species, for example Cercospora beticola; Cladiosporium species, for example Cladiosporium cucumerinum; Cochliobolus species, for example Cochliobolus sativus (conidial form: Drechslera, syn: Helminthosporium) or Cochliobolus miyabeanus; Colletotrichum species, for example Colletotrichum lindemuthanium; Corynespora species, for example Corynespora cassiicola; Cycloconium species, for example Cycloconium oleaginum; Diaporthe species, for example Diaporthe citri; Elsinoe species, for example Elsinoe fawcettii; Gloeosporium species, for example Gloeosporium laeticolor; Glomerella species, for example Glomerella cingulata; Guignardia species, for example Guignardia bidwelli; Leptosphaeria species, for example Leptosphaeria maculans; Magnaporthe species, for example Magnaporthe grisea; Microdochium species, for example Microdochium nivale; Mycosphaerella species, for example Mycosphaerella graminicola, Mycosphaerella arachidicola or Mycosphaerella fijiensis; Phaeosphaeria species, for example Phaeosphaeria nodorum; Pyrenophora species, for example Pyrenophora teres or Pyrenophora tritici repentis; Ramularia species, for example Ramularia collo-cygni or Ramularia areola; Rhynchosporium species, for example Rhynchosporium secalis; Septoria species, for example Septoria apii or Septoria lycopersici; Stagonospora species, for example Stagonospora nodorum; Typhula species, for example Typhula incarnata; Venturia species, for example Venturia inaequalis;
root and stem diseases caused, for example, by Corticium species, for example Corticium graminearum; Fusarium species, for example Fusarium oxysporum; Gaeumannomyces species, for example Gaeumannomyces graminis; Plasmodiophora species, for example Plasmodiophora brassicae; Rhizoctonia species, for example Rhizoctonia solani; Sarocladium species, for example Sarocladium oryzae; Sclerotium species, for example Sclerotium oryzae; Tapesia species, for example Tapesia acuformis; Thielaviopsis species, for example Thielaviopsis basicola;
ear and panicle diseases (including corn cobs) caused, for example, by Alternaria species, for example Alternaria spp.; Aspergillus species, for example Aspergillus flavus; Cladosporium species, for example Cladosporium cladosporioides; Claviceps species, for example Claviceps purpurea; Fusarium species, for example Fusarium culmorum; Gibberella species, for example Gibberella zeae; Monographella species, for example Monographella nivalis; Stagnospora species, for example Stagnospora nodorum; diseases caused by smut fungi, for example Sphacelotheca species, for example Sphacelotheca reiliana; Tilletia species, for example Tilletia caries or Tilletia controversa; Urocystis species, for example Urocystis occulta; Ustilago species, for example Ustilago nuda;
fruit rot caused, for example, by Aspergillus species, for example Aspergillus flavus; Botrytis species, for example Botrytis cinerea; Monilinia species, for example Monilinia laxa; Penicillium species, for example Penicillium expansum or Penicillium purpurogenum; Rhizopus species, for example Rhizopus stolonifer; Sclerotinia species, for example Sclerotinia sclerotiorum; Verticilium species, for example Verticilium alboatrum;
seed- and soil-borne rot and wilt diseases, and also diseases of seedlings, caused, for example, by Alternaria species, for example Alternaria brassicicola; Aphanomyces species, for example Aphanomyces euteiches; Ascochyta species, for example Ascochyta lentis; Aspergillus species, for example Aspergillus flavus; Cladosporium species, for example Cladosporium herbarum; Cochliobolus species, for example Cochliobolus sativus (conidial form: Drechslera, Bipolaris Syn: Helminthosporium); Colletotrichum species, for example Colletotrichum coccodes; Fusarium species, for example Fusarium culmorum; Gibberella species, for example Gibberella zeae; Macrophomina species, for example Macrophomina phaseolina; Microdochium species, for example Microdochium nivale; Monographella species, for example Monographella nivalis; Penicillium species, for example Penicillium expansum; Phoma species, for example Phoma lingam; Phomopsis species, for example Phomopsis sojae; Phytophthora species, for example Phytophthora cactorum; Pyrenophora species, for example Pyrenophora graminea; Pyricularia species, for example Pyricularia oryzae; Pythium species, for example Pythium ultimum; Rhizoctonia species, for example Rhizoctonia solani; Rhizopus species, for example Rhizopus oryzae; Sclerotium species, for example Sclerotium rolfsii; Septoria species, for example Septoria nodorum; Typhula species, for example Typhula incarnata; Verticillium species, for example Verticillium dahliae;
cancers, galls and witches' broom caused, for example, by Nectria species, for example Nectria galligena;
wilt diseases caused, for example, by Verticillium species, for example Verticillium longisporum; Fusarium species, for example Fusarium oxysporum;
deformations of leaves, flowers and fruits caused, for example, by Exobasidium species, for example Exobasidium vexans; Taphrina species, for example Taphrina deformans;
degenerative diseases in woody plants, caused, for example, by Esca species, for example Phaeomoniella chlamydospora, Phaeoacremonium aleophilum or Fomitiporia mediterranea; Ganoderma species, for example Ganoderma boninense;
diseases of plant tubers caused, for example, by Rhizoctonia species, for example Rhizoctonia solani; Helminthosporium species, for example Helminthosporium solani;
diseases caused by bacterial pathogens, for example Xanthomonas species, for example Xanthomonas campestris pv. oryzae; Pseudomonas species, for example Pseudomonas syringae pv. lachrymans; Erwinia species, for example Erwinia amylovora; Liberibacter species, for example Liberibacter asiaticus; Xyella species, for example Xylella fastidiosa; Ralstonia species, for example Ralstonia solanacearum; Dickeya species, for example Dickeya solani; Clavibacter species, for example Clavibacter michiganensis; Streptomyces species, for example Streptomyces scabies.
diseases of soya beans:
Fungal diseases on leaves, stems, pods and seeds caused, for example, by Alternaria leaf spot (Alternaria spec. atrans tenuissima), Anthracnose (Colletotrichum gloeosporoides dematium var. truncatum), brown spot (Septoria glycines), cercospora leaf spot and blight (Cercospora kikuchii), choanephora leaf blight (Choanephora infundibulifera trispora (Syn.)), dactuliophora leaf spot (Dactuliophora glycines), downy mildew (Peronospora manshurica), drechslera blight (Drechslera glycini), frogeye leaf spot (Cercospora sojina), leptosphaerulina leaf spot (Leptosphaerulina trifolii), phyllostica leaf spot (Phyllosticta sojaecola), pod and stem blight (Phomopsis sojae), powdery mildew (Microsphaera diffusa), pyrenochaeta leaf spot (Pyrenochaeta glycines), rhizoctonia aerial, foliage, and web blight (Rhizoctonia solani), rust (Phakopsora pachyrhizi, Phakopsora meibomiae), scab (Sphaceloma glycines), stemphylium leaf blight (Stemphylium botryosum), sudden death syndrome (Fusarium virguliforme), target spot (Corynespora cassiicola).
Fungal diseases on roots and the stem base caused, for example, by black root rot (Calonectria crotalariae), charcoal rot (Macrophomina phaseolina), fusarium blight or wilt, root rot, and pod and collar rot (Fusarium oxysporum, Fusarium orthoceras, Fusarium semitectum, Fusarium equiseti), mycoleptodiscus root rot (Mycoleptodiscus terrestris), neocosmospora (Neocosmospora vasinfecta), pod and stem blight (Diaporthe phaseolorum), stem canker (Diaporthe phaseolorum var. caulivora), phytophthora rot (Phytophthora megasperma), brown stem rot (Phialophora gregata), pythium rot (Pythium aphanidermatum, Pythium irregulare, Pythium debaryanum, Pythium myriotylum, Pythium ultimum), rhizoctonia root rot, stem decay, and damping-off (Rhizoctonia solani), sclerotinia stem decay (Sclerotinia sclerotiorum), sclerotinia southern blight (Sclerotinia rolfsii), thielaviopsis root rot (Thielaviopsis basicola).
In addition, the compound of formula (I) and the composition of the invention may reduce the mycotoxin content in the harvested material and the foods and feeds prepared therefrom. Mycotoxins include particularly, but not exclusively, the following: deoxynivalenol (DON), nivalenol, 15-Ac-DON, 3-Ac-DON, T2- and HT2-toxin, fumonisins, zearalenon, moniliformin, fusarin, diaceotoxyscirpenol (DAS), beauvericin, enniatin, fusaroproliferin, fusarenol, ochratoxins, patulin, ergot alkaloids and aflatoxins which can be produced, for example, by the following fungi: Fusarium spec., such as F. acuminatum, F. asiaticum, F. avenaceum, F. crookwellense, F. culmorum, F. graminearum (Gibberella zeae), F. equiseti, F. fujikoroi, F. musarum, F. oxysporum, F. proliferatum, F. poae, F. pseudograminearum, F. sambucinum, F. scirpi, F. semitectum, F. solani, F. sporotrichoides, F. langsethiae, F. subglutinans, F. tricinctum, F. verticilihoides, and also by Aspergillus spec., such as A. flavus, A. parasiticus, A. nomius, A. ochraceus, A. clavatus, A. terreus, A. versicolor, Penicillium spec., such as P. verrucosum, P. viridicatum, P. citrinum, P. expansum, P. claviforme, P. roqueforti, Claviceps spec., such as C. purpurea, C. fusiformis, C. paspali, C. africana, Stachybotrys spec. and others.
The compound of formula (I) and the composition of the invention may also be used in the protection of materials, especially for the protection of industrial materials against attack and destruction by phytopathogenic fungi.
In addition, the compound of formula (I) and the composition of the invention may be used as antifouling compositions, alone or in combinations with other active ingredients.
Industrial materials in the present context are understood to mean inanimate materials which have been prepared for use in industry. For example, industrial materials which are to be protected from microbial alteration or destruction may be adhesives, glues, paper, wallpaper and board/cardboard, textiles, carpets, leather, wood, fibers and tissues, paints and plastic articles, cooling lubricants and other materials which can be infected with or destroyed by microorganisms. Parts of production plants and buildings, for example cooling-water circuits, cooling and heating systems and ventilation and air-conditioning units, which may be impaired by the proliferation of microorganisms may also be mentioned within the scope of the materials to be protected. Industrial materials within the scope of the present invention preferably include adhesives, sizes, paper and card, leather, wood, paints, cooling lubricants and heat transfer fluids, more preferably wood.
The compound of formula (I) and the composition of the invention may prevent adverse effects, such as rotting, decay, discoloration, decoloration or formation of mould.
In the case of treatment of wood the compound of formula (I) and the composition of the invention may also be used against fungal diseases liable to grow on or inside timber.
Timber means all types of species of wood, and all types of working of this wood intended for construction, for example solid wood, high-density wood, laminated wood, and plywood. In addition, the compound of formula (I) and the composition of the invention may be used to protect objects which come into contact with saltwater or brackish water, especially hulls, screens, nets, buildings, moorings and signalling systems, from fouling.
The compound of formula (I) and the composition of the invention may also be employed for protecting storage goods. Storage goods are understood to mean natural substances of vegetable or animal origin or processed products thereof which are of natural origin, and for which long-term protection is desired. Storage goods of vegetable origin, for example plants or plant parts, such as stems, leaves, tubers, seeds, fruits, grains, may be protected freshly harvested or after processing by (pre)drying, moistening, comminuting, grinding, pressing or roasting. Storage goods also include timber, both unprocessed, such as construction timber, electricity poles and barriers, or in the form of finished products, such as furniture. Storage goods of animal origin are, for example, hides, leather, furs and hairs. The compound of formula (I) and the composition of the invention may prevent adverse effects, such as rotting, decay, discoloration, decoloration or formation of mould.
Microorganisms capable of degrading or altering industrial materials include, for example, bacteria, fungi, yeasts, algae and slime organisms. The compound of formula (I) and the composition of the invention preferably act against fungi, especially moulds, wood-discoloring and wood-destroying fungi (Ascomycetes, Basidiomycetes, Deuteromycetes and Zygomycetes), and against slime organisms and algae. Examples include microorganisms of the following genera: Alternaria, such as Alternaria tenuis; Aspergillus, such as Aspergillus niger; Chaetomium, such as Chaetomium globosum; Coniophora, such as Coniophora puetana; Lentinus, such as Lentinus tigrinus; Penicillium, such as Penicillium glaucum; Polyporus, such as Polyporus versicolor; Aureobasidium, such as Aureobasidium pullulans; Sclerophoma, such as Sclerophoma pityophila; Trichoderma, such as Trichoderma viride; Ophiostoma spp., Ceratocystis spp., Humicola spp., Petriella spp., Trichurus spp., Coriolus spp., Gloeophyllum spp., Pleurotus spp., Poria spp., Serpula spp. and Tyromyces spp., Cladosporium spp., Paecilomyces spp. Mucor spp., Escherichia, such as Escherichia coli; Pseudomonas, such as Pseudomonas aeruginosa; Staphylococcus, such as Staphylococcus aureus, Candida spp. and Saccharomyces spp., such as Saccharomyces cerevisae.
The compound of formula (I) and the composition of the invention may also be used to protect seeds from unwanted microorganisms, such as phytopathogenic microorganisms, for instance phytopathogenic fungi or phytopathogenic oomycetes. The term seed(s) as used herein include dormant seeds, primed seeds, pregerminated seeds and seeds with emerged roots and leaves.
Thus, the present invention also relates to a method for protecting seeds from unwanted microorganisms which comprises the step of treating the seeds with the compound of formula (I) or the composition of the invention.
The treatment of seeds with the compound of formula (I) or the composition of the invention protects the seeds from phytopathogenic microorganisms, but also protects the germinating seeds, the emerging seedlings and the plants after emergence from the treated seeds. Therefore, the present invention also relates to a method for protecting seeds, germinating seeds and emerging seedlings.
The seeds treatment may be performed prior to sowing, at the time of sowing or shortly thereafter.
When the seeds treatment is performed prior to sowing (e.g. so-called on-seed applications), the seeds treatment may be performed as follows: the seeds may be placed into a mixer with a desired amount of the compound of formula (I) or the composition of the invention, the seeds and the compound of formula (I) or the composition of the invention are mixed until an homogeneous distribution on seeds is achieved. If appropriate, the seeds may then be dried.
The invention also relates to seeds coated with the compound of formula (I) or the composition of the invention.
Preferably, the seeds are treated in a state in which it is sufficiently stable for no damage to occur in the course of treatment. In general, seeds can be treated at any time between harvest and shortly after sowing. It is customary to use seeds which have been separated from the plant and freed from cobs, shells, stalks, coats, hairs or the flesh of the fruits. For example, it is possible to use seeds which have been harvested, cleaned and dried down to a moisture content of less than 15% by weight. Alternatively, it is also possible to use seeds which, after drying, for example, have been treated with water and then dried again, or seeds just after priming, or seeds stored in primed conditions or pre-germinated seeds, or seeds sown on nursery trays, tapes or paper.
The amount of the compound of formula (I) or the composition of the invention applied to the seeds is typically such that the germination of the seed is not impaired, or that the resulting plant is not damaged. This must be ensured particularly in case the the compound of formula (I) would exhibit phytotoxic effects at certain application rates. The intrinsic phenotypes of transgenic plants should also be taken into consideration when determining the amount of the compound of formula (I) to be applied to the seed in order to achieve optimum seed and germinating plant protection with a minimum amount of compound being employed.
The compound of formula (I) can be applied as such, directly to the seeds, i.e. without the use of any other components and without having been diluted. Also the composition of the invention can be applied to the seeds.
The compound of formula (I) and the composition of the invention are suitable for protecting seeds of any plant variety. Preferred seeds are that of cereals (such as wheat, barley, rye, millet, triticale, and oats), oilseed rape, maize, cotton, soybean, rice, potatoes, sunflower, beans, coffee, peas, beet (e.g. sugar beet and fodder beet), peanut, vegetables (such as tomato, cucumber, onions and lettuce), lawns and ornamental plants. More preferred are seeds of wheat, soybean, oilseed rape, maize and rice.
The compound of formula (I) and the composition of the invention may be used for treating transgenic seeds, in particular seeds of plants capable of expressing a polypeptide or protein which acts against pests, herbicidal damage or abiotic stress, thereby increasing the protective effect. Seeds of plants capable of expressing a polypeptide or protein which acts against pests, herbicidal damage or abiotic stress may contain at least one heterologous gene which allows the expression of said polypeptide or protein. These heterologous genes in transgenic seeds may originate, for example, from microorganisms of the species Bacillus, Rhizobium, Pseudomonas, Serratia, Trichoderma, Clavibacter, Glomus or Gliocladium. These heterologous genes preferably originate from Bacillus sp., in which case the gene product is effective against the European corn borer and/or the Western corn rootworm. Particularly preferably, the heterologous genes originate from Bacillus thuringiensis.
The compound of formula (I) can be applied as such, or for example in the form of as ready-to-use solutions, emulsions, water- or oil-based suspensions, powders, wettable powders, pastes, soluble powders, dusts, soluble granules, granules for broadcasting, suspoemulsion concentrates, natural products impregnated with the compound of formula (I), synthetic substances impregnated with the compound of formula (I), fertilizers or microencapsulations in polymeric substances.
Application is accomplished in a customary manner, for example by watering, spraying, atomizing, broadcasting, dusting, foaming or spreading-on. It is also possible to deploy the compound of formula (I) by the ultra-low volume method, via a drip irrigation system or drench application, to apply it in-furrow or to inject it into the soil stem or trunk. It is further possible to apply the compound of formula (I) by means of a wound seal, paint or other wound dressing.
The effective and plant-compatible amount of the compound of formula (I) which is applied to the plants, plant parts, fruits, seeds or soil will depend on various factors, such as the compound/composition employed, the subject of the treatment (plant, plant part, fruit, seed or soil), the type of treatment (dusting, spraying, seed dressing), the purpose of the treatment (curative and protective), the type of microorganisms, the development stage of the microorganisms, the sensitivity of the microorganisms, the crop growth stage and the environmental conditions.
When the compound of formula (I) is used as a fungicide, the application rates can vary within a relatively wide range, depending on the kind of application. For the treatment of plant parts, such as leaves, the application rate may range from 0.1 to 10 000 g/ha, preferably from 10 to 1000 g/ha, more preferably from 50 to 300 g/ha (in the case of application by watering or dripping, it is even possible to reduce the application rate, especially when inert substrates such as rockwool or perlite are used). For the treatment of seeds, the application rate may range from 0.1 to 200 g per 100 kg of seeds, preferably from 1 to 150 g per 100 kg of seeds, more preferably from 2.5 to 25 g per 100 kg of seeds, even more preferably from 2.5 to 12.5 g per 100 kg of seeds. For the treatment of soil, the application rate may range from 0.1 to 10 000 g/ha, preferably from 1 to 5000 g/ha.
These application rates are merely examples and are not intended to limit the scope of the present invention.
The compound of formula (I) and the composition of the invention can be used in combination with models e.g. embedded in computer programs for site specific crop management, satellite farming, precision farming or precision agriculture. Such models support the site specific management of agricultural sites with data from various sources such as soils, weather, crops (e.g. type, growth stage, plant health), weeds (e.g. type, growth stage), diseases, pests, nutrients, water, moisture, biomass, satellite data, yield etc. with the purpose to optimize profitability, sustainability and protection of the environment. In particular, such models can help to optimize agronomical decisions, control the precision of pesticide applications and record the work performed.
As an example, the compound of formula (I) can be applied to a crop plant according to appropriate dose regime if a model models the development of a fungal disease and calculates that a threshold has been reached for which it is recommendable to apply the compound of formula (I) to the crop plant.
Commercially available systems which include agronomic models are e.g. FieldScripts™ from The Climate Corporation, Xarvio™ from BASF, AGLogic™ from John Deere, etc.
The compound of formula (I) can also be used in combination with smart spraying equipment such as e.g. spot spraying or precision spraying equipment attached to or housed within a farm vehicle such as a tractor, robot, helicopter, airplane, unmanned aerial vehicle (UAV) such as a drone, etc. Such an equipment usually includes input sensors (such as e.g. a camera) and a processing unit configured to analyze the input data and configured to provide a decision based on the analysis of the input data to apply the compound of the invention to the crop plants (respectively the weeds) in a specific and precise manner. The use of such smart spraying equipment usually also requires positions systems (e.g. GPS receivers) to localize recorded data and to guide or to control farm vehicles; geographic information systems (GIS) to represent the information on intelligible maps, and appropriate farm vehicles to perform the required farm action such as the spraying.
In an example, fungal diseases can be detected from imagery acquired by a camera. In an example fungal diseases can be identified and/or classified based on that imagery. Such identification and/classification can make use of image processing algorithms. Such image processing algorithms can utilize machine learning algorithms, such as trained neutral networks, decision trees and utilize artificial intelligence algorithms. In this manner, the compounds described herein can be applied only where needed.
Aspects of the present teaching may be further understood in light of the following examples, which should not be construed as limiting the scope of the present teaching in any way.
Measurement of Log P values as provided herein was performed according to EEC directive 79/831 Annex V.A8 by HPLC (High Performance Liquid Chromatography) on reversed phase columns with the following methods:
If more than one Log P value is available within the same method, all the values are given and separated by “+”.
Calibration was done with straight-chain alkan2-ones (with 3 to 16 carbon atoms) with known Log P values (measurement of Log P values using retention times with linear interpolation between successive alkanones). Lambda-max-values were determined using UV-spectra from 200 nm to 400 nm and the peak values of the chromatographic signals
1H-NMR data of selected examples as provided herein are written in form of 1H-NMR-peak lists. To each signal peak are listed the δ-value in ppm and the signal intensity in round brackets. Between the δ-value—signal intensity pairs are semicolons as delimiters.
The peak list of an example has therefore the form:
δ1 (intensity1); δ2 (intensity2); . . . ; ϵi (intensityi); . . . ; δn (intensityn)
Intensity of sharp signals correlates with the height of the signals in a printed example of a NMR spectrum in cm and shows the real relations of signal intensities. From broad signals several peaks or the middle of the signal and their relative intensity in comparison to the most intensive signal in the spectrum can be shown.
For calibrating chemical shift for 1H spectra, we use tetramethylsilane and/or the chemical shift of the solvent used, especially in the case of spectra measured in DMSO. Therefore in NMR peak lists, tetramethylsilane peak can occur but not necessarily.
The 1H-NMR peak lists are similar to classical 1H-NMR prints and contains therefore usually all peaks, which are listed at classical NMR-interpretation.
Additionally they can show like classical 1H-NMR prints signals of solvents, stereoisomers of the target compounds, which are also object of the invention, and/or peaks of impurities.
To show compound signals in the delta-range of solvents and/or water the usual peaks of solvents, for example peaks of DMSO in DMSO-D6 and the peak of water are shown in our 1H-NMR peak lists and have usually on average a high intensity.
The peaks of stereoisomers of the target compounds and/or peaks of impurities have usually on average a lower intensity than the peaks of target compounds (for example with a purity >90%).
Such stereoisomers and/or impurities can be typical for the specific preparation process. Therefore their peaks can help to recognize the reproduction of our preparation process via “side-products-fingerprints”.
An expert, who calculates the peaks of the target compounds with known methods (MestreC, ACD-simulation, but also with empirically evaluated expectation values) can isolate the peaks of the target compounds as needed optionally using additional intensity filters. This isolation would be similar to relevant peak picking at classical 1H-NMR interpretation.
Further details of NMR-data description with peak lists you find in the publication “Citation of NMR Peaklist Data within Patent Applications” of the Research Disclosure Database Number 564025.
The following examples illustrate in a non-limiting manner the preparation and biological activity of the compounds of formula (I) according to the invention.
To a stirred solution under argon of 3-(trifluoromethyl)benzenethiol (43 mg, 0.24 mmol) in 0.5 mL of 2-methyltetrahydrofuran was added at room temperature cesium carbonate (86 mg g, 0.26 mol) and the reaction mixture was stirred during 5 minutes. Then a solution of (5RS)-3-(3,6-dichloropyridazin-4-yl)-5-(2,4-dimethylbenzyl)-5,6-dihydro-4H-1,2,4-oxadiazine [2446130-43-2] (100 mg, 72% purity, 0.20 mmol) in 1 mL of 2-methyltetrahydrofuran was added and the reaction mixture was stirred at 70° C. for 3.5 h. The reaction mixture was poured over a potassium carbonate aqueous solution and extracted with ethyl acetate. The organic extracts were dried over magnesium sulfate, filtered and concentrated under reduced pressure. Purification of the residue by preparative HPLC afforded 59 mg (99% purity, 58% yield) of the title compound.
To a stirred solution of (5RS)-3-(6-chloro-3-{[3-(trifluoromethyl)phenyl]sulfanyl}pyridazin-4-yl)-5-(2,4-dimethylbenzyl)-5,6-dihydro-4H-1,2,4-oxadiazine compound (1-017) (36 mg, 0.07 mmol) in 1 mL dichloromethane was added meta-chloroperoxybenzoic acid (39 mg, 70% purity, 0.16 mmol). The reaction mixture was stirred at room temperature for 20 h. The reaction mixture was quenched with a 1:1 mixture of saturated aqueous solution of sodium bicarbonate and 10% aqueous solution of sodium sulfite. The mixture was extracted with ethyl acetate and the combined organic layers were dried over magnesium sulfate, filtered and concentrated under reduced pressure. The crude product was purified by preparative HPLC to afford 4 mg (99% purity, 12% yield) of the title compound.
In a microwave vial, a mixture of ethyl 6-chloro-3-methyl-1,2,4-triazine-5-carboxylate (80 mg, 0.39 mmol), 3-methoxybenzenethiol (72 mg, 0.51 mmol), 1-butyl-1H-imidazole (24 mg, 0.19 mmol), copper iodide (7 mg, 0.04 mmol) and cesium carbonate (258 mg, 0.79 mmol) were suspended in dry toluene (3.6 mL). The tube was sealed, and the reaction mixture was heated under microwave irradiation at 120° C. for 16 h. The crude reaction mixture was poured on a silica gel cartridge and eluted twice with 8 mL dichloromethane. After evaporation of the solvents, the crude product was purified by preparative HPLC to afford 51 mg (98% purity, 41% yield) of ethyl 6-[(3-methoxyphenyl)sulfanyl]-3-methyl-1,2,4-triazine-5-carboxylate.
To a stirred mixture of 3-bromo-5,6-dimethylpyridazine-4-carbonitrile [1526403-62-2] (10 g, 47.16 mmol) and NH2OH×H2O (24.07 g, 235.79 mmol, 50%) in THF (50 mL) was added Na2CO3 (14.99 g, 141.48 mmol) in portions at room temperature under nitrogen atmosphere. The resulting mixture was stirred for 5 hours at 50° C. under nitrogen atmosphere. The resulting mixture was concentrated under reduced pressure. The resulting mixture was extracted with ethyl acetate. The combined organic layers were washed with brine, dried over anhydrous Na2SO4. After filtration, the filtrate was concentrated under reduced pressure to afford 3-bromo-N′-hydroxy-5,6-dimethylpyridazine-4-carboximidamide (6.8 g, 55%) as a yellow solid.
To a stirred mixture of 3-bromo-N′-hydroxy-5,6-dimethylpyridazine-4-carboximidamide (6.1 g, 24.89 mmol) and allyl bromide (3.01 g, 24.89 mmol) in acetonitrile (60 mL) was added Cs2CO3 (16.22 g, 49.78 mmol) in portions at room temperature under air atmosphere. The resulting mixture was stirred for overnight at room temperature under nitrogen atmosphere. The resulting mixture was extracted with ethyl acetate. The combined organic layers were washed with brine, dried over anhydrous Na2SO4. After filtration, the filtrate was concentrated under reduced pressure. The residue was purified by silica gel column chromatography, eluted with petroleum ether/ethyl acetate (2:1) to afford N′-(allyloxy)-3-bromo-5,6-dimethylpyridazine-4-carboximidamide (4.2 g, 59%) as a yellow solid.
To a stirred mixture of N′-(allyloxy)-3-bromo-5,6-dimethylpyridazine-4-carboximidamide (6 g, 21.04 mmol) and NaIO4 (13.50 g, 63.12 mmol) in THF (60 mL) and H2O (20 mL) were added OsO4 (0.53 g, 2.10 mmol) in portions at room temperature under nitrogen atmosphere. The resulting mixture was stirred for overnight at room temperature under nitrogen atmosphere. The reaction was quenched by the addition of aqueous saturated sodium hyposulfite solution (300 mL) at room temperature. The resulting mixture was extracted with ethyl acetate. The combined organic layers were washed with brine (3×200 mL), dried over anhydrous Na2SO4 and used directly for the next step without further purification.
A mixture of (5RS)-3-(3-bromo-5,6-dimethylpyridazin-4-yl)-5,6-dihydro-4H-1,2,4-oxadiazin-5-ol (4 g, 13.9 mmol) and 2-methylthiophene [554-14-3] (2.74 g, 27.8 mmol) in formic acid (40 mL) was stirred for overnight at room temperature under nitrogen atmosphere. The resulting mixture was extracted with ethyl acetate (3×50 mL). The combined organic layers were washed with brine (3×20 mL), dried over anhydrous Na2SO4. After filtration, the filtrate was concentrated under reduced pressure. The residue was purified by silica gel column chromatography, eluted with petroleum ether/ethyl acetate/dichloromethane (1:1:1) to afford the tittle compound (2.1 g, 41%) as a brown solid.
To a stirred solution under argon of 3-methylbenzenethiol [108-40-7] (19 mg, 0.15 mmol) in 1 mL of 2-methyltetrahydrofuran was added at room temperature cesium carbonate (91 mg, 0.28 mol) and the reaction mixture was stirred for 5 minutes. Then a solution of (5RS)-3-(3-bromo-5,6-dimethylpyridazin-4-yl)-5-(5-methyl-2-thienyl)-5,6-dihydro-4H-1,2,4-oxadiazine (51 mg, 0.14 mmol) in 1 mL of 2-methyltetrahydrofuran was added and the reaction mixture was stirred at 70° C. for 24 h. The reaction solution was quenched with water (1.5 mL) and then transferred onto a 2 g Alox cartridge and eluted twice with 8 ml dichloromethane. After evaporation of the solvent, the crude residue was purified by preparative HPLC (SunFire Waters 5 μm 30×150 acetonitrile/H2O (0.1% formic acid)) to afford 22 mg (99% purity, 38% yield) of the title compound.
To a stirred solution under argon of 3-(trifluoromethyl)benzenethiol [937-00-8] (27 mg, 0.15 mmol) in 1 mL of 2-methyltetrahydrofuran was added at room temperature cesium carbonate (91 mg, 0.28 mol) and the reaction mixture was stirred for 5 minutes. Then a solution of (5RS)-3-(3-bromo-5,6-dimethyl-pyridazin-4-yl)-5-(2,5-dimethyl-3-thienyl)-5,6-dihydro-4H-1,2,4-oxadiazine (53 mg, 0.14 mmol) in 1 mL of 2-methyltetrahydrofuran was added and the reaction mixture was stirred at 70° C. for 24 h. The reaction solution was quenched with water (1.5 mL) and then transferred onto a 2 g Alox cartridge and eluted twice with 8 ml dichloromethane. After evaporation of the solvent, the crude residue was purified by preparative HPLC (SunFire Waters 5 μm 30×150 acetonitrile/H2O (0.1% formic acid)) to afford 5 mg (99% purity, 8% yield) of the title compound.
The compounds as shown in table 1 below were prepared in analogy with the examples provided above or following methods described herein.
1H-NMR Peak List
1H-NMR(499.9 MHz, CDCl3) δ = 8.3300 (3.0); 8.2577 (1.7); 8.2418 (1.8); 8.0032 (1.6); 7.9875 (1.8); 7.8705 (8.3); 7.7965 (1.4); 7.7807 (2.4); 7.7649 (1.1); 7.2594 (16.0); 7.1304 (2.4); 7.1151 (2.9); 7.0261 (3.2); 7.0043 (1.9); 6.9889 (1.5); 5.5698 (2.0); 4.1671 (1.3); 4.1607 (1.5); 4.1457 (1.7); 4.1394 (1.6); 3.9730 (0.4); 3.9597 (0.9); 3.9528 (1.0); 3.9470 (1.1); 3.9408 (0.8); 3.9328 (0.8); 3.9224 (2.4); 3.9107 (1.2); 3.9010 (1.8); 3.8893 (1.2); 3.0321 (0.9); 3.0187 (0.9); 3.0043 (1.7); 2.9907 (1.5); 2.9471 (1.6); 2.9320 (1.6); 2.9193 (0.9); 2.9039 (0.8); 2.3324 (16.0); 2.3002 (14.9); 2.0048 (4.5); 1.5453 (5.9); 0.0059 (1.8); −0.0002 (18.5); −0.0067 (0.8)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.0235 (4.5); 7.6215 (2.4); 7.6161 (2.4); 7.5608 (4.5); 7.5136 (1.1); 7.5041 (1.1); 7.4393 (1.6); 7.4186 (2.6); 7.3712 (0.8); 7.3666 (2.1); 7.3612 (1.8); 7.3515 (1.5); 7.3460 (1.6); 7.3406 (1.3); 7.3302 (0.9); 6.9900 (4.4); 6.9821 (1.6); 6.9763 (1.8); 6.9734 (1.9); 6.9674 (0.7); 3.8166 (1.1); 3.8103 (0.7); 3.7958 (1.6); 3.7519 (16.0); 3.7150 (0.6); 3.7050 (1.0); 3.6853 (0.8); 3.6755 (0.3); 3.3383 (85.2); 3.0541 (0.4); 3.0361 (0.4); 3.0204 (0.8); 3.0024 (0.8); 2.9537 (0.7); 2.9380 (0.8); 2.9200 (0.5); 2.9043 (0.4); 2.8909 (2.5); 2.7310 (2.0); 2.6719 (0.4); 2.5253 (1.1); 2.5206 (1.6); 2.5119 (19.7); 2.5074 (41.0); 2.5029 (54.4); 2.4983 (38.0); 2.4938 (17.3); 2.3296 (0.3); 0.0000 (7.0)
1H-NMR(300.2 MHz, d6-DMSO) δ = 7.9359 (4.3); 7.8486 (1.1); 7.8206 (2.5); 7.7808 (2.3); 7.7532 (1.1); 7.7028 (0.8); 7.6902 (0.8); 7.6581 (1.6); 7.6512 (1.7); 7.5090 (0.8); 7.4814 (2.0); 7.4477 (1.4); 7.4408 (1.2); 7.4202 (0.6); 7.4133 (0.6); 3.9400 (0.3); 3.9290 (0.5); 3.8961 (1.1); 3.8765 (0.4); 3.8651 (0.3); 3.8182 (0.6); 3.8108 (0.7); 3.7844 (0.5); 3.3498 (16.0); 3.0747 (0.5); 3.0503 (0.5); 3.0199 (0.6); 2.9989 (0.6); 2.5343 (1.0); 2.5284 (2.0); 2.5223 (2.6); 2.5163 (1.9); 2.5104 (0.9); 0.0184 (1.0)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.2790 (0.9); 8.2724 (7.6); 8.2674 (3.1); 8.2599 (5.0); 8.2551 (3.9); 8.2502 (8.9); 8.2431 (2.3); 8.2376 (5.3); 8.2305 (0.7); 8.1885 (0.4); 7.9535 (14.7); 7.8414 (0.4); 7.8264 (0.6); 7.8195 (5.5); 7.8144 (1.6); 7.8016 (2.2); 7.7969 (6.0); 7.7943 (9.1); 7.7892 (3.0); 7.7770 (2.5); 7.7720 (8.0); 7.7655 (0.9); 7.7594 (0.6); 7.7180 (0.4); 7.7018 (2.4); 7.6920 (2.7); 7.6715 (0.3); 7.6390 (4.9); 7.6338 (5.1); 7.4807 (3.0); 7.4600 (6.0); 7.4254 (3.9); 7.4201 (3.6); 7.4047 (1.9); 7.3995 (1.9); 6.5419 (0.3); 3.9124 (1.1); 3.9041 (1.6); 3.8779 (3.0); 3.8645 (1.2); 3.8566 (1.3); 3.8480 (1.0); 3.8389 (0.6); 3.7907 (1.7); 3.7841 (2.1); 3.7641 (1.8); 3.7576 (1.1); 3.3382 (207.9); 3.0854 (1.1); 3.0670 (1.0); 3.0514 (1.7); 3.0332 (1.6); 2.9899 (1.9); 2.9737 (1.9); 2.9558 (0.9); 2.9399 (0.8); 2.8911 (16.0); 2.7312 (13.2); 2.6765 (0.7); 2.6720 (1.0); 2.6675 (0.7); 2.5255 (2.8); 2.5207 (4.2); 2.5120 (54.2); 2.5076 (113.4); 2.5031 (151.0); 2.4986 (107.3); 2.4941 (50.5); 2.3344 (0.7); 2.3299 (0.9); 2.3254 (0.7); 0.9121 (0.5); 0.0080 (0.6); −0.0002 (18.1); −0.0080 (0.6)
1H-NMR(300.2 MHz, CDCl3) δ = 7.7902 (0.6); 7.7217 (1.2); 7.7159 (2.3); 7.7101 (1.5); 7.6110 (0.8); 7.6075 (0.9); 7.6047 (0.8); 7.6013 (0.8); 7.5843 (1.0); 7.5808 (1.1); 7.5780 (1.1); 7.5746 (1.0); 7.5267 (0.8); 7.5231 (1.0); 7.5180 (0.8); 7.5031 (6.2); 7.4957 (1.8); 7.4912 (2.5); 7.4851 (2.2); 7.4720 (0.4); 7.3543 (1.6); 7.3279 (2.4); 7.3202 (0.6); 7.3143 (0.5); 7.2991 (19.7); 7.2929 (3.8); 7.2862 (5.0); 7.2560 (0.5); 4.9627 (0.9); 4.0741 (0.5); 4.0648 (0.9); 4.0339 (2.1); 4.0090 (0.8); 3.9948 (1.1); 3.9759 (0.9); 3.9532 (0.8); 3.1444 (2.4); 3.1228 (2.0); 2.0460 (1.1); 1.5944 (16.0); 1.2928 (0.5); 0.1069 (1.3); 0.0483 (1.0); 0.0374 (23.4); 0.0265 (0.9)
1H-NMR(400.1 MHz, CDCl3) δ = 8.4329 (1.1); 8.4271 (0.9); 8.4234 (0.9); 8.4208 (0.8); 8.4129 (0.9); 8.4090 (1.2); 8.0828 (1.0); 8.0789 (0.8); 8.0690 (0.8); 8.0650 (0.9); 8.0587 (1.2); 7.7886 (0.5); 7.7769 (1.7); 7.7724 (2.2); 7.7627 (2.5); 7.7527 (2.1); 7.7489 (1.5); 7.7367 (0.4); 7.2946 (1.0); 7.2741 (2.4); 7.2596 (9.5); 7.2539 (2.0); 7.1320 (3.4); 7.1263 (2.4); 7.1218 (1.9); 7.1181 (1.5); 7.1160 (1.5); 7.0695 (1.7); 7.0505 (2.1); 6.9912 (2.3); 6.9293 (1.3); 6.9101 (2.1); 6.9068 (1.9); 6.8896 (1.1); 6.8854 (1.0); 5.2978 (3.8); 4.7439 (1.5); 4.2516 (1.0); 4.2323 (1.2); 4.2183 (0.4); 3.9887 (0.7); 3.9770 (1.8); 3.9676 (1.1); 3.9573 (1.7); 3.7784 (16.0); 3.7271 (0.6); 3.7244 (0.6); 3.0664 (0.5); 3.0531 (0.6); 3.0320 (0.9); 3.0185 (0.8); 2.9361 (0.8); 2.9162 (0.8); 2.9020 (0.6); 2.8817 (0.5); 2.3238 (11.3); 2.2613 (10.5); 1.5627 (5.6); 1.2853 (0.5); 1.2752 (0.4); 1.2566 (0.9); 0.8810 (0.3); 0.0699 (1.0); −0.0002 (11.3); −0.0082 (0.6)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.1081 (6.7); 7.8949 (2.2); 7.8400 (2.1); 7.8205 (2.8); 7.7230 (1.2); 7.7037 (1.5); 7.6841 (0.7); 7.4837 (1.4); 7.4755 (1.4); 7.0737 (1.7); 7.0546 (2.5); 7.0119 (2.3); 6.9744 (1.4); 6.9552 (0.9); 3.7641 (0.3); 3.7552 (0.5); 3.7501 (0.5); 3.7423 (0.7); 3.7332 (0.7); 3.7278 (0.6); 3.7182 (0.6); 3.7068 (3.8); 3.6989 (2.3); 3.3465 (127.0); 2.9482 (0.6); 2.9344 (0.6); 2.9148 (0.9); 2.9004 (0.9); 2.8916 (2.1); 2.7769 (0.9); 2.7560 (0.9); 2.7434 (0.7); 2.7317 (1.7); 2.7221 (0.7); 2.6731 (0.4); 2.6276 (16.0); 2.5265 (1.1); 2.5218 (1.7); 2.5130 (18.9); 2.5086 (39.4); 2.5041 (52.4); 2.4995 (36.8); 2.4950 (16.9); 2.3309 (0.4); 2.2981 (11.7); 2.2470 (10.3); 0.0000 (1.1)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.6545 (2.1); 8.5283 (0.7); 8.3189 (0.4); 8.1730 (9.8); 8.1721 (10.1); 7.9528 (1.5); 7.6703 (0.8); 7.6678 (0.9); 7.6642 (0.6); 7.6155 (5.8); 7.6101 (16.0); 7.5990 (0.7); 7.5949 (0.4); 7.5906 (0.6); 7.5854 (0.5); 7.5671 (1.2); 7.5621 (1.3); 7.5545 (1.9); 7.5521 (1.8); 7.5464 (0.7); 7.5427 (0.7); 7.5394 (0.7); 7.5141 (2.4); 7.5047 (2.5); 7.4550 (0.4); 7.4503 (1.0); 7.4410 (14.8); 7.4372 (7.6); 7.4337 (7.1); 7.4256 (7.0); 7.4173 (0.8); 7.4113 (6.7); 7.4043 (1.6); 7.3914 (2.0); 7.3840 (0.6); 7.3752 (1.4); 7.3700 (1.2); 7.3596 (5.2); 7.3542 (6.5); 7.3484 (2.4); 7.3459 (1.9); 7.3422 (1.8); 7.3388 (3.9); 7.3337 (3.3); 7.1367 (2.0); 7.1355 (2.1); 3.8228 (0.5); 3.8042 (3.1); 3.7964 (1.6); 3.7814 (3.6); 3.7740 (2.1); 3.7024 (1.4); 3.6925 (2.5); 3.6783 (0.8); 3.6728 (1.9); 3.6627 (0.8); 3.3398 (263.0); 3.0408 (1.0); 3.0228 (1.0); 3.0075 (1.9); 2.9885 (1.7); 2.9748 (0.4); 2.9439 (1.8); 2.9286 (1.9); 2.9108 (1.2); 2.8910 (12.8); 2.7319 (9.5); 2.7308 (9.8); 2.6766 (0.7); 2.6720 (0.9); 2.6674 (0.7); 2.6628 (0.3); 2.5255 (2.8); 2.5209 (4.1); 2.5121 (52.7); 2.5076 (111.7); 2.5030 (149.3); 2.4984 (104.5); 2.4939 (47.7); 2.3344 (0.7); 2.3299 (0.9); 2.3253 (0.7); 0.0080 (0.5); −0.0002 (18.7); −0.0080 (0.5)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.0134 (1.4); 7.4174 (0.4); 7.3309 (1.1); 7.3109 (2.1); 7.2910 (1.4); 7.1238 (0.7); 7.1200 (1.1); 7.1076 (0.9); 7.1055 (1.2); 7.1032 (1.4); 7.1013 (1.3); 7.0884 (0.6); 7.0860 (0.8); 7.0840 (1.2); 7.0818 (1.2); 7.0794 (0.8); 7.0752 (1.8); 7.0697 (2.0); 7.0648 (1.2); 7.0595 (0.7); 7.0149 (0.5); 6.8830 (0.9); 6.8813 (0.9); 6.8768 (0.9); 6.8751 (0.8); 6.8624 (0.8); 6.8605 (0.8); 6.8563 (0.8); 6.8544 (0.7); 3.7737 (4.1); 3.7359 (16.0); 3.7124 (0.8); 3.7045 (0.5); 3.3460 (16.9); 2.8909 (0.3); 2.7328 (0.4); 2.6040 (3.2); 2.5132 (4.0); 2.5088 (8.3); 2.5042 (11.0); 2.4996 (7.6); 2.4951 (3.5); 2.3035 (2.4); 2.2501 (2.1); 0.0000 (1.0)
1H-NMR(400.2 MHz, d6-DMSO) δ = 7.9866 (6.8); 7.9538 (1.3); 7.4744 (1.4); 7.4655 (1.6); 7.4071 (0.7); 7.3877 (3.0); 7.3825 (2.5); 7.3700 (2.5); 7.3453 (1.9); 7.3258 (1.0); 7.3149 (1.8); 7.3032 (3.0); 7.2943 (3.1); 7.2747 (2.7); 7.1449 (1.4); 7.1426 (1.4); 7.1257 (1.2); 7.1234 (1.2); 3.8822 (0.4); 3.8727 (0.5); 3.8667 (0.6); 3.8622 (0.7); 3.8577 (0.7); 3.8530 (0.7); 3.8474 (0.6); 3.8379 (0.5); 3.7361 (3.6); 3.7273 (3.3); 3.3502 (72.4); 3.3341 (5.2); 3.0860 (0.7); 3.0709 (0.7); 3.0523 (1.1); 3.0371 (1.0); 2.9479 (1.1); 2.9277 (1.1); 2.9142 (0.8); 2.8918 (10.7); 2.8756 (0.5); 2.7322 (8.6); 2.7168 (0.4); 2.5959 (16.0); 2.5797 (0.8); 2.5274 (0.5); 2.5227 (0.8); 2.5139 (10.0); 2.5094 (21.8); 2.5049 (30.2); 2.5003 (22.7); 2.4958 (12.1); 2.3327 (11.7); 2.3176 (0.8); 2.2941 (10.6); 0.0000 (1.0)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.6262 (0.6); 7.9528 (8.3); 7.6242 (4.2); 7.6189 (4.4); 7.5453 (8.3); 7.5066 (1.9); 7.4969 (1.9); 7.4459 (2.8); 7.4343 (0.7); 7.4252 (4.7); 7.4170 (0.4); 7.3730 (3.3); 7.3676 (3.2); 7.3523 (2.2); 7.3472 (3.0); 7.3289 (2.6); 7.3101 (2.7); 7.2765 (3.1); 7.2411 (3.7); 7.2246 (2.4); 7.2231 (2.4); 6.9233 (0.6); 3.8156 (2.0); 3.8091 (1.2); 3.7944 (2.7); 3.7090 (1.0); 3.6990 (1.8); 3.6793 (1.4); 3.6694 (0.6); 3.3363 (140.4); 3.0581 (0.7); 3.0396 (0.7); 3.0241 (1.4); 3.0061 (1.4); 2.9540 (1.3); 2.9380 (1.3); 2.9200 (0.8); 2.9043 (0.7); 2.8908 (4.6); 2.7316 (3.5); 2.7306 (3.6); 2.6761 (0.5); 2.6715 (0.8); 2.6670 (0.5); 2.5251 (2.3); 2.5204 (3.4); 2.5117 (42.1); 2.5072 (88.9); 2.5026 (118.3); 2.4980 (83.2); 2.4935 (38.2); 2.3632 (1.3); 2.3340 (0.6); 2.3294 (0.8); 2.3249 (0.6); 2.3204 (0.4); 2.3035 (16.0); 0.0080 (1.0); −0.0002 (34.7); −0.0080 (1.1)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.6219 (2.4); 8.0651 (1.3); 8.0463 (1.5); 8.0404 (1.7); 8.0380 (1.7); 8.0171 (1.8); 7.9523 (0.6); 7.8357 (0.6); 7.8324 (0.7); 7.8182 (1.0); 7.8151 (1.3); 7.7976 (0.8); 7.7942 (0.8); 7.7501 (0.6); 7.7313 (0.9); 7.7129 (0.4); 7.6743 (1.1); 7.3359 (0.6); 7.3152 (1.4); 7.2947 (0.8); 7.0905 (0.5); 7.0199 (3.7); 7.0163 (2.8); 7.0143 (3.0); 7.0099 (2.0); 7.0014 (1.4); 6.9705 (1.2); 6.9419 (1.0); 6.9245 (1.0); 6.9202 (0.9); 3.8337 (0.5); 3.8115 (0.6); 3.8024 (0.8); 3.7932 (0.9); 3.7855 (0.8); 3.7766 (0.6); 3.7676 (0.5); 3.7287 (16.0); 3.3450 (63.5); 2.8897 (5.4); 2.7311 (4.0); 2.7302 (4.0); 2.5247 (0.8); 2.5200 (1.1); 2.5112 (14.0); 2.5068 (29.6); 2.5022 (39.4); 2.4976 (27.7); 2.4931 (12.8); 2.2715 (3.2); 2.2139 (6.2); 0.0000 (3.5)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.1353 (6.7); 7.9540 (1.0); 7.8827 (2.2); 7.8334 (1.1); 7.8284 (1.2); 7.8144 (1.5); 7.8092 (1.8); 7.8049 (1.6); 7.7529 (0.4); 7.7185 (1.8); 7.6988 (1.7); 7.6791 (0.7); 7.6534 (0.4); 7.6108 (0.4); 7.5916 (0.5); 7.5175 (1.4); 7.5084 (1.4); 7.2998 (2.5); 7.2852 (2.1); 7.2658 (2.6); 7.1318 (1.4); 7.1293 (1.4); 7.1124 (1.1); 7.1100 (1.1); 4.2528 (0.6); 3.8780 (0.3); 3.8686 (0.5); 3.8623 (0.6); 3.8580 (0.6); 3.8534 (0.6); 3.8488 (0.6); 3.8434 (0.5); 3.8336 (0.4); 3.7317 (3.5); 3.7229 (3.0); 3.3392 (65.5); 3.0795 (0.7); 3.0645 (0.7); 3.0460 (1.0); 3.0308 (1.0); 2.9363 (1.1); 2.9161 (1.0); 2.9024 (0.8); 2.8917 (7.9); 2.8824 (0.7); 2.7318 (6.5); 2.6730 (0.3); 2.6273 (16.0); 2.5265 (0.9); 2.5219 (1.4); 2.5131 (18.2); 2.5086 (38.5); 2.5041 (51.7); 2.4995 (36.6); 2.4950 (17.1); 2.3310 (0.4); 2.2892 (10.5); 2.1504 (0.4); 2.1337 (0.4); 2.0005 (2.8); 0.0000 (5.9)
1H-NMR(300.2 MHz, CDCl3) δ = 7.5236 (8.6); 7.4832 (4.3); 7.3569 (3.6); 7.3467 (4.6); 7.3294 (5.6); 7.2988 (34.7); 7.2849 (9.9); 7.2811 (9.8); 7.2563 (1.5); 7.2440 (0.7); 5.0531 (1.4); 4.0272 (1.2); 4.0190 (1.8); 3.9903 (3.2); 3.9808 (1.9); 3.9540 (1.9); 3.9374 (1.7); 3.9156 (1.0); 3.8988 (0.5); 3.8329 (0.3); 3.1624 (0.4); 3.1380 (2.4); 3.1267 (2.3); 3.1170 (2.4); 3.1022 (2.0); 3.0811 (0.4); 3.0557 (0.4); 2.3948 (16.0); 2.0423 (3.3); 1.6285 (4.5); 1.2961 (0.8); 0.1085 (4.7); 0.0502 (1.3); 0.0393 (37.4); 0.0284 (1.5)
1H-NMR(400.2 MHz, d6-DMSO) δ = 7.9527 (1.3); 7.8879 (16.0); 7.6560 (2.9); 7.6434 (7.7); 7.6380 (6.6); 7.6138 (3.8); 7.6116 (5.1); 7.6076 (3.6); 7.5621 (1.4); 7.5556 (2.0); 7.5495 (1.5); 7.5457 (2.2); 7.5391 (3.5); 7.5338 (2.9); 7.5249 (0.7); 7.5206 (1.7); 7.5165 (1.3); 7.5049 (10.2); 7.4976 (3.1); 7.4886 (3.7); 7.4851 (4.2); 7.4767 (0.6); 7.4696 (1.2); 7.4643 (7.2); 7.4269 (4.8); 7.4215 (4.5); 7.4063 (2.4); 7.4009 (2.5); 3.9092 (1.3); 3.9009 (1.9); 3.8746 (3.6); 3.8615 (1.5); 3.8537 (1.5); 3.8449 (1.1); 3.8358 (0.7); 3.8270 (0.4); 3.7903 (2.1); 3.7838 (2.6); 3.7639 (2.1); 3.7572 (1.3); 3.3357 (205.5); 3.0860 (1.2); 3.0677 (1.2); 3.0521 (2.0); 3.0337 (1.9); 2.9925 (2.3); 2.9764 (2.4); 2.9584 (1.1); 2.9424 (0.9); 2.8907 (11.0); 2.7306 (8.8); 2.6806 (0.4); 2.6761 (0.8); 2.6715 (1.1); 2.6669 (0.8); 2.6626 (0.4); 2.5250 (3.7); 2.5203 (5.4); 2.5115 (66.2); 2.5071 (139.4); 2.5026 (185.8); 2.4980 (131.0); 2.4935 (60.5); 2.3384 (0.4); 2.3339 (0.9); 2.3294 (1.2); 2.3248 (0.8); 0.0080 (0.7); −0.0002 (23.8); −0.0080 (0.7)
1H-NMR(400.2 MHz, d6-DMSO) δ = 7.9532 (2.1); 7.9026 (4.8); 7.8801 (1.6); 7.8594 (1.2); 7.8391 (1.7); 7.7280 (0.9); 7.7087 (1.3); 7.6894 (0.6); 7.6713 (1.1); 7.6615 (1.0); 7.6427 (2.0); 7.6374 (2.0); 7.4904 (1.3); 7.4696 (2.4); 7.4261 (1.5); 7.4209 (1.4); 7.4054 (0.8); 7.4003 (0.9); 3.9195 (0.5); 3.9112 (0.7); 3.8850 (1.2); 3.8713 (0.5); 3.8631 (0.5); 3.8545 (0.4); 3.7990 (0.8); 3.7925 (0.9); 3.7726 (0.8); 3.7661 (0.5); 3.3418 (66.5); 3.0942 (0.4); 3.0756 (0.4); 3.0602 (0.8); 3.0416 (0.7); 2.9989 (0.8); 2.9827 (0.8); 2.9647 (0.4); 2.9488 (0.4); 2.8915 (16.0); 2.7318 (13.9); 2.5258 (0.9); 2.5209 (1.3); 2.5123 (16.5); 2.5080 (33.9); 2.5036 (44.9); 2.4992 (32.1); 2.4949 (15.4); 2.0757 (0.5); 0.0000 (2.6)
1H-NMR(300.2 MHz, CDCl3) δ = 7.8197 (2.8); 7.7768 (1.4); 7.7509 (1.9); 7.7251 (1.3); 7.6988 (1.8); 7.6000 (1.6); 7.5740 (2.2); 7.5481 (0.9); 7.4730 (9.0); 7.2989 (3.8); 7.1211 (1.8); 7.0957 (3.6); 7.0746 (3.0); 7.0490 (2.1); 7.0234 (1.0); 5.0075 (1.9); 4.2043 (0.4); 4.1859 (1.6); 4.1602 (1.8); 4.1414 (0.7); 3.9118 (1.2); 3.8939 (2.7); 3.8852 (1.0); 3.8697 (2.4); 3.8519 (0.7); 3.0492 (0.7); 3.0310 (0.7); 3.0037 (1.2); 2.9842 (1.2); 2.9204 (1.4); 2.8947 (1.3); 2.8755 (0.7); 2.8477 (0.6); 2.3615 (16.0); 2.3392 (14.9); 2.2037 (2.2); 2.0408 (0.9); 1.6145 (0.6); 0.0392 (4.6)
1H-NMR(499.9 MHz, CDCl3) δ = 8.1992 (3.9); 8.1826 (4.2); 7.8836 (4.6); 7.8669 (4.2); 7.8551 (7.6); 7.2590 (7.3); 7.1260 (2.4); 7.1107 (3.0); 7.0246 (3.3); 6.9999 (2.0); 6.9845 (1.5); 5.5618 (2.1); 4.1608 (1.3); 4.1545 (1.5); 4.1394 (1.7); 4.1333 (1.6); 3.9701 (0.4); 3.9569 (0.9); 3.9502 (1.0); 3.9442 (1.1); 3.9383 (0.8); 3.9300 (0.8); 3.9207 (2.3); 3.9091 (1.1); 3.8993 (1.7); 3.8877 (1.1); 3.0266 (0.9); 3.0133 (0.9); 2.9989 (1.7); 2.9853 (1.6); 2.9464 (1.6); 2.9314 (1.6); 2.9186 (0.9); 2.9032 (0.8); 2.3550 (0.4); 2.3307 (16.0); 2.2986 (15.0); 1.5564 (1.8); −0.0002 (8.2); −0.0066 (0.4)
1H-NMR(400.2 MHz, d6-DMSO) δ = 7.9528 (0.8); 7.8957 (16.0); 7.6634 (2.8); 7.6537 (2.9); 7.6410 (6.1); 7.6357 (6.3); 7.6288 (1.6); 7.6094 (4.6); 7.5899 (6.9); 7.5850 (5.8); 7.5812 (4.0); 7.5699 (0.9); 7.5659 (1.8); 7.5618 (0.9); 7.5472 (3.7); 7.4974 (2.2); 7.4865 (4.4); 7.4788 (1.8); 7.4658 (6.9); 7.4248 (4.5); 7.4195 (4.2); 7.4042 (2.4); 7.3988 (2.4); 3.9120 (1.3); 3.9035 (1.8); 3.8774 (3.5); 3.8640 (1.4); 3.8561 (1.5); 3.8474 (1.1); 3.8384 (0.7); 3.8301 (0.3); 3.7928 (2.0); 3.7863 (2.5); 3.7665 (2.1); 3.7598 (1.2); 3.3435 (245.9); 3.0882 (1.2); 3.0699 (1.2); 3.0541 (1.9); 3.0358 (1.8); 2.9940 (2.2); 2.9777 (2.3); 2.9600 (1.1); 2.9438 (0.9); 2.8912 (6.9); 2.7312 (5.6); 2.6770 (0.6); 2.6724 (0.9); 2.6679 (0.6); 2.5259 (2.6); 2.5212 (3.8); 2.5124 (48.8); 2.5079 (103.2); 2.5034 (138.1); 2.4989 (97.9); 2.4944 (45.8); 2.3347 (0.6); 2.3303 (0.9); 2.3257 (0.6); 0.0000 (6.4)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.6572 (0.8); 8.1898 (7.8); 7.9533 (1.9); 7.6319 (0.6); 7.6243 (8.1); 7.6174 (0.7); 7.6108 (4.1); 7.6055 (4.1); 7.5983 (0.5); 7.5676 (0.5); 7.5624 (0.5); 7.5554 (1.5); 7.5464 (0.4); 7.5419 (0.5); 7.5362 (2.2); 7.5333 (2.4); 7.5254 (0.8); 7.5139 (4.5); 7.5030 (2.0); 7.4936 (0.5); 7.4824 (0.4); 7.4739 (0.5); 7.4627 (0.4); 7.4420 (0.4); 7.4303 (2.7); 7.4096 (4.7); 7.3976 (2.8); 7.3943 (2.8); 7.3776 (5.9); 7.3754 (6.2); 7.3623 (1.7); 7.3562 (3.7); 7.3508 (3.0); 7.3355 (1.7); 7.3301 (1.7); 7.1940 (0.8); 3.8186 (0.4); 3.7987 (2.4); 3.7755 (2.7); 3.7680 (1.4); 3.6897 (1.2); 3.6799 (2.0); 3.6602 (1.6); 3.6503 (0.6); 3.3771 (0.6); 3.3468 (217.6); 3.3251 (1.0); 3.0377 (0.8); 3.0198 (0.8); 3.0042 (1.4); 2.9855 (1.3); 2.9389 (1.4); 2.9235 (1.5); 2.9052 (0.9); 2.8917 (16.0); 2.7319 (12.5); 2.6775 (0.4); 2.6730 (0.5); 2.6687 (0.4); 2.5264 (1.6); 2.5217 (2.5); 2.5130 (30.3); 2.5086 (62.9); 2.5040 (83.3); 2.4995 (58.4); 2.4950 (26.7); 2.3355 (0.4); 2.3308 (0.5); 2.3262 (0.4); 1.2340 (0.4); 1.0952 (0.9); 1.0798 (0.9); 0.0000 (3.5)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.1330 (6.8); 7.9537 (1.0); 7.6329 (1.0); 7.6126 (2.7); 7.5922 (2.2); 7.5622 (2.1); 7.5591 (1.9); 7.5456 (2.9); 7.5423 (2.8); 7.5096 (1.4); 7.5009 (1.5); 7.4865 (1.2); 7.4838 (1.2); 7.4663 (0.8); 7.4633 (0.9); 7.2998 (2.5); 7.2840 (2.1); 7.2646 (2.7); 7.1330 (1.4); 7.1307 (1.4); 7.1137 (1.1); 3.8757 (0.4); 3.8662 (0.5); 3.8601 (0.6); 3.8557 (0.7); 3.8511 (0.7); 3.8467 (0.6); 3.8409 (0.6); 3.8312 (0.4); 3.7298 (3.5); 3.7210 (3.1); 3.3385 (48.8); 3.0784 (0.7); 3.0630 (0.7); 3.0446 (1.0); 3.0294 (1.0); 2.9357 (1.1); 2.9156 (1.1); 2.9018 (0.8); 2.8914 (8.0); 2.8818 (0.8); 2.7318 (6.6); 2.6259 (16.0); 2.5261 (1.0); 2.5213 (1.4); 2.5125 (17.8); 2.5082 (36.8); 2.5037 (48.7); 2.4992 (34.5); 2.4947 (16.2); 2.3305 (0.3); 2.2895 (10.8); 0.0079 (0.4); −0.0002 (13.4); −0.0080 (0.4)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.6483 (0.8); 8.2010 (5.0); 7.9534 (1.9); 7.8679 (0.4); 7.7280 (2.7); 7.7221 (1.9); 7.7171 (1.2); 7.6595 (0.4); 7.6545 (0.4); 7.6448 (1.9); 7.6410 (4.2); 7.6351 (1.4); 7.6299 (5.5); 7.6227 (1.3); 7.6085 (2.7); 7.6031 (3.0); 7.5592 (0.5); 7.5540 (0.5); 7.5256 (1.2); 7.5158 (1.2); 7.4316 (1.8); 7.4108 (3.0); 7.3990 (0.7); 7.3752 (0.4); 7.3700 (0.4); 7.3521 (1.9); 7.3468 (1.8); 7.3315 (1.2); 7.3261 (1.2); 7.2407 (0.8); 7.2395 (0.8); 3.8109 (0.5); 3.7994 (1.4); 3.7941 (1.3); 3.7737 (1.7); 3.7654 (0.9); 3.6877 (0.7); 3.6798 (1.2); 3.6602 (1.0); 3.3437 (104.7); 3.0395 (0.5); 3.0215 (0.5); 3.0060 (0.9); 2.9872 (0.8); 2.9374 (0.9); 2.9220 (1.0); 2.9033 (0.7); 2.8917 (16.0); 2.7327 (12.2); 2.7315 (12.9); 2.6729 (0.3); 2.5264 (1.0); 2.5218 (1.5); 2.5130 (18.4); 2.5085 (39.6); 2.5040 (53.3); 2.4994 (37.9); 2.4949 (17.7); 2.3308 (0.3); 1.1157 (0.4); 1.1002 (0.4); 0.0000 (3.9)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.5721 (3.4); 8.0601 (1.8); 8.0413 (2.0); 8.0392 (2.0); 8.0276 (2.1); 8.0071 (2.4); 7.9522 (0.8); 7.8258 (0.9); 7.8225 (1.0); 7.8084 (1.5); 7.8052 (1.8); 7.7878 (1.2); 7.7843 (1.1); 7.7455 (0.9); 7.7262 (1.3); 7.7115 (0.6); 7.7083 (0.6); 7.6710 (1.6); 7.6645 (1.7); 7.3024 (3.3); 7.2763 (2.0); 7.2655 (2.5); 7.2461 (0.8); 7.1881 (1.5); 7.1706 (1.2); 7.1093 (0.7); 7.0927 (0.8); 6.9731 (1.8); 6.8897 (0.3); 4.2224 (0.5); 3.8423 (0.7); 3.8105 (0.8); 3.8019 (1.0); 3.7928 (1.2); 3.7846 (1.0); 3.7757 (0.8); 3.7673 (0.5); 3.3442 (93.6); 2.9010 (0.8); 2.8895 (6.9); 2.7303 (5.1); 2.5246 (0.9); 2.5199 (1.3); 2.5111 (15.7); 2.5067 (33.2); 2.5021 (44.4); 2.4976 (31.3); 2.4931 (14.4); 2.3290 (0.5); 2.3244 (0.4); 2.2796 (16.0); 2.2161 (9.6); 0.9298 (0.4); 0.9113 (0.9); 0.8928 (0.4); 0.0000 (5.2)
1H-NMR(400.2 MHz, d6-DMSO) δ = 9.1214 (0.4); 8.6980 (4.2); 8.5239 (0.6); 8.3182 (0.5); 8.0846 (3.0); 8.0658 (7.4); 8.0458 (4.2); 7.9523 (2.0); 7.8663 (1.5); 7.8487 (2.7); 7.8309 (1.7); 7.8284 (1.7); 7.7731 (1.2); 7.7551 (1.8); 7.7350 (1.3); 7.7263 (0.9); 7.7196 (0.6); 7.7117 (1.0); 7.7021 (0.4); 7.6783 (2.7); 7.6700 (2.9); 7.6565 (0.9); 7.4486 (5.8); 7.3998 (13.7); 7.3712 (0.4); 7.1460 (0.3); 7.0801 (0.7); 6.9625 (1.7); 6.8994 (0.4); 4.2385 (1.0); 4.2221 (2.2); 4.2057 (1.1); 3.8108 (1.8); 3.8026 (2.2); 3.7941 (2.0); 3.7865 (1.4); 3.3466 (277.6); 2.8902 (16.0); 2.7307 (13.2); 2.6762 (0.6); 2.6717 (0.8); 2.6673 (0.6); 2.5250 (2.6); 2.5198 (4.1); 2.5115 (47.4); 2.5072 (96.8); 2.5028 (128.1); 2.4983 (90.6); 2.4938 (42.0); 2.3296 (1.7); 2.3257 (1.2); 2.2645 (4.2); 2.2079 (11.4); 2.0458 (0.9); 1.6596 (0.6); 1.6422 (0.8); 1.6222 (0.7); 1.4016 (0.5); 1.3826 (0.8); 1.3638 (0.8); 1.3455 (0.5); 1.3365 (0.6); 1.2248 (0.8); 0.9299 (1.9); 0.9116 (3.7); 0.8930 (1.6); 0.0000 (5.2)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.7121 (6.3); 8.0950 (4.2); 8.0757 (10.0); 8.0550 (5.8); 7.9532 (2.0); 7.8740 (2.1); 7.8563 (3.8); 7.8385 (2.3); 7.8358 (2.3); 7.7802 (1.7); 7.7614 (2.4); 7.7430 (1.2); 7.6673 (3.8); 7.5277 (2.0); 7.5078 (5.1); 7.4877 (3.8); 7.4331 (5.3); 7.4123 (3.5); 7.3895 (6.2); 7.3356 (2.8); 7.3151 (2.3); 7.0822 (0.9); 7.0659 (0.8); 6.9599 (2.2); 6.8559 (0.3); 6.8114 (0.4); 6.7991 (0.4); 6.7930 (0.4); 6.6421 (0.4); 3.8682 (1.0); 3.7989 (2.9); 3.4188 (0.3); 3.4078 (0.5); 3.4041 (0.4); 3.3954 (0.7); 3.3554 (439.5); 3.3188 (0.6); 3.3098 (0.4); 2.8912 (16.0); 2.7322 (13.2); 2.6773 (0.6); 2.6729 (0.7); 2.6685 (0.6); 2.5263 (2.0); 2.5215 (2.8); 2.5126 (39.7); 2.5084 (82.7); 2.5039 (109.6); 2.4995 (78.8); 2.4956 (38.3); 2.3352 (0.7); 2.3308 (0.9); 2.3266 (0.7); 2.3215 (0.5); 2.2570 (5.0); 2.2045 (12.7); 1.2348 (0.7); 0.0000 (2.2)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.1074 (6.8); 7.9538 (0.8); 7.6384 (1.0); 7.6181 (2.7); 7.5979 (2.5); 7.5793 (1.0); 7.5757 (2.3); 7.5724 (1.9); 7.5592 (2.8); 7.5557 (2.5); 7.4933 (1.1); 7.4904 (1.2); 7.4875 (1.1); 7.4845 (0.9); 7.4767 (1.7); 7.4701 (2.2); 7.0731 (1.7); 7.0540 (2.4); 7.0114 (2.2); 6.9750 (1.3); 6.9557 (0.9); 3.7538 (0.4); 3.7488 (0.5); 3.7406 (0.7); 3.7321 (0.7); 3.7269 (0.6); 3.7060 (3.8); 3.6980 (2.2); 3.3491 (109.7); 3.3229 (0.3); 2.9477 (0.6); 2.9337 (0.6); 2.9143 (0.9); 2.8997 (0.9); 2.8919 (6.5); 2.7773 (0.9); 2.7563 (0.9); 2.7437 (0.7); 2.7331 (5.0); 2.7321 (5.2); 2.7225 (0.6); 2.6268 (16.0); 2.5271 (0.7); 2.5224 (1.0); 2.5137 (13.3); 2.5092 (28.2); 2.5046 (37.7); 2.5000 (26.4); 2.4955 (12.1); 2.2979 (11.5); 2.2473 (10.1); 0.0000 (1.2)
1H-NMR(300.2 MHz, CDCl3) δ = 7.7132 (1.1); 7.6828 (13.2); 7.6490 (0.8); 7.4929 (8.2); 7.2988 (8.9); 7.1239 (1.8); 7.0982 (3.8); 7.0858 (3.2); 7.0548 (2.2); 7.0292 (1.0); 4.9028 (1.8); 4.2190 (0.4); 4.2002 (1.6); 4.1745 (1.8); 4.1559 (0.7); 3.9134 (1.2); 3.9005 (2.5); 3.8868 (1.0); 3.8751 (2.5); 3.8569 (0.7); 3.0578 (0.8); 3.0399 (0.8); 3.0122 (1.2); 2.9931 (1.2); 2.9167 (1.3); 2.8906 (1.3); 2.8718 (0.7); 2.8436 (0.6); 2.3680 (16.0); 2.3480 (14.9); 1.5915 (3.6); 0.0491 (0.4); 0.0383 (11.2); 0.0277 (0.5)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.5166 (0.4); 7.9524 (0.8); 7.8460 (8.7); 7.6418 (5.3); 7.6366 (4.9); 7.4894 (2.3); 7.4687 (4.1); 7.4254 (2.6); 7.4201 (2.6); 7.4048 (1.5); 7.3995 (1.5); 7.3746 (0.8); 7.3550 (3.2); 7.3489 (3.3); 7.3383 (3.7); 7.3297 (3.1); 7.3157 (0.9); 7.3109 (0.9); 7.2891 (2.1); 7.2766 (0.9); 7.2717 (1.2); 6.6840 (0.4); 3.8954 (0.8); 3.8868 (1.3); 3.8759 (0.6); 3.8626 (2.6); 3.8501 (1.0); 3.8404 (0.8); 3.8315 (0.5); 3.7841 (1.1); 3.7789 (1.6); 3.7589 (1.3); 3.3898 (0.6); 3.3494 (407.6); 3.0851 (0.7); 3.0667 (0.7); 3.0512 (1.2); 3.0328 (1.2); 2.9923 (1.4); 2.9767 (1.4); 2.9586 (0.7); 2.9425 (0.6); 2.8912 (5.5); 2.7317 (4.7); 2.6768 (0.6); 2.6723 (0.8); 2.6679 (0.6); 2.5257 (2.4); 2.5209 (3.5); 2.5120 (49.1); 2.5078 (102.3); 2.5034 (135.6); 2.4989 (98.1); 2.3305 (16.0); 2.3083 (0.4); 1.2349 (0.4); 0.0000 (2.9)
1H-NMR(400.1 MHz, CDCl3) δ = 8.4484 (0.4); 8.4403 (1.6); 8.4342 (1.3); 8.4302 (1.3); 8.4284 (1.3); 8.4200 (1.5); 8.4162 (1.8); 8.0739 (1.6); 8.0697 (1.3); 8.0613 (1.4); 8.0559 (1.4); 8.0497 (1.8); 8.0417 (0.5); 7.8559 (3.2); 7.8083 (0.9); 7.7964 (4.1); 7.7926 (4.8); 7.7825 (4.3); 7.7730 (4.9); 7.7568 (0.9); 7.6456 (1.5); 7.6255 (2.1); 7.5335 (1.6); 7.5140 (2.4); 7.4946 (1.1); 7.2596 (11.8); 7.0918 (2.4); 7.0726 (3.1); 7.0001 (3.4); 6.9384 (2.0); 6.9197 (1.6); 5.2981 (3.0); 4.7628 (2.3); 4.2983 (0.5); 4.2840 (1.6); 4.2646 (1.8); 4.2510 (0.8); 4.0244 (1.2); 4.0116 (2.9); 4.0045 (1.9); 3.9922 (2.8); 3.0927 (0.8); 3.0796 (0.9); 3.0582 (1.4); 3.0448 (1.3); 2.9718 (1.4); 2.9519 (1.4); 2.9380 (0.9); 2.9169 (0.8); 2.3341 (16.0); 2.2631 (15.2); 1.5529 (14.8); 1.2846 (0.4); 1.2561 (0.7); 0.0701 (4.9); −0.0002 (14.3)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.7177 (7.4); 8.0978 (5.2); 8.0756 (10.5); 8.0527 (7.0); 7.9529 (1.9); 7.8767 (2.4); 7.8741 (2.6); 7.8566 (4.7); 7.8389 (2.8); 7.8359 (2.8); 7.7812 (2.0); 7.7626 (11.2); 7.7470 (1.6); 7.6916 (10.4); 7.6734 (10.8); 7.6185 (4.2); 7.5998 (4.0); 7.5794 (1.8); 7.0837 (1.0); 7.0750 (1.0); 6.9564 (2.2); 6.8622 (0.4); 6.8475 (0.3); 6.8347 (0.3); 6.7662 (0.5); 6.6208 (0.4); 3.8055 (3.6); 3.3973 (0.5); 3.3915 (0.7); 3.3519 (500.8); 3.3170 (0.7); 3.3095 (0.4); 3.3009 (0.4); 3.2893 (0.3); 2.8907 (16.0); 2.7312 (12.1); 2.6813 (0.4); 2.6771 (0.7); 2.6726 (1.0); 2.6680 (0.7); 2.5261 (2.9); 2.5214 (4.2); 2.5125 (52.7); 2.5081 (112.3); 2.5036 (150.9); 2.4990 (107.7); 2.4945 (50.4); 2.3349 (1.0); 2.3304 (1.3); 2.3259 (1.2); 2.2570 (5.3); 2.2009 (12.2); 1.2339 (0.8); 0.0000 (5.0)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.1051 (6.8); 7.9537 (1.1); 7.6321 (1.0); 7.6293 (1.8); 7.6273 (2.3); 7.6241 (1.8); 7.6222 (1.4); 7.5599 (0.6); 7.5550 (0.5); 7.5483 (1.4); 7.5425 (1.0); 7.5366 (1.8); 7.5314 (1.9); 7.5276 (1.0); 7.5226 (0.6); 7.5167 (0.5); 7.5074 (5.0); 7.5044 (2.5); 7.4978 (1.7); 7.4946 (2.6); 7.4722 (1.3); 7.4638 (1.3); 7.4169 (0.4); 7.4128 (0.5); 7.3957 (0.6); 7.3946 (0.6); 7.3886 (0.4); 7.3840 (0.4); 7.3807 (0.6); 7.3777 (0.4); 7.0739 (1.6); 7.0547 (2.4); 7.0116 (2.1); 6.9762 (1.3); 6.9567 (0.9); 4.2164 (0.4); 3.7543 (0.4); 3.7493 (0.5); 3.7416 (0.7); 3.7325 (0.7); 3.7269 (0.5); 3.7065 (3.7); 3.6985 (2.2); 3.3444 (67.3); 2.9483 (0.6); 2.9343 (0.6); 2.9148 (0.9); 2.9004 (0.9); 2.8914 (9.1); 2.7785 (0.9); 2.7576 (0.8); 2.7449 (0.7); 2.7328 (7.0); 2.7316 (7.4); 2.7239 (0.7); 2.6234 (16.0); 2.5267 (0.6); 2.5220 (0.9); 2.5132 (11.9); 2.5087 (25.6); 2.5042 (34.3); 2.4996 (24.1); 2.4950 (11.0); 2.2993 (11.1); 2.2479 (9.8); 2.0144 (2.0); 0.0000 (2.4)
1H-NMR(400.2 MHz, d6-DMSO) δ = 7.9688 (6.7); 7.9539 (1.1); 7.4452 (1.4); 7.4369 (1.4); 7.4110 (0.7); 7.3916 (4.5); 7.3740 (2.3); 7.3530 (1.9); 7.3375 (0.6); 7.3338 (0.8); 7.3210 (1.5); 7.3013 (0.9); 7.0807 (1.7); 7.0616 (2.4); 7.0155 (2.3); 6.9827 (1.4); 6.9631 (0.9); 3.7686 (0.3); 3.7542 (0.5); 3.7466 (0.7); 3.7378 (0.7); 3.7312 (0.6); 3.7121 (4.0); 3.7041 (2.3); 3.3841 (0.4); 3.3577 (103.7); 3.3352 (0.4); 2.9530 (0.6); 2.9394 (0.6); 2.9197 (0.9); 2.9053 (0.9); 2.8918 (8.6); 2.7889 (0.9); 2.7682 (0.9); 2.7555 (0.8); 2.7333 (7.2); 2.7323 (7.3); 2.5973 (16.0); 2.5275 (0.6); 2.5229 (0.8); 2.5141 (9.6); 2.5097 (20.3); 2.5051 (27.0); 2.5005 (19.0); 2.4960 (8.8); 2.3348 (11.7); 2.3041 (11.5); 2.2505 (10.2); 0.0000 (3.0)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.1304 (6.8); 7.9536 (1.2); 7.6121 (2.3); 7.6093 (2.3); 7.6068 (1.3); 7.5541 (0.6); 7.5492 (0.5); 7.5448 (0.7); 7.5400 (1.3); 7.5338 (1.3); 7.5306 (2.1); 7.5255 (1.8); 7.5207 (1.1); 7.5154 (0.6); 7.5033 (4.2); 7.5021 (4.1); 7.4983 (3.2); 7.4947 (3.4); 7.4892 (3.2); 7.4864 (3.0); 7.4797 (0.4); 7.4763 (0.3); 7.4169 (0.4); 7.4130 (0.5); 7.3952 (0.7); 7.3891 (0.4); 7.3845 (0.4); 7.3812 (0.6); 7.3784 (0.4); 7.3003 (2.3); 7.2855 (2.0); 7.2661 (2.6); 7.1349 (1.3); 7.1324 (1.3); 7.1156 (1.0); 7.1132 (1.0); 4.2166 (0.4); 3.8772 (0.3); 3.8678 (0.5); 3.8618 (0.5); 3.8573 (0.6); 3.8526 (0.6); 3.8481 (0.6); 3.8424 (0.5); 3.8327 (0.4); 3.7320 (3.3); 3.7232 (2.9); 3.3815 (0.5); 3.3578 (147.9); 3.0785 (0.6); 3.0629 (0.7); 3.0447 (1.0); 3.0295 (0.9); 2.9385 (1.0); 2.9183 (1.0); 2.9046 (0.8); 2.8921 (10.6); 2.8849 (0.8); 2.7334 (8.1); 2.7321 (8.5); 2.6227 (16.0); 2.5278 (0.7); 2.5231 (1.0); 2.5143 (13.4); 2.5098 (28.6); 2.5053 (38.4); 2.5007 (27.0); 2.4961 (12.3); 2.2909 (10.0); 2.0140 (2.1)
1H-NMR(300.2 MHz, CDCl3) δ = 7.5217 (5.9); 7.4782 (2.4); 7.3797 (1.0); 7.3529 (1.8); 7.3266 (1.4); 7.2985 (14.3); 7.2797 (5.4); 7.2759 (6.0); 7.1277 (1.3); 7.1257 (1.3); 7.1227 (1.1); 7.1004 (1.4); 7.0969 (1.5); 7.0944 (1.6); 7.0860 (1.8); 7.0807 (1.2); 7.0076 (1.1); 7.0048 (1.0); 6.9991 (0.9); 6.9799 (0.9); 6.9769 (0.8); 6.9715 (0.8); 5.0589 (0.9); 5.0504 (0.9); 4.0210 (0.8); 4.0136 (1.1); 3.9845 (2.0); 3.9761 (1.3); 3.9530 (1.3); 3.9365 (1.0); 3.9140 (0.6); 3.8975 (0.3); 3.8310 (16.0); 3.1303 (1.8); 3.1245 (1.6); 3.1087 (1.6); 3.1001 (1.4); 2.0414 (1.1); 1.5952 (3.3); 1.2952 (0.5); 0.1082 (2.0); 0.0495 (0.5); 0.0388 (15.5); 0.0295 (0.5); 0.0279 (0.6)
1H-NMR(300.2 MHz, d6-DMSO) δ = 7.9336 (1.7); 7.8491 (0.4); 7.8212 (1.0); 7.7803 (1.0); 7.7704 (0.9); 7.7635 (0.8); 7.7528 (0.5); 7.7007 (0.3); 7.6880 (0.3); 7.5475 (0.4); 7.5407 (0.4); 7.4368 (0.7); 7.4093 (0.5); 3.8964 (0.4); 3.3520 (16.0); 2.5343 (0.6); 2.5283 (1.2); 2.5223 (1.6); 2.5162 (1.2); 2.5104 (0.5); 0.0189 (0.4)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.4889 (0.4); 8.4867 (0.4); 8.4693 (1.6); 8.4667 (1.6); 8.4649 (1.5); 8.4572 (1.6); 8.4546 (1.6); 7.9508 (1.8); 7.8076 (0.4); 7.8037 (0.4); 7.7659 (1.0); 7.7612 (1.0); 7.7462 (1.7); 7.7421 (1.8); 7.7271 (1.2); 7.7224 (1.3); 7.7051 (1.9); 7.6333 (0.7); 7.6131 (0.6); 7.3721 (2.5); 7.3520 (2.2); 7.2949 (1.6); 7.2828 (1.6); 7.2780 (1.6); 7.2658 (1.4); 7.2645 (1.4); 6.6863 (3.3); 4.7023 (1.0); 4.0932 (0.7); 4.0835 (0.8); 4.0657 (0.9); 4.0564 (0.8); 3.6604 (0.4); 3.3293 (35.9); 2.8907 (12.6); 2.7323 (10.8); 2.6309 (16.0); 2.5100 (5.6); 2.5057 (12.0); 2.5012 (16.3); 2.4967 (12.1); 2.4924 (6.0); 2.3507 (6.0); 2.3288 (13.9); 2.2471 (1.4); −0.0002 (0.5)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.2083 (2.1); 8.1875 (2.2); 8.1064 (2.3); 8.0857 (2.5); 8.0405 (2.2); 8.0202 (2.4); 7.9509 (0.9); 7.9395 (3.0); 7.9034 (2.5); 7.8857 (2.8); 7.6140 (2.0); 7.5938 (3.4); 7.5755 (3.7); 7.5561 (1.6); 7.5241 (1.6); 7.5212 (1.6); 7.5034 (2.2); 7.5006 (1.5); 7.4860 (1.0); 7.4832 (0.9); 4.8279 (0.9); 4.8239 (1.0); 4.8128 (1.6); 4.8076 (1.2); 4.8016 (1.0); 4.1928 (1.1); 4.1829 (1.2); 4.1653 (1.4); 4.1555 (1.2); 3.7861 (0.9); 3.7692 (0.9); 3.7589 (0.9); 3.7422 (0.8); 3.3289 (44.4); 2.8892 (4.3); 2.7325 (3.7); 2.5092 (7.6); 2.5051 (14.3); 2.5007 (18.0); 2.4963 (12.6); 2.4920 (6.0); 2.4751 (18.0); 2.3955 (16.0); 2.3243 (7.9); 2.2965 (3.2)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.5119 (2.6); 8.5098 (2.3); 8.5047 (1.6); 8.4936 (2.9); 8.4879 (2.9); 8.4773 (0.4); 8.3087 (1.6); 8.2306 (2.6); 8.1449 (1.9); 8.1400 (2.2); 8.1290 (1.7); 8.1218 (3.2); 8.1208 (3.2); 8.1124 (0.5); 8.0537 (0.8); 8.0500 (1.1); 8.0370 (2.6); 8.0330 (2.5); 8.0268 (3.2); 8.0197 (4.8); 8.0127 (2.5); 8.0067 (2.7); 8.0025 (2.9); 7.9897 (1.3); 7.9857 (1.0); 7.9519 (1.3); 7.8021 (6.1); 7.7968 (6.4); 7.7052 (5.7); 7.6841 (7.2); 7.5396 (4.0); 7.5342 (4.0); 7.5186 (3.3); 7.5132 (3.3); 6.9808 (4.1); 6.9723 (4.5); 6.7124 (3.2); 6.7066 (3.1); 6.7041 (3.0); 5.1009 (1.0); 5.0911 (2.2); 5.0827 (2.4); 5.0735 (1.2); 4.2418 (1.1); 4.2205 (1.2); 4.0108 (0.9); 4.0001 (1.0); 3.9841 (0.9); 3.3292 (94.1); 3.3120 (6.0); 2.8912 (8.9); 2.8742 (0.3); 2.7325 (7.7); 2.7166 (0.4); 2.5245 (0.3); 2.5108 (10.0); 2.5066 (21.1); 2.5021 (28.9); 2.4976 (22.0); 2.4933 (11.9); 2.4604 (1.4); 2.4301 (16.0); −0.0002 (0.4)
1H-NMR(400.2 MHz, d6-DMSO) δ = 7.9511 (1.1); 7.8022 (3.1); 7.7965 (3.9); 7.6097 (3.2); 7.5887 (4.8); 7.5067 (2.4); 7.5010 (2.3); 7.4856 (1.6); 7.4800 (1.6); 6.7942 (1.6); 4.7537 (0.8); 4.7478 (0.9); 4.7425 (1.3); 4.7373 (1.0); 4.7313 (0.8); 4.7274 (0.7); 4.1380 (0.9); 4.1281 (1.0); 4.1106 (1.2); 4.1008 (1.0); 3.7118 (0.7); 3.6949 (0.8); 3.6847 (0.8); 3.6676 (0.6); 3.3262 (25.0); 3.3221 (34.8); 2.8910 (8.3); 2.7324 (6.9); 2.5604 (15.9); 2.5185 (0.4); 2.5099 (5.8); 2.5056 (12.2); 2.5011 (16.6); 2.4966 (12.1); 2.4922 (5.9); 2.3589 (13.6); 2.3167 (16.0); −0.0002 (0.3)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.4842 (2.4); 8.4781 (1.5); 8.4654 (2.8); 8.4604 (2.6); 8.3067 (0.9); 8.2432 (2.2); 8.1195 (1.9); 8.1150 (2.3); 8.1023 (1.6); 8.0954 (3.0); 8.0235 (0.8); 8.0200 (1.0); 8.0067 (2.4); 8.0032 (2.2); 7.9931 (2.8); 7.9876 (4.0); 7.9830 (2.2); 7.9728 (2.3); 7.9689 (2.4); 7.9555 (1.3); 7.9516 (1.9); 7.3416 (2.5); 7.3216 (5.0); 7.3017 (3.4); 7.1146 (2.9); 7.1129 (2.7); 7.0952 (2.5); 7.0706 (3.0); 7.0649 (4.5); 7.0607 (3.1); 6.9863 (2.9); 6.9780 (3.0); 6.9641 (2.6); 6.9580 (2.3); 6.9433 (2.2); 6.9373 (2.0); 6.7109 (2.9); 6.7052 (2.7); 6.7027 (2.6); 5.0948 (0.9); 5.0853 (2.1); 5.0764 (2.2); 5.0675 (1.0); 4.2285 (0.8); 4.2031 (1.0); 4.0207 (2.2); 4.0034 (6.7); 3.9859 (6.8); 3.9686 (2.5); 3.3423 (77.8); 3.3391 (78.8); 2.8901 (8.9); 2.7320 (7.6); 2.5190 (0.4); 2.5105 (8.2); 2.5061 (17.6); 2.5016 (24.3); 2.4971 (17.8); 2.4927 (8.7); 2.4608 (1.4); 2.4323 (14.3); 1.3070 (7.6); 1.2897 (16.0); 1.2722 (7.5)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.5008 (4.2); 8.4858 (4.4); 7.9514 (1.8); 7.7495 (2.7); 7.3726 (4.7); 7.3691 (3.6); 7.3610 (3.7); 7.3574 (4.7); 6.6442 (3.1); 6.5099 (0.6); 4.7100 (1.3); 4.1121 (1.0); 4.1022 (1.1); 4.0848 (1.2); 4.0751 (1.1); 3.6657 (0.7); 3.3409 (51.1); 3.3357 (83.5); 3.3319 (78.1); 3.3276 (98.0); 3.3252 (97.2); 3.2798 (0.4); 2.8919 (11.0); 2.7331 (9.8); 2.6707 (0.4); 2.6410 (16.0); 2.5062 (41.7); 2.5020 (51.8); 2.4979 (39.4); 2.3632 (7.6); 2.3339 (14.8); 2.2976 (0.6); 2.2471 (2.0); 2.0735 (0.6); −0.0002 (0.8)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.5077 (2.7); 8.5054 (2.4); 8.5003 (1.6); 8.4894 (2.8); 8.4838 (3.0); 8.2372 (2.6); 8.1420 (2.1); 8.1368 (2.4); 8.1259 (1.7); 8.1181 (3.4); 8.1093 (0.4); 8.0432 (1.1); 8.0302 (2.6); 8.0262 (2.6); 8.0203 (3.4); 8.0131 (5.0); 8.0060 (2.5); 8.0001 (3.0); 7.9960 (3.0); 7.9832 (1.1); 7.9791 (0.8); 7.9514 (1.4); 7.4990 (1.2); 7.4829 (1.4); 7.4785 (3.0); 7.4629 (3.1); 7.4577 (2.2); 7.4430 (2.1); 7.3874 (4.2); 7.3850 (3.8); 7.3787 (2.0); 7.3714 (3.8); 7.3682 (5.6); 7.3547 (2.0); 7.3487 (2.5); 7.3446 (1.8); 7.2580 (1.4); 7.2518 (1.3); 7.2359 (2.4); 7.2309 (2.2); 7.2151 (1.2); 7.2089 (1.0); 6.9797 (4.2); 6.9713 (4.5); 6.7100 (3.3); 6.7043 (3.2); 6.7020 (3.0); 5.0981 (1.1); 5.0886 (2.4); 5.0797 (2.5); 5.0710 (1.2); 4.2353 (1.1); 4.2125 (1.2); 4.0002 (1.0); 3.9841 (0.9); 3.3433 (95.0); 3.3401 (86.7); 2.8912 (10.6); 2.7328 (9.0); 2.5114 (10.9); 2.5071 (23.3); 2.5027 (32.1); 2.4982 (24.3); 2.4939 (12.4); 2.4587 (1.6); 2.4291 (16.0); −0.0002 (0.5)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.0400 (1.2); 7.9508 (2.0); 7.3357 (2.5); 7.2573 (1.6); 7.2379 (2.8); 7.1871 (1.8); 7.1676 (1.0); 6.9517 (0.9); 6.7070 (1.8); 6.7043 (2.0); 6.6986 (1.8); 6.6958 (1.8); 5.0153 (0.5); 5.0059 (1.2); 4.9973 (1.2); 4.9886 (0.6); 4.1141 (0.6); 4.1068 (0.6); 4.0862 (0.7); 4.0800 (0.6); 3.8908 (0.5); 3.8835 (0.5); 3.8660 (0.4); 3.3255 (62.4); 2.8906 (16.0); 2.7318 (13.0); 2.5245 (15.8); 2.5100 (9.2); 2.5055 (19.5); 2.5010 (26.6); 2.4964 (19.3); 2.4919 (9.3); 2.4550 (1.1); 2.4224 (10.3); 2.3185 (0.7); 2.2931 (9.6); 2.2708 (11.4); 2.2521 (11.8); −0.0002 (0.4)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.3068 (0.4); 8.0609 (1.5); 7.9513 (0.7); 7.8537 (2.8); 7.8428 (1.8); 7.8222 (1.9); 7.7969 (1.3); 7.7771 (1.9); 7.6982 (1.5); 7.6788 (2.2); 7.6594 (0.9); 6.9464 (1.5); 6.9386 (1.7); 6.7039 (1.8); 6.7011 (2.0); 6.6954 (2.0); 6.6927 (1.9); 5.0221 (0.6); 5.0129 (1.3); 5.0034 (1.4); 4.9946 (0.8); 4.1271 (0.7); 4.1186 (0.7); 4.0993 (0.9); 4.0918 (0.8); 3.8941 (0.6); 3.8831 (0.7); 3.8667 (0.6); 3.8555 (0.5); 3.3324 (81.6); 3.3296 (92.1); 3.3076 (8.9); 2.8915 (5.1); 2.7323 (4.4); 2.5717 (16.0); 2.5517 (0.7); 2.5245 (0.4); 2.5198 (0.5); 2.5110 (10.1); 2.5066 (22.0); 2.5020 (30.9); 2.4975 (23.8); 2.4932 (13.0); 2.4494 (1.2); 2.4151 (10.2); 2.3296 (11.2); 1.0468 (0.4); 1.0316 (0.4); −0.0002 (0.3)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.0546 (1.3); 7.9505 (1.8); 7.5129 (1.9); 7.4940 (2.2); 7.3736 (3.8); 7.3633 (4.5); 7.2645 (0.8); 7.2536 (1.2); 7.2441 (1.0); 7.2339 (1.0); 7.2229 (0.5); 6.9518 (1.0); 6.7033 (1.8); 6.6975 (1.8); 6.6950 (1.7); 5.0093 (1.2); 5.0010 (1.2); 4.1169 (0.6); 4.1102 (0.6); 4.0899 (0.7); 4.0828 (0.7); 3.8942 (0.5); 3.8859 (0.5); 3.8685 (0.5); 3.3294 (73.8); 2.8905 (13.4); 2.7318 (11.6); 2.5267 (15.0); 2.5056 (17.1); 2.5012 (23.7); 2.4968 (18.1); 2.4550 (1.0); 2.4211 (10.3); 2.3062 (16.0); 2.2972 (10.5); 1.0465 (0.4); 1.0313 (0.4)
1H-NMR(400.2 MHz, d6-DMSO) δ = 7.9502 (0.5); 7.7455 (2.5); 7.3423 (1.4); 7.3223 (2.8); 7.3024 (1.8); 7.0800 (1.8); 7.0604 (1.8); 7.0505 (2.0); 7.0449 (2.8); 7.0409 (1.9); 6.9744 (1.6); 6.9686 (1.4); 6.9538 (1.4); 6.9481 (1.2); 6.7958 (0.4); 4.7326 (1.2); 4.7222 (0.8); 4.1254 (0.8); 4.1157 (0.9); 4.0982 (1.0); 4.0886 (1.0); 4.0344 (1.4); 4.0170 (4.6); 3.9996 (4.7); 3.9822 (1.5); 3.7195 (0.5); 3.7019 (0.5); 3.6791 (0.4); 3.3457 (80.5); 2.8909 (4.0); 2.7327 (3.4); 2.5632 (16.0); 2.5107 (5.5); 2.5064 (11.5); 2.5019 (15.6); 2.4975 (11.4); 2.4933 (5.6); 2.3573 (14.1); 2.3114 (6.3); 1.3267 (5.2); 1.3093 (10.8); 1.2919 (5.0)
1H-NMR(400.2 MHz, d6-DMSO) δ = 7.7592 (2.8); 7.5933 (0.7); 7.5739 (2.4); 7.5544 (5.2); 7.5380 (0.7); 7.5344 (0.8); 7.4998 (2.7); 7.4242 (1.5); 7.4074 (1.2); 6.7684 (1.1); 4.7374 (1.4); 4.1387 (1.0); 4.1291 (1.1); 4.1111 (1.2); 4.1017 (1.1); 3.7250 (0.6); 3.7073 (0.8); 3.7006 (0.8); 3.6821 (0.6); 3.3457 (45.4); 3.3412 (50.4); 3.3393 (50.2); 3.3372 (49.0); 3.3330 (51.4); 2.8916 (1.7); 2.7336 (1.5); 2.7327 (1.5); 2.5789 (16.0); 2.5064 (14.8); 2.5023 (19.1); 2.4980 (14.6); 2.3575 (14.5); 2.3307 (8.2); 2.2898 (4.4)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.4332 (2.4); 8.4140 (2.5); 8.4110 (2.5); 8.3400 (2.4); 8.3335 (2.4); 8.3081 (1.2); 8.1020 (1.9); 8.0992 (2.3); 8.0796 (2.9); 7.9982 (1.1); 7.9817 (2.2); 7.9621 (3.1); 7.9588 (3.1); 7.9410 (2.1); 7.9385 (2.1); 7.9243 (0.9); 7.9214 (0.9); 7.7795 (0.9); 7.7629 (1.2); 7.7584 (2.0); 7.7421 (2.0); 7.7377 (1.3); 7.7210 (1.0); 7.4968 (0.9); 7.4903 (1.0); 7.4735 (1.8); 7.4671 (1.9); 7.4504 (1.0); 7.4439 (1.0); 7.2526 (0.9); 7.2463 (0.9); 7.2314 (1.9); 7.2252 (1.7); 7.2100 (0.9); 7.2037 (0.8); 6.9960 (3.2); 6.9876 (3.5); 6.7240 (2.8); 6.7179 (2.6); 6.7158 (2.6); 5.1102 (0.8); 5.1012 (2.0); 5.0925 (2.1); 5.0839 (0.9); 4.2435 (1.1); 4.2353 (1.1); 4.2156 (1.4); 4.2075 (1.3); 4.0429 (1.2); 4.0316 (1.2); 4.0151 (1.0); 4.0040 (0.9); 3.3364 (40.7); 3.3323 (55.3); 2.8906 (3.1); 2.7323 (2.8); 2.5061 (15.4); 2.5019 (20.9); 2.4976 (15.8); 2.4731 (1.3); 2.4446 (16.0)
1H-NMR(400.2 MHz, d6-DMSO) δ = 7.9499 (1.6); 7.7415 (1.9); 7.4797 (2.9); 7.4578 (3.4); 7.0251 (3.3); 7.0031 (3.2); 4.7378 (1.0); 4.7277 (0.6); 4.1277 (0.6); 4.1180 (0.7); 4.1002 (0.7); 4.0908 (0.7); 3.7998 (16.0); 3.7386 (0.5); 3.7349 (0.5); 3.7173 (0.4); 3.7109 (0.4); 3.6946 (0.3); 3.3244 (28.7); 2.8897 (11.1); 2.7311 (9.7); 2.5254 (11.4); 2.5089 (3.6); 2.5047 (7.7); 2.5002 (10.8); 2.4957 (8.5); 2.3647 (10.0); 2.3292 (5.7); 2.2856 (4.1)
1H-NMR(400.2 MHz, d6-DMSO) δ = 7.9507 (0.6); 7.7484 (2.6); 7.5007 (0.6); 7.4801 (1.5); 7.4648 (1.5); 7.4597 (1.1); 7.4448 (1.0); 7.3605 (3.3); 7.3500 (1.2); 7.3425 (1.9); 7.3309 (1.4); 7.2695 (0.8); 7.2651 (0.7); 7.2489 (1.4); 7.2430 (1.2); 7.2281 (0.6); 7.2220 (0.6); 6.7631 (1.0); 4.7336 (1.3); 4.7231 (0.8); 4.1326 (0.9); 4.1227 (1.0); 4.1051 (1.2); 4.0953 (1.1); 3.7199 (0.6); 3.7022 (0.6); 3.6942 (0.6); 3.6776 (0.5); 3.3225 (35.5); 2.8905 (3.6); 2.7321 (3.2); 2.5787 (16.0); 2.5049 (11.6); 2.5006 (15.5); 2.4963 (11.7); 2.3563 (14.5); 2.3276 (7.6); 2.2908 (3.9)
1H-NMR(400.2 MHz, d6-DMSO) δ = 7.9507 (2.2); 7.8181 (2.5); 7.7140 (0.6); 7.6975 (0.8); 7.6929 (1.4); 7.6765 (1.3); 7.6722 (1.0); 7.6555 (0.7); 7.4640 (0.6); 7.4577 (0.7); 7.4409 (1.3); 7.4345 (1.4); 7.4178 (0.7); 7.4114 (0.7); 7.2357 (0.6); 7.2298 (0.7); 7.2144 (1.2); 7.2085 (1.2); 7.1932 (0.6); 7.1872 (0.6); 6.8120 (1.2); 4.7607 (0.8); 4.7556 (1.0); 4.7500 (1.4); 4.7450 (1.1); 4.7398 (0.9); 4.7351 (0.8); 4.1430 (0.9); 4.1332 (1.0); 4.1156 (1.1); 4.1060 (1.0); 3.7462 (0.8); 3.7298 (0.9); 3.7188 (0.9); 3.7024 (0.8); 3.3362 (75.3); 2.8914 (16.0); 2.7325 (13.6); 2.5310 (15.1); 2.5109 (6.3); 2.5066 (13.7); 2.5021 (19.4); 2.4976 (15.4); 2.4934 (8.4); 2.3672 (13.0); 2.3386 (10.5); 2.2964 (11.2)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.4081 (1.9); 8.3887 (2.1); 8.3863 (2.0); 8.2611 (1.6); 8.2555 (1.7); 8.0736 (1.4); 8.0709 (1.7); 8.0510 (2.3); 7.9742 (0.9); 7.9600 (1.5); 7.9573 (1.7); 7.9399 (1.2); 7.9362 (1.2); 7.9312 (1.8); 7.9273 (1.8); 7.9141 (0.9); 7.9102 (1.9); 7.9068 (1.6); 7.8932 (0.8); 7.8898 (0.8); 7.4598 (3.0); 7.4402 (3.4); 7.2093 (3.0); 7.0830 (1.6); 7.0805 (1.6); 7.0634 (1.4); 7.0612 (1.4); 7.0004 (1.6); 6.9928 (1.7); 6.7209 (2.0); 6.7182 (2.2); 6.7126 (2.1); 6.7098 (2.0); 5.0997 (0.7); 5.0905 (1.6); 5.0817 (1.6); 5.0727 (0.7); 4.2340 (0.6); 4.2087 (0.7); 4.0238 (0.6); 4.0147 (0.6); 3.9975 (0.6); 3.9880 (0.5); 3.3325 (53.5); 2.8899 (2.9); 2.7320 (2.4); 2.5101 (6.1); 2.5057 (13.1); 2.5012 (18.0); 2.4966 (13.2); 2.4922 (6.5); 2.4705 (1.2); 2.4390 (10.9); 2.3269 (15.4); 2.3137 (16.0)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.0617 (1.9); 8.0570 (2.0); 7.9512 (0.8); 7.6518 (2.8); 7.6303 (4.1); 7.6106 (3.0); 7.6044 (3.6); 7.5359 (2.3); 7.5301 (2.0); 7.5144 (1.6); 7.5087 (1.4); 6.9421 (2.4); 6.9337 (2.7); 6.6978 (2.0); 6.6953 (2.2); 6.6896 (2.2); 6.6870 (2.1); 5.0046 (1.5); 4.9961 (1.6); 4.1128 (0.9); 4.1041 (1.1); 4.0853 (1.2); 4.0766 (1.2); 3.8850 (1.0); 3.8727 (1.0); 3.8572 (0.8); 3.8455 (0.8); 3.3219 (104.3); 2.8913 (5.2); 2.7320 (4.5); 2.5842 (16.0); 2.5059 (29.6); 2.5015 (40.7); 2.4970 (32.2); 2.4454 (1.2); 2.4132 (12.0); 2.3374 (14.8); 1.0464 (0.3); 1.0311 (0.3); −0.0002 (0.8)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.0299 (1.0); 7.9504 (1.3); 7.4830 (0.4); 7.4753 (3.5); 7.4704 (1.3); 7.4584 (1.2); 7.4533 (4.0); 7.4458 (0.4); 7.0300 (0.4); 7.0223 (3.8); 7.0003 (3.5); 6.9928 (0.4); 6.9418 (0.6); 6.7052 (1.4); 6.7027 (1.5); 6.6969 (1.4); 6.6943 (1.4); 5.0001 (0.9); 4.9920 (1.0); 4.1002 (0.4); 4.0783 (0.5); 3.8868 (0.4); 3.8676 (0.4); 3.8005 (16.0); 3.3343 (66.3); 3.3310 (55.2); 2.8905 (9.7); 2.7318 (8.4); 2.5259 (11.9); 2.5100 (6.1); 2.5058 (12.5); 2.5013 (17.0); 2.4969 (12.5); 2.4515 (0.7); 2.4231 (8.6); 2.2853 (7.3); 1.0467 (0.5); 1.0314 (0.5)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.0483 (1.4); 7.9511 (1.4); 7.5940 (0.7); 7.5747 (2.5); 7.5563 (5.8); 7.5415 (0.4); 7.5378 (0.6); 7.5021 (2.4); 7.4301 (1.3); 7.4123 (1.0); 6.9398 (1.6); 6.9319 (1.7); 6.6981 (2.0); 6.6922 (1.9); 6.6898 (1.8); 5.0139 (0.6); 5.0045 (1.3); 4.9956 (1.4); 4.9863 (0.6); 4.1191 (0.7); 4.1114 (0.7); 4.0912 (0.8); 4.0839 (0.8); 3.8848 (0.6); 3.8751 (0.6); 3.8579 (0.5); 3.8478 (0.5); 3.3750 (0.4); 3.3384 (94.2); 3.3360 (99.1); 2.8915 (10.1); 2.7326 (8.7); 2.5762 (16.0); 2.5245 (0.3); 2.5068 (18.8); 2.5023 (25.9); 2.4979 (19.6); 2.4457 (1.1); 2.4136 (10.4); 2.3272 (11.2); 1.0471 (0.6); 1.0318 (0.6)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.5700 (3.2); 8.5646 (2.1); 8.5587 (2.0); 8.5545 (2.8); 8.5458 (3.4); 8.5380 (0.8); 8.3068 (0.6); 8.2678 (3.0); 8.2311 (1.7); 8.2244 (11.6); 8.2196 (4.8); 8.2071 (4.1); 8.2021 (13.2); 8.1931 (3.2); 8.1830 (2.5); 8.1739 (2.3); 8.1681 (3.9); 8.0882 (1.3); 8.0842 (1.5); 8.0775 (7.0); 8.0714 (4.2); 8.0677 (4.5); 8.0633 (3.8); 8.0596 (4.3); 8.0532 (5.9); 8.0426 (1.1); 7.9515 (2.1); 7.6628 (1.8); 7.6560 (11.1); 7.6515 (4.6); 7.6387 (3.5); 7.6338 (10.4); 6.9581 (6.1); 6.9495 (6.4); 6.6984 (3.7); 6.6926 (3.6); 5.0888 (1.4); 5.0790 (3.0); 5.0704 (3.0); 5.0614 (1.4); 4.2281 (1.3); 4.2036 (1.4); 3.9830 (1.2); 3.9667 (1.1); 3.3399 (141.4); 2.8917 (15.3); 2.7330 (13.1); 2.5115 (13.4); 2.5072 (27.4); 2.5027 (37.2); 2.4983 (28.2); 2.4940 (14.4); 2.4448 (1.8); 2.4166 (16.0); −0.0002 (0.4)
1H-NMR(400.2 MHz, d6-DMSO) δ = 7.7593 (1.7); 7.3295 (1.9); 7.2638 (1.0); 7.2446 (1.7); 7.1887 (1.2); 7.1855 (1.2); 7.1691 (0.7); 7.1662 (0.7); 4.7444 (0.8); 4.1384 (0.5); 4.1286 (0.6); 4.1110 (0.7); 4.1014 (0.6); 3.7264 (0.4); 3.7088 (0.4); 3.7013 (0.4); 3.3254 (22.3); 2.8902 (1.6); 2.7321 (1.3); 2.5233 (9.8); 2.5047 (8.1); 2.5003 (10.6); 2.4959 (7.8); 2.3685 (8.9); 2.3279 (4.9); 2.2913 (3.7); 2.2701 (16.0)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.4930 (2.4); 8.4906 (2.0); 8.4855 (1.5); 8.4749 (2.3); 8.4700 (2.5); 8.3063 (2.6); 8.2783 (2.7); 8.1451 (1.8); 8.1399 (2.0); 8.1291 (1.4); 8.1239 (2.5); 8.1218 (2.8); 8.0371 (1.0); 8.0242 (2.6); 8.0200 (2.6); 8.0148 (2.9); 8.0074 (4.5); 7.9998 (2.5); 7.9946 (2.5); 7.9903 (2.4); 7.9775 (0.9); 7.9733 (0.7); 7.9517 (0.9); 7.8081 (4.3); 7.8029 (4.5); 7.5419 (3.2); 7.5207 (5.8); 7.4786 (3.7); 7.4758 (2.5); 7.4731 (3.6); 7.4574 (2.0); 7.4546 (1.3); 7.4519 (2.0); 6.9803 (3.8); 6.9719 (4.1); 6.7115 (2.9); 6.7090 (3.0); 6.7033 (3.1); 5.0874 (2.2); 5.0790 (2.3); 4.2330 (1.2); 4.2252 (1.2); 4.2053 (1.4); 4.1978 (1.4); 4.0170 (1.2); 4.0056 (1.2); 3.9892 (1.0); 3.9785 (1.0); 3.3429 (117.5); 3.3375 (142.3); 3.3359 (144.8); 2.8914 (6.2); 2.7329 (5.2); 2.5067 (29.4); 2.5024 (38.8); 2.4980 (29.8); 2.4602 (1.6); 2.4322 (16.0); −0.0002 (0.4)
1H-NMR(400.2 MHz, d6-DMSO) δ = 7.9508 (0.4); 7.7882 (2.9); 7.6253 (1.9); 7.6221 (2.1); 7.6054 (2.6); 7.6023 (2.6); 7.5924 (2.0); 7.5883 (2.2); 7.5733 (2.5); 7.5691 (2.6); 7.4801 (1.0); 7.4759 (1.2); 7.4614 (2.2); 7.4571 (2.1); 7.4419 (1.5); 7.4375 (1.4); 7.4088 (1.7); 7.4052 (1.8); 7.3898 (2.3); 7.3864 (2.3); 7.3710 (0.9); 7.3676 (0.9); 6.8171 (1.2); 4.7613 (0.8); 4.7575 (0.9); 4.7516 (1.1); 4.7462 (1.5); 4.7412 (1.1); 4.7352 (0.9); 4.7312 (0.9); 4.1364 (1.1); 4.1265 (1.2); 4.1090 (1.3); 4.0991 (1.2); 3.7138 (0.8); 3.6967 (0.8); 3.6866 (0.8); 3.6697 (0.7); 3.3248 (38.7); 2.8905 (3.0); 2.7324 (2.5); 2.5574 (18.8); 2.5183 (0.4); 2.5095 (5.9); 2.5052 (12.4); 2.5006 (16.8); 2.4962 (12.3); 2.4918 (6.0); 2.3593 (16.0); 2.3149 (13.9); 2.3073 (10.6)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.4583 (2.6); 8.4541 (1.8); 8.4392 (3.0); 8.4356 (2.8); 8.3050 (1.0); 8.2600 (2.3); 8.2546 (2.3); 8.1078 (1.9); 8.1041 (2.5); 8.0895 (2.0); 8.0845 (3.2); 8.0139 (1.2); 8.0109 (1.2); 7.9970 (2.3); 7.9941 (2.2); 7.9779 (4.2); 7.9731 (4.0); 7.9607 (1.3); 7.9570 (2.6); 7.9534 (3.1); 7.9403 (1.1); 7.9367 (1.0); 7.6683 (0.4); 7.6602 (4.1); 7.6549 (1.8); 7.6467 (4.5); 7.6380 (4.8); 7.6300 (1.9); 7.6247 (4.4); 7.6167 (0.5); 7.3291 (0.5); 7.3211 (4.5); 7.3159 (1.5); 7.3041 (1.8); 7.2989 (8.4); 7.2820 (1.4); 7.2767 (3.9); 7.2686 (0.4); 6.9935 (2.8); 6.9854 (2.9); 6.7209 (2.9); 6.7182 (3.1); 6.7125 (3.0); 6.7099 (2.8); 5.1036 (0.9); 5.0942 (2.2); 5.0855 (2.2); 5.0763 (1.0); 4.2377 (0.9); 4.2159 (1.1); 4.0239 (0.9); 4.0143 (0.9); 3.9977 (0.8); 3.9878 (0.7); 3.4070 (0.4); 3.3891 (0.5); 3.3520 (187.3); 3.3078 (0.4); 2.8916 (7.3); 2.7335 (6.1); 2.5254 (0.4); 2.5206 (0.6); 2.5122 (9.7); 2.5078 (20.4); 2.5032 (27.7); 2.4987 (20.1); 2.4944 (9.7); 2.4673 (1.6); 2.4380 (16.0)
1H-NMR(400.2 MHz, d6-DMSO) δ = 7.9512 (2.4); 7.7355 (2.3); 7.6548 (2.9); 7.6509 (1.8); 7.5653 (7.0); 7.5607 (6.7); 6.7387 (1.9); 4.7448 (0.7); 4.7337 (1.1); 4.7223 (0.8); 4.1430 (0.9); 4.1330 (0.9); 4.1156 (1.1); 4.1057 (1.0); 3.7135 (0.6); 3.6958 (0.6); 3.6874 (0.6); 3.6691 (0.5); 3.3377 (79.8); 2.8919 (16.0); 2.7335 (13.9); 2.5995 (14.5); 2.5069 (13.4); 2.5026 (17.8); 2.4982 (13.2); 2.3568 (13.5); 2.3424 (7.7); 2.3198 (0.7); 2.2951 (4.9)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.4660 (1.6); 8.4471 (1.9); 8.4432 (1.7); 8.2471 (1.4); 8.2426 (1.5); 8.1100 (1.2); 8.1060 (1.5); 8.0919 (1.2); 8.0867 (2.0); 8.0095 (0.8); 7.9958 (1.4); 7.9928 (1.4); 7.9780 (2.4); 7.9732 (2.4); 7.9536 (3.0); 7.9410 (0.8); 7.9373 (0.6); 7.3895 (2.8); 7.3621 (0.9); 7.3426 (2.4); 7.3293 (2.1); 7.3109 (3.0); 7.2918 (1.3); 7.2260 (1.9); 7.2077 (1.3); 6.9892 (1.8); 6.9810 (1.9); 6.7162 (1.8); 6.7137 (1.9); 6.7080 (1.8); 6.7055 (1.7); 5.0943 (0.6); 5.0849 (1.4); 5.0760 (1.4); 5.0669 (0.6); 4.2290 (0.5); 4.2031 (0.6); 4.0047 (0.6); 3.9880 (0.5); 3.3300 (39.3); 2.8900 (16.0); 2.7322 (13.7); 2.5098 (5.5); 2.5055 (11.5); 2.5010 (15.7); 2.4965 (11.5); 2.4922 (5.7); 2.4633 (1.0); 2.4357 (9.7); 2.3065 (14.8)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.0462 (2.3); 7.9506 (2.6); 7.5989 (2.9); 7.5939 (1.9); 7.5854 (3.5); 7.5769 (4.2); 7.5687 (2.0); 7.5634 (3.6); 7.3136 (3.1); 7.2914 (5.9); 7.2694 (2.8); 6.9387 (2.0); 6.7025 (3.0); 6.6969 (3.0); 6.6943 (2.9); 5.0025 (2.0); 4.9954 (2.1); 4.1046 (1.1); 4.0835 (1.2); 4.0784 (1.3); 3.8834 (1.0); 3.8676 (0.9); 3.3244 (105.0); 2.8907 (16.0); 2.7317 (14.1); 2.5443 (20.0); 2.5238 (0.8); 2.5054 (28.7); 2.5012 (39.5); 2.4969 (33.3); 2.4505 (1.3); 2.4211 (15.5); 2.3031 (14.6); 1.0463 (0.4); 1.0310 (0.4); −0.0002 (0.5)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.0458 (2.0); 7.9511 (1.3); 7.5446 (3.0); 7.5386 (1.5); 7.5286 (2.4); 7.5226 (13.2); 7.5081 (12.9); 7.5021 (2.9); 7.4920 (1.8); 7.4860 (3.0); 7.2745 (0.3); 6.9382 (1.9); 6.9309 (2.0); 6.7023 (2.7); 6.6996 (2.9); 6.6939 (2.9); 6.6911 (2.8); 5.0073 (0.8); 4.9983 (1.9); 4.9895 (2.0); 4.9807 (1.0); 4.1097 (0.9); 4.1014 (1.0); 4.0815 (1.2); 4.0741 (1.1); 3.8840 (0.8); 3.8753 (0.8); 3.8590 (0.8); 3.3236 (140.4); 3.3067 (7.9); 2.8910 (10.3); 2.8747 (0.4); 2.7324 (8.6); 2.7159 (0.5); 2.5572 (23.6); 2.5237 (0.6); 2.5188 (0.9); 2.5102 (16.1); 2.5057 (34.0); 2.5012 (46.5); 2.4967 (34.9); 2.4923 (18.7); 2.4466 (1.7); 2.4192 (15.6); 2.3321 (0.5); 2.3112 (16.0); 1.0463 (0.3); −0.0002 (0.9)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.0424 (0.5); 7.9506 (0.6); 7.4547 (7.2); 6.9381 (0.3); 6.7020 (0.5); 6.6992 (0.6); 6.6937 (0.7); 6.6909 (0.6); 4.9965 (0.4); 4.9895 (0.5); 3.3359 (5.5); 3.3287 (29.9); 3.3261 (31.4); 2.8909 (4.0); 2.8866 (1.4); 2.7323 (3.4); 2.5388 (4.4); 2.5099 (2.8); 2.5057 (6.2); 2.5013 (8.9); 2.4968 (7.6); 2.4927 (4.5); 2.4195 (3.1); 2.2980 (2.8); 1.3069 (16.0)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.5608 (1.3); 8.5526 (1.3); 8.5475 (0.9); 8.5430 (0.9); 8.5365 (1.5); 8.2119 (1.2); 8.1739 (1.1); 8.1677 (0.9); 8.1644 (0.9); 8.1583 (1.5); 8.1495 (1.6); 8.1412 (0.4); 8.0640 (0.7); 8.0553 (3.1); 8.0472 (2.3); 8.0395 (2.2); 8.0309 (2.6); 7.9510 (2.2); 7.6093 (1.5); 7.5898 (3.0); 7.5704 (1.7); 7.1423 (2.6); 7.1234 (2.3); 7.0145 (2.1); 6.9948 (1.9); 6.9473 (2.6); 6.9389 (2.7); 6.6900 (1.8); 6.6841 (1.7); 5.0659 (0.6); 5.0564 (1.4); 5.0479 (1.4); 5.0388 (0.6); 4.1984 (0.5); 4.1735 (0.6); 3.9651 (0.5); 3.9496 (0.5); 3.3448 (64.7); 3.3399 (55.8); 2.8907 (14.5); 2.7321 (12.5); 2.5066 (10.4); 2.5022 (14.3); 2.4979 (11.0); 2.4273 (16.0); 2.4168 (9.1)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.4846 (2.4); 8.4780 (1.7); 8.4660 (2.6); 8.4610 (2.6); 8.3058 (0.5); 8.2791 (2.7); 8.1406 (1.9); 8.1358 (2.3); 8.1239 (1.6); 8.1170 (3.0); 8.0284 (1.0); 8.0150 (2.5); 8.0114 (2.4); 8.0037 (2.8); 7.9973 (4.5); 7.9908 (2.4); 7.9833 (2.4); 7.9796 (2.5); 7.9664 (0.9); 7.9627 (0.8); 7.9510 (1.6); 7.6301 (2.8); 7.6272 (2.9); 7.6103 (3.4); 7.6074 (3.5); 7.5205 (2.4); 7.5165 (2.8); 7.5013 (3.1); 7.4973 (3.5); 7.4609 (1.4); 7.4571 (1.4); 7.4420 (3.0); 7.4380 (2.8); 7.4226 (2.0); 7.4187 (1.7); 7.3835 (2.3); 7.3804 (2.3); 7.3645 (3.0); 7.3615 (3.0); 7.3456 (1.2); 7.3428 (1.1); 6.9850 (3.7); 6.9766 (4.1); 6.7081 (3.1); 6.7024 (3.1); 5.0969 (1.0); 5.0882 (2.4); 5.0799 (2.4); 4.2291 (1.1); 4.2217 (1.2); 4.2012 (1.4); 4.1947 (1.4); 4.0202 (1.2); 4.0097 (1.2); 3.9928 (1.1); 3.9821 (1.0); 3.3479 (49.5); 3.3397 (109.8); 3.2968 (0.5); 2.8907 (10.5); 2.7325 (9.0); 2.5064 (21.8); 2.5021 (29.2); 2.4978 (22.8); 2.4609 (1.5); 2.4314 (16.0); −0.0002 (0.4)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.4907 (2.5); 8.4851 (1.7); 8.4718 (3.0); 8.4671 (2.7); 8.2345 (2.3); 8.2293 (2.4); 8.1316 (1.9); 8.1272 (2.5); 8.1141 (1.8); 8.1082 (3.1); 8.0405 (0.9); 8.0370 (1.1); 8.0236 (2.4); 8.0202 (2.2); 8.0086 (3.0); 8.0035 (3.8); 7.9882 (2.5); 7.9844 (2.6); 7.9713 (1.0); 7.9674 (0.9); 7.9522 (0.7); 7.8154 (2.7); 7.8098 (3.0); 7.7979 (2.7); 7.7923 (2.9); 7.6303 (1.3); 7.6246 (1.3); 7.6187 (1.5); 7.6129 (1.5); 7.6087 (2.1); 7.6030 (2.1); 7.5971 (2.1); 7.5914 (1.9); 7.5314 (3.5); 7.5086 (4.8); 7.4866 (2.3); 6.9906 (3.6); 6.9822 (3.8); 6.7204 (2.8); 6.7178 (3.0); 6.7121 (2.9); 6.7094 (2.8); 5.1078 (0.9); 5.0982 (2.1); 5.0891 (2.1); 5.0800 (1.0); 4.2526 (0.9); 4.2461 (1.0); 4.2250 (1.1); 4.0193 (0.8); 4.0092 (0.9); 3.9935 (0.8); 3.9833 (0.7); 3.3317 (60.7); 2.8914 (5.6); 2.7330 (4.6); 2.5113 (9.2); 2.5068 (19.7); 2.5023 (27.1); 2.4978 (19.8); 2.4933 (9.6); 2.4661 (1.4); 2.4350 (16.0); −0.0002 (0.4)
1H-NMR(400.2 MHz, d6-DMSO) δ = 7.9503 (1.3); 7.7602 (3.3); 7.5358 (2.6); 7.5300 (2.9); 7.5166 (4.2); 7.5133 (4.1); 7.4554 (0.8); 7.4339 (4.3); 7.4171 (6.2); 6.8084 (0.6); 4.7372 (1.7); 4.1285 (1.1); 4.1193 (1.2); 4.1013 (1.3); 4.0922 (1.3); 3.7279 (0.7); 3.7084 (0.9); 3.3316 (79.5); 2.8903 (6.7); 2.7321 (6.4); 2.5521 (16.8); 2.5009 (28.5); 2.3888 (0.3); 2.3600 (16.0); 2.3076 (11.5)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.4800 (2.5); 8.4782 (2.6); 8.4746 (1.9); 8.4613 (2.8); 8.4571 (2.8); 8.4562 (2.8); 8.3086 (1.0); 8.2520 (2.4); 8.1226 (1.9); 8.1185 (2.5); 8.1054 (1.7); 8.0995 (3.2); 8.0984 (3.2); 8.0242 (1.1); 8.0107 (2.4); 8.0075 (2.5); 7.9963 (2.8); 7.9910 (4.0); 7.9873 (2.7); 7.9760 (2.4); 7.9722 (2.6); 7.9590 (1.2); 7.9518 (1.9); 7.5851 (0.6); 7.5786 (6.0); 7.5738 (2.9); 7.5624 (2.8); 7.5570 (12.0); 7.5140 (1.5); 7.5077 (11.2); 7.4913 (2.1); 7.4861 (6.3); 6.9830 (3.3); 6.9747 (3.6); 6.7153 (2.7); 6.7129 (3.2); 6.7072 (3.0); 6.7045 (3.0); 5.0964 (1.0); 5.0867 (2.2); 5.0782 (2.3); 5.0692 (1.0); 4.2325 (1.0); 4.2092 (1.1); 4.0026 (0.9); 3.9864 (0.8); 3.3295 (59.6); 2.8899 (11.4); 2.7316 (9.9); 2.5099 (7.5); 2.5057 (16.4); 2.5012 (23.1); 2.4967 (18.0); 2.4927 (9.4); 2.4615 (1.5); 2.4328 (16.0); −0.0002 (0.4)
1H-NMR(400.2 MHz, d6-DMSO) δ = 7.9514 (2.2); 7.8337 (1.9); 7.7530 (0.6); 7.7492 (0.7); 7.7322 (1.4); 7.7154 (0.8); 7.7116 (0.8); 7.6217 (0.7); 7.6179 (0.7); 7.6055 (0.8); 7.6021 (1.4); 7.5985 (0.9); 7.5863 (0.8); 7.5825 (0.8); 7.3431 (1.0); 7.3234 (1.8); 7.3033 (0.8); 6.7995 (1.4); 4.7690 (0.5); 4.7646 (0.6); 4.7593 (0.7); 4.7539 (1.1); 4.7486 (0.8); 4.7433 (0.6); 4.7387 (0.6); 4.1476 (0.7); 4.1377 (0.8); 4.1200 (0.9); 4.1104 (0.8); 3.7465 (0.7); 3.7301 (0.7); 3.7191 (0.7); 3.7027 (0.6); 3.3311 (28.4); 2.8916 (16.0); 2.7332 (13.5); 2.5466 (12.4); 2.5109 (4.3); 2.5065 (9.1); 2.5020 (12.4); 2.4976 (9.0); 2.4932 (4.4); 2.3683 (10.6); 2.3349 (8.3); 2.3120 (9.9)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.7800 (0.3); 8.7646 (0.4); 8.5047 (4.4); 8.5012 (3.2); 8.4932 (3.0); 8.4895 (4.6); 8.4682 (1.4); 8.4530 (1.5); 8.3077 (0.4); 8.1837 (0.5); 8.1642 (0.4); 8.0633 (0.6); 8.0446 (1.5); 7.9511 (1.7); 7.7498 (0.4); 7.7342 (0.4); 7.3859 (0.6); 7.3773 (4.6); 7.3738 (3.6); 7.3658 (3.2); 7.3621 (4.8); 7.2962 (0.4); 7.2781 (0.4); 6.9071 (2.5); 6.8987 (2.8); 6.6834 (1.8); 6.6772 (1.8); 6.5166 (1.5); 6.2984 (0.4); 6.2787 (0.4); 4.9871 (0.8); 4.9779 (1.5); 4.9687 (1.4); 4.9594 (0.7); 4.0817 (0.7); 4.0608 (0.8); 3.8450 (0.6); 3.8416 (0.6); 3.8225 (0.5); 3.3728 (0.3); 3.3234 (225.2); 3.3210 (216.3); 2.8913 (11.6); 2.7485 (1.2); 2.7321 (10.6); 2.6751 (0.6); 2.6707 (0.7); 2.6661 (0.5); 2.6361 (16.0); 2.5060 (72.3); 2.5017 (98.6); 2.4973 (74.4); 2.4244 (1.7); 2.4039 (9.0); 2.3592 (11.2); 2.3377 (0.5); 2.3325 (0.6); 2.3286 (0.8); 2.3242 (0.6); 2.1488 (0.8); 1.0461 (1.8); 1.0308 (1.8); −0.0002 (1.8)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.1075 (2.8); 7.9500 (2.8); 7.7073 (0.7); 7.6867 (1.8); 7.6698 (1.7); 7.6491 (0.8); 7.4602 (0.8); 7.4539 (1.0); 7.4371 (1.6); 7.4309 (2.1); 7.4140 (0.9); 7.4078 (1.1); 7.2225 (1.0); 7.2069 (1.7); 7.2013 (1.9); 7.1858 (1.0); 7.1809 (0.9); 6.9449 (2.4); 6.9373 (2.9); 6.7045 (2.7); 6.7022 (2.6); 6.6988 (2.8); 6.6962 (3.0); 5.0106 (2.0); 5.0028 (2.2); 4.1131 (1.1); 4.1050 (1.3); 4.0855 (1.5); 4.0772 (1.6); 3.9092 (1.2); 3.8984 (1.3); 3.8823 (1.1); 3.8711 (1.0); 3.3268 (91.7); 2.8905 (15.5); 2.7317 (14.7); 2.5321 (17.7); 2.5011 (34.0); 2.4974 (31.4); 2.4534 (1.3); 2.4234 (15.2); 2.2978 (16.0)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.0319 (1.1); 7.9508 (1.6); 7.3416 (1.4); 7.3218 (2.8); 7.3018 (1.8); 7.0817 (1.8); 7.0620 (1.7); 7.0514 (2.1); 7.0456 (2.7); 7.0415 (1.8); 6.9785 (1.5); 6.9723 (1.3); 6.9577 (1.4); 6.9516 (1.4); 6.9351 (1.0); 6.6979 (1.8); 6.6921 (1.7); 5.0053 (0.5); 4.9964 (1.2); 4.9876 (1.2); 4.9781 (0.5); 4.1044 (0.5); 4.0971 (0.5); 4.0762 (0.6); 4.0377 (1.4); 4.0203 (4.4); 4.0029 (4.5); 3.9855 (1.4); 3.8761 (0.5); 3.8568 (0.4); 3.3302 (93.3); 2.8908 (12.5); 2.7322 (10.6); 2.5601 (16.0); 2.5234 (0.4); 2.5102 (9.1); 2.5058 (18.6); 2.5013 (25.0); 2.4968 (17.8); 2.4924 (8.4); 2.4457 (1.1); 2.4182 (10.0); 2.3095 (9.2); 1.3299 (5.3); 1.3125 (11.0); 1.2951 (5.1)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.0688 (1.7); 8.0633 (1.8); 7.9509 (2.2); 7.7968 (2.7); 7.7914 (3.1); 7.6071 (3.2); 7.5860 (4.2); 7.5009 (2.2); 7.4953 (2.2); 7.4799 (1.5); 7.4743 (1.6); 6.9420 (2.2); 6.9335 (2.4); 6.6968 (2.1); 6.6911 (2.0); 6.6884 (2.0); 5.0107 (0.6); 5.0017 (1.4); 4.9931 (1.4); 4.9841 (0.7); 4.1079 (0.9); 4.0993 (1.0); 4.0803 (1.2); 4.0716 (1.1); 3.8889 (0.9); 3.8771 (0.9); 3.8612 (0.8); 3.8497 (0.7); 3.3296 (119.8); 2.8912 (15.4); 2.7320 (13.4); 2.5613 (16.0); 2.5241 (0.4); 2.5062 (24.7); 2.5018 (34.4); 2.4974 (26.4); 2.4470 (1.1); 2.4161 (12.3); 2.3200 (14.7); 1.0463 (0.6); 1.0310 (0.6); −0.0002 (0.9)
1H-NMR(400.2 MHz, d6-DMSO) δ = 7.9514 (2.1); 7.7791 (5.1); 7.7580 (4.5); 7.6919 (4.4); 7.6716 (2.8); 6.7382 (1.6); 4.7445 (0.7); 4.7335 (1.1); 4.7225 (0.8); 4.1325 (0.9); 4.1227 (1.0); 4.1050 (1.1); 4.0954 (1.0); 3.7233 (0.5); 3.7053 (0.6); 3.6968 (0.6); 3.6797 (0.5); 3.3309 (42.9); 2.8913 (15.5); 2.7325 (13.0); 2.5917 (16.0); 2.5107 (6.1); 2.5063 (12.7); 2.5018 (17.2); 2.4973 (12.5); 2.4928 (6.0); 2.3524 (14.6); 2.3418 (7.5); 2.2763 (2.6)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.4241 (1.3); 8.4027 (1.5); 8.3068 (1.6); 8.2431 (1.2); 8.0752 (1.2); 8.0551 (1.6); 7.9819 (0.6); 7.9650 (1.2); 7.9480 (1.3); 7.9430 (1.8); 7.9388 (1.4); 7.9216 (1.2); 7.9184 (1.2); 7.9047 (0.5); 7.9015 (0.5); 7.5710 (0.4); 7.5633 (3.5); 7.5464 (1.2); 7.5412 (4.0); 7.0433 (0.4); 7.0357 (3.8); 7.0136 (3.7); 7.0055 (0.8); 6.9989 (1.1); 6.9919 (1.2); 6.7200 (1.5); 6.7143 (1.5); 6.7117 (1.4); 5.1008 (0.4); 5.0916 (1.1); 5.0833 (1.1); 5.0748 (0.5); 4.2331 (0.5); 4.2073 (0.5); 4.0173 (0.5); 3.9989 (0.4); 3.9830 (0.3); 3.8039 (16.0); 3.3411 (51.3); 3.3167 (1.0); 2.8901 (4.1); 2.7323 (3.5); 2.5061 (8.5); 2.5017 (11.9); 2.4973 (9.4); 2.4701 (1.0); 2.4406 (7.8)
1H-NMR(400.2 MHz, d6-DMSO) δ = 7.9505 (0.7); 7.7482 (2.1); 7.3484 (2.4); 7.3348 (0.4); 7.3235 (3.2); 7.3110 (3.4); 7.2342 (1.0); 7.2239 (1.2); 7.2145 (0.6); 4.7351 (1.0); 4.1266 (0.7); 4.1169 (0.8); 4.0993 (0.8); 4.0897 (0.8); 3.7248 (0.4); 3.7009 (0.5); 3.6858 (0.4); 3.3394 (26.6); 3.3340 (50.1); 2.8905 (4.4); 2.7322 (4.0); 2.5511 (13.0); 2.5052 (10.1); 2.5011 (13.2); 2.4972 (10.0); 2.3605 (11.9); 2.3139 (16.0); 2.3066 (8.4)
1H-NMR(400.2 MHz, d6-DMSO) δ = 7.9503 (1.4); 7.7489 (1.8); 7.3605 (0.8); 7.3399 (1.8); 7.3205 (1.2); 7.0923 (1.4); 7.0747 (3.3); 7.0713 (3.0); 6.9970 (1.1); 6.9912 (1.0); 6.9772 (0.9); 6.9735 (1.0); 6.9691 (0.8); 4.7331 (0.9); 4.1259 (0.6); 4.1161 (0.7); 4.0985 (0.8); 4.0889 (0.7); 3.7512 (16.0); 3.7255 (0.4); 3.7052 (0.4); 3.3397 (45.7); 3.3367 (46.8); 2.8907 (10.1); 2.7323 (8.7); 2.5617 (11.6); 2.5058 (9.4); 2.5014 (12.8); 2.4970 (9.4); 2.3577 (10.3); 2.3113 (5.0)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.4410 (1.8); 8.4214 (1.8); 8.4190 (1.9); 8.2354 (1.6); 8.0878 (1.5); 8.0677 (2.2); 7.9924 (0.8); 7.9760 (1.6); 7.9519 (4.4); 7.9350 (1.6); 7.9182 (0.7); 7.3694 (3.0); 7.3181 (1.3); 7.3148 (1.2); 7.2985 (1.9); 7.2951 (1.9); 7.2089 (2.8); 7.1893 (2.0); 6.9926 (1.7); 6.9851 (1.8); 6.7155 (2.0); 6.7095 (1.9); 5.0937 (0.6); 5.0844 (1.5); 5.0759 (1.5); 5.0669 (0.6); 4.2270 (0.6); 4.2025 (0.7); 4.0147 (0.6); 4.0073 (0.6); 3.9892 (0.5); 3.3294 (35.0); 2.8897 (16.0); 2.7319 (14.2); 2.5050 (11.0); 2.5007 (14.7); 2.4967 (11.3); 2.4658 (0.9); 2.4373 (10.4); 2.2504 (13.6); 2.2199 (14.0)
1H-NMR(400.2 MHz, d6-DMSO) δ = 7.9509 (2.5); 7.7599 (2.8); 7.5995 (2.4); 7.5943 (1.4); 7.5859 (2.9); 7.5777 (3.2); 7.5692 (1.6); 7.5641 (2.7); 7.3158 (2.5); 7.2936 (4.6); 7.2715 (2.1); 6.8059 (0.6); 4.7385 (1.6); 4.1336 (1.0); 4.1240 (1.1); 4.1061 (1.2); 4.0968 (1.2); 3.7368 (0.7); 3.7197 (0.8); 3.7109 (0.8); 3.6937 (0.6); 3.3334 (37.3); 2.8909 (16.0); 2.7325 (14.1); 2.5453 (16.4); 2.5056 (13.8); 2.5013 (17.7); 2.4969 (13.6); 2.3638 (14.8); 2.3196 (8.8); 2.3062 (8.9)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.0346 (1.3); 7.9515 (1.7); 7.5559 (3.1); 7.5539 (3.1); 7.4341 (0.6); 7.4122 (6.0); 7.4079 (3.8); 7.3911 (0.4); 7.3880 (0.4); 6.9426 (1.2); 6.9353 (1.3); 6.7046 (1.7); 6.7022 (1.9); 6.6967 (1.8); 6.6940 (1.7); 5.0119 (0.6); 5.0025 (1.2); 4.9937 (1.3); 4.9844 (0.6); 4.1127 (0.6); 4.1047 (0.6); 4.0852 (0.8); 4.0776 (0.7); 3.8861 (0.5); 3.8760 (0.5); 3.8603 (0.5); 3.3853 (0.3); 3.3296 (173.6); 2.8916 (13.2); 2.7327 (11.6); 2.5587 (16.1); 2.5242 (0.7); 2.5109 (16.7); 2.5065 (34.9); 2.5021 (47.4); 2.4976 (34.5); 2.4933 (16.8); 2.4486 (1.2); 2.4205 (11.0); 2.3631 (16.0); 2.3330 (0.5); 2.3120 (10.6); 1.0464 (0.6); 1.0311 (0.6); −0.0002 (1.0)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.0358 (1.5); 7.9516 (2.1); 7.7623 (1.6); 7.7571 (1.7); 7.7448 (1.6); 7.7394 (1.7); 7.5772 (0.6); 7.5717 (0.6); 7.5651 (0.7); 7.5595 (0.8); 7.5557 (1.5); 7.5503 (1.5); 7.5436 (1.4); 7.5382 (1.3); 7.5253 (2.2); 7.5027 (2.8); 7.4808 (1.0); 6.9456 (1.6); 6.9376 (1.7); 6.7069 (2.0); 6.7042 (2.1); 6.6985 (2.0); 6.6958 (1.8); 5.0154 (0.6); 5.0063 (1.3); 4.9979 (1.4); 4.9884 (0.6); 4.1205 (0.8); 4.1116 (0.8); 4.0925 (0.9); 4.0841 (0.9); 3.8906 (0.7); 3.8796 (0.7); 3.8635 (0.6); 3.8514 (0.5); 3.3252 (90.9); 2.8918 (15.3); 2.7331 (13.1); 2.5651 (16.0); 2.5239 (0.4); 2.5106 (11.2); 2.5063 (22.9); 2.5019 (30.6); 2.4974 (22.5); 2.4932 (11.1); 2.4506 (1.1); 2.4221 (11.3); 2.3201 (11.9); −0.0002 (0.5)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.0363 (0.8); 7.9508 (1.1); 7.3604 (0.8); 7.3405 (1.7); 7.3208 (1.2); 7.0955 (1.3); 7.0768 (3.1); 7.0715 (2.1); 7.0009 (1.0); 6.9948 (0.9); 6.9817 (0.8); 6.9794 (0.8); 6.9761 (0.8); 6.9737 (0.7); 6.9342 (0.7); 6.7007 (1.2); 6.6981 (1.3); 6.6924 (1.2); 6.6897 (1.2); 5.0061 (0.4); 4.9971 (0.8); 4.9882 (0.8); 4.9787 (0.4); 4.1044 (0.4); 4.0974 (0.4); 4.0752 (0.4); 3.8771 (0.3); 3.7541 (16.0); 3.7352 (0.7); 3.3296 (67.4); 2.8908 (8.9); 2.7321 (7.4); 2.5589 (11.2); 2.5235 (0.3); 2.5103 (6.8); 2.5058 (14.0); 2.5013 (18.7); 2.4968 (13.3); 2.4924 (6.2); 2.4459 (0.8); 2.4183 (6.9); 2.3093 (6.6)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.0344 (1.7); 7.9513 (2.0); 7.6451 (0.8); 7.6399 (0.8); 7.6259 (0.9); 7.6203 (1.3); 7.6132 (0.9); 7.5991 (0.8); 7.5941 (0.8); 7.5573 (0.6); 7.5357 (1.4); 7.5307 (0.9); 7.5140 (1.0); 7.5092 (1.5); 7.4879 (0.8); 7.4066 (1.0); 7.4014 (1.1); 7.3974 (1.1); 7.3921 (0.9); 7.3867 (0.8); 7.3807 (0.8); 7.3761 (0.7); 6.9414 (1.7); 6.9336 (1.9); 6.7048 (2.0); 6.7022 (2.1); 6.6965 (2.1); 6.6939 (1.9); 5.0016 (1.4); 4.9933 (1.5); 4.9843 (0.7); 4.1155 (0.8); 4.1069 (0.8); 4.0876 (1.0); 4.0794 (1.0); 3.8890 (0.7); 3.8776 (0.7); 3.8620 (0.6); 3.8499 (0.6); 3.3238 (99.8); 2.8917 (13.2); 2.7332 (11.2); 2.7324 (11.0); 2.5662 (16.0); 2.5061 (23.2); 2.5017 (30.9); 2.4973 (23.4); 2.4484 (1.1); 2.4204 (11.7); 2.3194 (12.3); −0.0002 (0.7)
1H-NMR(400.2 MHz, d6-DMSO) δ = 7.9512 (0.4); 7.8520 (3.0); 7.8213 (1.9); 7.7927 (1.4); 7.7729 (4.7); 7.6987 (1.6); 7.6792 (2.2); 7.6599 (0.8); 6.7838 (0.9); 4.7441 (1.3); 4.7334 (0.9); 4.1467 (1.0); 4.1368 (1.0); 4.1193 (1.2); 4.1094 (1.1); 3.7326 (0.6); 3.7162 (0.7); 3.7065 (0.7); 3.6893 (0.6); 3.3373 (61.9); 3.3330 (52.3); 2.8915 (2.8); 2.7327 (2.5); 2.5918 (0.4); 2.5734 (16.0); 2.5067 (12.1); 2.5023 (16.9); 2.4981 (13.4); 2.3613 (14.5); 2.3324 (8.0); 2.2932 (4.5)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.3059 (0.5); 7.9499 (0.5); 7.7576 (2.8); 7.3978 (2.5); 7.3783 (2.9); 7.1950 (2.9); 7.0709 (1.6); 7.0518 (1.4); 4.7438 (1.4); 4.7339 (0.9); 4.1355 (0.9); 4.1261 (1.0); 4.1082 (1.1); 4.0988 (1.0); 3.7274 (0.6); 3.7097 (0.7); 3.7020 (0.7); 3.6846 (0.5); 3.3418 (37.8); 3.3365 (57.5); 2.8903 (3.3); 2.7321 (2.9); 2.5148 (15.9); 2.5056 (12.8); 2.5012 (16.6); 2.4968 (13.1); 2.3666 (13.8); 2.3266 (9.2); 2.3197 (15.4); 2.2804 (16.0)
1H-NMR(400.2 MHz, d6-DMSO) δ = 7.9510 (2.1); 7.7589 (1.7); 7.7536 (2.0); 7.7416 (3.8); 7.7363 (2.4); 7.5799 (0.6); 7.5745 (0.5); 7.5678 (0.7); 7.5622 (0.7); 7.5583 (1.4); 7.5530 (1.4); 7.5463 (1.3); 7.5409 (1.3); 7.5286 (2.1); 7.5060 (2.6); 7.4842 (1.0); 6.7801 (0.8); 4.7481 (0.7); 4.7374 (1.2); 4.7266 (0.8); 4.1414 (0.9); 4.1316 (1.0); 4.1140 (1.1); 4.1043 (1.0); 3.7305 (0.6); 3.7137 (0.7); 3.7035 (0.7); 3.6863 (0.5); 3.3343 (58.0); 2.8916 (16.0); 2.7327 (13.4); 2.5659 (15.8); 2.5199 (0.4); 2.5111 (5.4); 2.5067 (11.7); 2.5022 (16.1); 2.4976 (11.9); 2.4933 (5.9); 2.3634 (13.6); 2.3214 (10.3)
1H-NMR(400.2 MHz, d6-DMSO) δ = 7.9503 (1.2); 7.7139 (1.8); 7.6413 (1.5); 7.6218 (3.2); 7.6024 (1.8); 7.1517 (2.7); 7.1412 (1.8); 7.1329 (2.7); 7.1217 (1.5); 6.6940 (3.0); 4.7049 (1.1); 4.0985 (0.8); 4.0890 (0.8); 4.0712 (1.0); 4.0619 (0.9); 3.6585 (0.4); 3.3305 (16.4); 3.3249 (41.8); 2.8904 (8.0); 2.7318 (7.0); 2.6238 (15.1); 2.5048 (11.2); 2.5005 (15.0); 2.4963 (11.6); 2.4255 (16.0); 2.3465 (6.0); 2.3326 (14.5); 2.2985 (0.6); 2.2513 (1.5)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.4823 (1.2); 8.4766 (0.8); 8.4635 (1.3); 8.4587 (1.2); 8.2476 (1.1); 8.1199 (0.9); 8.1156 (1.1); 8.1027 (0.8); 8.0967 (1.4); 8.0191 (0.5); 8.0058 (1.1); 8.0026 (1.0); 7.9920 (1.3); 7.9867 (1.9); 7.9824 (1.1); 7.9716 (1.1); 7.9679 (1.2); 7.9510 (2.0); 7.3575 (1.2); 7.3371 (2.4); 7.3162 (1.2); 7.1194 (1.5); 7.1176 (1.5); 7.1094 (1.3); 7.1034 (3.0); 7.1000 (3.7); 6.9863 (2.6); 6.9794 (2.4); 6.9673 (1.0); 6.9626 (1.0); 6.9588 (0.9); 6.7114 (1.4); 6.7056 (1.3); 6.7031 (1.3); 5.0955 (0.4); 5.0861 (1.0); 5.0773 (1.0); 5.0681 (0.5); 4.2307 (0.4); 4.2050 (0.5); 4.0029 (0.4); 3.9859 (0.4); 3.7408 (16.0); 3.3426 (29.9); 3.3406 (30.2); 2.8902 (12.1); 2.7320 (10.3); 2.5106 (4.0); 2.5062 (8.4); 2.5017 (11.6); 2.4973 (8.5); 2.4930 (4.2); 2.4611 (0.8); 2.4327 (6.9)
1H-NMR(400.2 MHz, d6-DMSO) δ = 7.9513 (1.9); 7.7424 (2.4); 7.6440 (0.8); 7.6387 (0.8); 7.6249 (0.8); 7.6182 (1.2); 7.6118 (0.9); 7.5980 (0.8); 7.5928 (0.8); 7.5614 (0.6); 7.5399 (1.4); 7.5349 (0.8); 7.5185 (0.9); 7.5132 (1.5); 7.4918 (0.8); 7.4087 (0.9); 7.4031 (1.0); 7.3980 (1.0); 7.3927 (0.9); 7.3872 (0.7); 7.3817 (0.7); 7.3765 (0.7); 6.7713 (1.0); 4.7448 (0.8); 4.7343 (1.3); 4.7233 (0.8); 4.1375 (1.0); 4.1277 (1.0); 4.1101 (1.2); 4.1004 (1.1); 3.7307 (0.7); 3.7139 (0.7); 3.7038 (0.7); 3.6868 (0.6); 3.3439 (55.2); 3.3387 (56.2); 2.8922 (13.8); 2.7337 (12.2); 2.5680 (16.0); 2.5116 (6.0); 2.5073 (12.4); 2.5029 (16.7); 2.4985 (12.2); 2.3615 (14.1); 2.3224 (9.6); 2.3137 (7.9); 2.0746 (0.6)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.3079 (0.5); 8.2188 (1.9); 8.2040 (2.5); 8.1830 (2.5); 8.1058 (2.9); 8.0850 (3.1); 8.0361 (2.6); 8.0165 (2.9); 7.9515 (1.1); 7.9027 (2.9); 7.9002 (2.9); 7.8850 (3.5); 7.8824 (3.1); 7.6107 (2.9); 7.5905 (4.4); 7.5720 (5.0); 7.5541 (2.1); 7.5510 (2.0); 7.5290 (1.9); 7.5255 (2.0); 7.5117 (1.3); 7.5081 (2.6); 7.5048 (2.0); 7.4908 (1.2); 7.4876 (1.1); 6.9911 (1.4); 6.7187 (2.6); 6.7161 (2.7); 6.7103 (2.6); 6.7077 (2.4); 5.0788 (1.6); 5.0704 (1.6); 4.1745 (1.1); 4.1657 (1.2); 4.1466 (1.4); 4.1381 (1.2); 3.9466 (0.9); 3.9344 (0.9); 3.9187 (0.8); 3.9073 (0.7); 3.3244 (169.9); 2.8905 (8.6); 2.7317 (6.9); 2.6702 (0.4); 2.5236 (0.9); 2.5189 (1.5); 2.5103 (24.2); 2.5058 (50.6); 2.5012 (68.5); 2.4967 (48.4); 2.4921 (22.7); 2.4824 (3.6); 2.4743 (25.2); 2.4226 (11.0); 2.3224 (16.0); 1.0465 (0.6); 1.0313 (0.6); 1.0281 (0.3); −0.0002 (1.9)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.0231 (1.8); 7.9504 (0.8); 7.3072 (3.9); 7.2644 (1.4); 7.2446 (2.7); 7.2044 (3.6); 7.1847 (1.9); 6.9383 (1.3); 6.7026 (2.5); 6.6999 (2.7); 6.6943 (2.7); 6.6918 (2.3); 4.9944 (1.8); 4.9872 (1.8); 4.0982 (0.8); 4.0712 (1.0); 3.8807 (0.7); 3.8639 (0.7); 3.3250 (84.0); 2.8902 (4.5); 2.7314 (4.0); 2.5336 (17.4); 2.5004 (30.8); 2.4964 (23.7); 2.4488 (1.3); 2.4213 (13.4); 2.2912 (11.6); 2.2505 (15.5); 2.2256 (16.0); −0.0002 (0.4)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.0328 (1.6); 7.9506 (2.1); 7.4244 (4.8); 7.4042 (6.3); 7.2560 (5.0); 7.2360 (4.1); 6.9381 (1.2); 6.7018 (2.2); 6.6991 (2.4); 6.6934 (2.4); 6.6908 (2.2); 4.9964 (1.6); 4.9881 (1.6); 4.0967 (0.7); 4.0746 (0.9); 3.8834 (0.6); 3.8649 (0.6); 3.3291 (95.5); 2.8906 (15.1); 2.7320 (12.7); 2.5363 (18.8); 2.5097 (10.4); 2.5055 (21.3); 2.5011 (28.9); 2.4966 (21.8); 2.4482 (1.4); 2.4200 (13.0); 2.3430 (16.0); 2.2938 (11.7); 1.0467 (0.7); 1.0314 (0.7)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.0342 (1.5); 7.9503 (1.8); 7.3473 (3.1); 7.3344 (0.4); 7.3215 (4.0); 7.3101 (4.7); 7.2897 (0.4); 7.2362 (1.3); 7.2261 (1.6); 6.9371 (1.2); 6.6996 (2.2); 6.6940 (2.1); 6.6916 (2.1); 4.9961 (1.5); 4.9877 (1.5); 4.0982 (0.7); 4.0725 (0.8); 3.8820 (0.6); 3.8625 (0.6); 3.3240 (78.8); 2.8902 (11.1); 2.7316 (9.8); 2.5486 (15.7); 2.5048 (19.3); 2.5006 (26.6); 2.4964 (21.7); 2.4478 (1.1); 2.4197 (11.5); 2.3157 (16.0); 2.3036 (10.6); 1.0462 (0.3); 1.0310 (0.3); −0.0002 (0.4)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.5288 (2.4); 8.5261 (2.0); 8.5194 (1.4); 8.5110 (2.0); 8.5046 (2.6); 8.4957 (0.5); 8.3072 (0.5); 8.2670 (2.6); 8.2610 (2.7); 8.1688 (1.9); 8.1628 (1.7); 8.1545 (1.4); 8.1480 (2.1); 8.1445 (3.0); 8.0663 (0.5); 8.0618 (1.0); 8.0493 (2.7); 8.0432 (4.2); 8.0339 (5.0); 8.0238 (3.8); 8.0186 (2.5); 8.0062 (0.9); 8.0016 (0.6); 7.9518 (0.8); 7.6635 (4.7); 7.6426 (6.1); 7.5378 (0.4); 7.5216 (3.4); 7.5157 (6.8); 7.5106 (5.5); 7.5044 (2.0); 7.4964 (0.4); 7.4896 (3.2); 7.4834 (2.1); 6.9782 (4.4); 6.9697 (4.7); 6.7058 (3.0); 6.6999 (2.8); 6.6978 (2.8); 5.1018 (1.0); 5.0925 (2.2); 5.0836 (2.3); 5.0746 (1.0); 4.2431 (1.2); 4.2353 (1.2); 4.2155 (1.5); 4.2075 (1.4); 4.0160 (1.2); 4.0046 (1.2); 3.9885 (1.0); 3.9767 (1.0); 3.3409 (108.4); 2.8915 (6.0); 2.7330 (5.2); 2.5253 (0.3); 2.5117 (9.2); 2.5074 (19.4); 2.5030 (26.6); 2.4985 (19.8); 2.4942 (9.9); 2.4569 (1.8); 2.4257 (16.0); −0.0002 (0.4)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.4652 (2.8); 8.4476 (2.8); 8.4447 (3.0); 8.2554 (2.7); 8.1147 (2.0); 8.1115 (2.6); 8.0920 (3.4); 8.0129 (1.2); 7.9962 (2.5); 7.9794 (3.9); 7.9767 (4.1); 7.9575 (2.8); 7.9442 (1.2); 7.5714 (3.9); 7.5668 (4.2); 7.5514 (6.0); 7.5478 (6.0); 7.4545 (1.0); 7.4508 (0.9); 7.4460 (1.6); 7.4417 (1.4); 7.4317 (5.9); 7.4141 (9.0); 7.4023 (1.7); 7.3991 (1.5); 7.3861 (0.4); 7.3823 (0.4); 6.9883 (3.0); 6.9806 (3.2); 6.7124 (3.4); 6.7098 (3.0); 6.7067 (3.2); 6.7043 (3.1); 5.0882 (2.4); 5.0798 (2.5); 4.2303 (1.0); 4.2063 (1.2); 4.0071 (1.0); 3.9897 (0.9); 3.3232 (43.8); 2.8890 (6.7); 2.7310 (5.8); 2.5045 (16.3); 2.5003 (22.4); 2.4962 (18.2); 2.4632 (1.7); 2.4333 (16.0); −0.0002 (0.4)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.4614 (3.8); 8.4422 (4.2); 8.4398 (4.0); 8.3067 (7.7); 8.2192 (6.7); 8.2165 (6.6); 8.1406 (3.1); 8.1378 (3.4); 8.1181 (4.4); 8.0261 (1.7); 8.0094 (3.3); 7.9915 (3.0); 7.9864 (4.7); 7.9821 (3.8); 7.9654 (6.3); 7.9610 (5.8); 7.9553 (9.0); 7.9488 (7.3); 7.9441 (6.4); 7.9338 (9.4); 7.9255 (3.3); 7.5966 (1.4); 7.5890 (7.5); 7.5809 (5.5); 7.5733 (5.7); 7.5651 (9.8); 7.5464 (4.1); 7.5418 (4.0); 7.0026 (3.8); 6.9946 (3.9); 6.7151 (4.0); 6.7093 (3.8); 5.1195 (1.4); 5.1104 (3.1); 5.1019 (3.1); 5.0929 (1.4); 4.2534 (1.4); 4.2315 (1.6); 4.0384 (1.3); 4.0292 (1.4); 4.0119 (1.2); 3.3489 (188.0); 3.3482 (188.0); 3.3250 (3.5); 2.8899 (8.1); 2.7327 (6.8); 2.5112 (14.9); 2.5071 (28.3); 2.5026 (36.6); 2.4981 (26.6); 2.4939 (13.2); 2.4683 (2.0); 2.4288 (16.0); −0.0002 (0.3)
1H-NMR(400.2 MHz, d6-DMSO) δ = 7.9500 (0.6); 7.7466 (2.9); 7.4264 (4.2); 7.4063 (5.4); 7.2573 (4.7); 7.2374 (3.8); 4.7344 (1.5); 4.1249 (1.0); 4.1153 (1.0); 4.0974 (1.2); 4.0880 (1.1); 3.7304 (0.6); 3.7132 (0.7); 3.7055 (0.7); 3.6897 (0.5); 3.3456 (78.7); 3.3424 (116.1); 2.8906 (4.0); 2.7321 (3.4); 2.5374 (17.8); 2.5060 (15.3); 2.5016 (20.4); 2.4972 (15.2); 2.3605 (16.0); 2.3416 (16.0); 2.3132 (6.4); 2.2953 (7.1)
1H-NMR(400.2 MHz, d6-DMSO) δ = 7.9503 (0.8); 7.7528 (2.7); 7.5614 (3.1); 7.5577 (2.5); 7.5079 (0.6); 7.5020 (0.7); 7.4972 (0.6); 7.4852 (2.7); 7.4813 (2.8); 7.4693 (6.5); 7.4526 (1.2); 7.4337 (0.3); 6.7710 (1.0); 4.7362 (1.3); 4.7258 (0.9); 4.1362 (1.0); 4.1265 (1.0); 4.1087 (1.2); 4.0991 (1.1); 3.7206 (0.6); 3.7031 (0.7); 3.6961 (0.7); 3.6776 (0.5); 3.3299 (45.8); 2.8906 (5.6); 2.7320 (5.0); 2.5766 (16.0); 2.5055 (10.9); 2.5011 (15.2); 2.4968 (12.2); 2.3585 (14.4); 2.3265 (7.7); 2.2977 (4.9)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.4455 (1.9); 8.4261 (2.2); 8.4228 (2.0); 8.3077 (1.3); 8.2488 (1.6); 8.2441 (1.6); 8.0948 (1.4); 8.0912 (1.7); 8.0761 (1.6); 8.0715 (2.3); 7.9985 (0.7); 7.9956 (0.8); 7.9817 (1.7); 7.9790 (1.6); 7.9614 (2.9); 7.9568 (2.7); 7.9401 (1.8); 7.9367 (1.6); 7.9233 (0.8); 7.9198 (0.6); 7.4799 (5.1); 7.4597 (6.2); 7.2602 (5.0); 7.2400 (4.1); 6.9910 (1.8); 6.9831 (1.9); 6.7166 (2.1); 6.7141 (2.2); 6.7083 (2.1); 6.7058 (1.9); 5.0953 (0.7); 5.0861 (1.6); 5.0773 (1.6); 5.0680 (0.7); 4.2301 (0.6); 4.2046 (0.7); 4.0164 (0.6); 4.0079 (0.6); 3.9902 (0.6); 3.3419 (21.1); 3.3376 (40.7); 3.3351 (44.4); 3.3127 (0.6); 2.8896 (4.0); 2.7321 (3.4); 2.5229 (0.3); 2.5097 (5.9); 2.5054 (11.8); 2.5009 (15.6); 2.4964 (10.9); 2.4920 (5.0); 2.4646 (1.1); 2.4365 (11.3); 2.3423 (16.0)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.4364 (0.9); 8.4313 (0.9); 8.3445 (1.3); 8.3235 (1.4); 8.2860 (1.1); 8.2648 (1.2); 8.1264 (1.1); 8.1186 (1.4); 8.1055 (1.5); 8.0979 (1.5); 8.0515 (1.3); 8.0314 (1.4); 7.9974 (0.6); 7.9773 (1.9); 7.9752 (1.9); 7.9591 (2.4); 7.9567 (2.4); 7.9520 (2.3); 7.9279 (0.9); 7.9248 (1.0); 7.9109 (0.6); 7.9071 (1.2); 7.9038 (0.9); 7.8898 (0.5); 7.8867 (0.6); 7.6315 (1.3); 7.6132 (1.4); 7.6112 (1.6); 7.5927 (1.5); 7.5718 (1.3); 7.5542 (0.8); 7.5516 (0.8); 7.5090 (0.8); 7.5060 (0.8); 7.4917 (0.6); 7.4883 (1.2); 7.4851 (0.9); 7.4709 (0.5); 7.4679 (0.5); 7.0411 (1.0); 7.0334 (1.0); 6.7280 (1.1); 6.7221 (1.0); 5.1747 (0.4); 5.1657 (0.9); 5.1569 (0.9); 5.1477 (0.4); 4.2994 (0.4); 4.2924 (0.4); 4.2723 (0.5); 4.2655 (0.4); 4.0791 (0.4); 4.0687 (0.4); 4.0520 (0.4); 4.0422 (0.3); 3.3432 (31.8); 2.8899 (16.0); 2.7323 (13.5); 2.5112 (4.7); 2.5068 (9.9); 2.5023 (13.6); 2.4978 (10.3); 2.4934 (4.8); 2.4346 (4.2)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.1314 (2.0); 8.1245 (2.0); 7.9513 (0.9); 7.7534 (0.9); 7.7502 (1.0); 7.7329 (1.9); 7.7160 (1.0); 7.7126 (1.0); 7.6140 (0.9); 7.6105 (1.0); 7.5947 (2.0); 7.5789 (1.1); 7.5752 (1.0); 7.3379 (1.5); 7.3180 (2.6); 7.2977 (1.4); 6.9455 (2.5); 6.9370 (2.6); 6.7074 (2.1); 6.7049 (2.2); 6.6991 (2.1); 6.6967 (2.0); 5.0243 (0.7); 5.0158 (1.6); 5.0070 (1.6); 4.9977 (0.7); 4.1166 (1.0); 4.1078 (1.1); 4.0887 (1.4); 4.0801 (1.3); 3.9107 (1.1); 3.8993 (1.1); 3.8831 (0.9); 3.8715 (0.9); 3.3231 (87.3); 2.8912 (6.2); 2.7323 (5.3); 2.5479 (17.7); 2.5238 (0.5); 2.5059 (27.0); 2.5015 (36.3); 2.4971 (26.7); 2.4549 (1.2); 2.4240 (13.3); 2.3131 (16.0); −0.0002 (0.7)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.0427 (1.7); 7.9505 (0.9); 7.5630 (3.4); 7.5595 (2.8); 7.5062 (0.6); 7.5028 (0.7); 7.4928 (1.3); 7.4839 (3.2); 7.4793 (5.6); 7.4743 (4.8); 7.4716 (5.1); 7.4624 (1.6); 7.4527 (0.9); 7.4341 (0.4); 6.9395 (1.7); 6.9325 (1.9); 6.7002 (2.3); 6.6946 (2.2); 6.6921 (2.2); 5.0021 (1.5); 4.9933 (1.6); 4.1127 (0.8); 4.1071 (0.8); 4.0865 (0.9); 4.0801 (0.9); 3.8822 (0.7); 3.8738 (0.7); 3.8564 (0.7); 3.3247 (93.0); 2.8907 (5.6); 2.7317 (5.2); 2.5741 (16.0); 2.5054 (25.6); 2.5012 (36.2); 2.4971 (30.3); 2.4467 (1.1); 2.4175 (12.1); 2.3242 (11.8); −0.0002 (0.5)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.4684 (1.9); 8.4665 (1.9); 8.4572 (2.0); 7.9989 (1.0); 7.9518 (0.9); 7.7657 (1.1); 7.7616 (0.9); 7.7459 (2.1); 7.7424 (1.9); 7.7269 (1.2); 7.7227 (1.1); 7.3750 (1.9); 7.3552 (1.7); 7.3004 (1.4); 7.2868 (1.7); 7.2837 (1.6); 7.2700 (1.3); 6.8978 (2.5); 6.8900 (2.7); 6.6730 (2.2); 4.9595 (1.7); 4.9525 (1.8); 4.0547 (0.6); 4.0315 (0.7); 3.8323 (0.6); 3.3271 (122.3); 3.3255 (125.8); 2.8915 (4.6); 2.7326 (4.3); 2.6268 (16.0); 2.5052 (36.6); 2.5015 (43.7); 2.4197 (1.6); 2.4003 (8.9); 2.3477 (11.7); 1.0463 (0.7); 1.0311 (0.6); −0.0002 (0.3)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.2444 (0.5); 8.2378 (4.9); 8.2327 (1.6); 8.2204 (1.6); 8.2153 (5.4); 8.2087 (0.6); 8.0692 (1.0); 7.9511 (2.0); 7.6969 (0.4); 7.6940 (0.7); 7.6873 (4.8); 7.6822 (1.6); 7.6747 (0.5); 7.6700 (1.4); 7.6649 (4.5); 7.6582 (0.5); 6.9206 (2.0); 6.9121 (2.2); 6.6916 (1.4); 6.6891 (1.6); 6.6833 (1.5); 6.6807 (1.4); 5.0013 (0.5); 4.9920 (1.1); 4.9831 (1.1); 4.9736 (0.5); 4.1058 (0.5); 4.0977 (0.6); 4.0785 (0.7); 4.0707 (0.6); 3.8672 (0.4); 3.8566 (0.5); 3.8410 (0.4); 3.8305 (0.4); 3.3355 (85.5); 2.8919 (16.0); 2.7327 (12.9); 2.6209 (14.3); 2.5200 (0.4); 2.5115 (7.7); 2.5070 (16.5); 2.5025 (22.6); 2.4979 (16.3); 2.4934 (7.8); 2.4332 (1.0); 2.4059 (7.6); 2.3573 (10.2); 1.0469 (0.6); 1.0317 (0.6)
1H-NMR(400.2 MHz, d6-DMSO) δ = 7.9508 (2.3); 7.7660 (3.3); 7.7608 (3.7); 7.7456 (2.3); 7.7117 (2.8); 7.6907 (3.4); 7.5120 (2.0); 7.5068 (2.0); 7.4910 (1.6); 7.4858 (1.7); 6.7550 (1.2); 4.7434 (0.8); 4.7322 (1.1); 4.7218 (0.8); 4.1387 (0.9); 4.1288 (0.9); 4.1110 (1.0); 4.1014 (0.9); 3.7224 (0.6); 3.7050 (0.6); 3.6967 (0.6); 3.6789 (0.5); 3.3349 (38.6); 2.8915 (16.0); 2.7328 (13.7); 2.5799 (13.4); 2.5585 (0.4); 2.5107 (5.2); 2.5065 (10.5); 2.5020 (14.3); 2.4976 (11.0); 2.4934 (5.8); 2.3584 (12.2); 2.3307 (7.5); 2.3037 (5.3)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.4615 (2.3); 8.4563 (1.7); 8.4424 (2.9); 8.4384 (2.4); 8.3552 (2.5); 8.3482 (2.5); 8.3087 (0.4); 8.1281 (1.8); 8.1241 (2.4); 8.1102 (1.9); 8.1049 (2.8); 8.0235 (0.9); 8.0199 (1.2); 8.0066 (2.4); 8.0030 (2.2); 7.9880 (3.3); 7.9840 (3.4); 7.9722 (1.1); 7.9687 (2.2); 7.9651 (2.3); 7.9519 (2.5); 7.7514 (1.2); 7.7476 (1.4); 7.7306 (2.5); 7.7138 (1.4); 7.7100 (1.5); 7.6481 (1.3); 7.6442 (1.4); 7.6319 (1.5); 7.6283 (2.8); 7.6247 (1.7); 7.6124 (1.6); 7.6085 (1.4); 7.3475 (1.9); 7.3453 (1.9); 7.3274 (3.3); 7.3255 (3.3); 7.3076 (1.6); 7.3054 (1.6); 6.9924 (3.8); 6.9838 (4.0); 6.7250 (2.7); 6.7223 (3.0); 6.7166 (2.8); 6.7138 (2.7); 5.1130 (0.9); 5.1038 (2.1); 5.0949 (2.1); 5.0859 (0.9); 4.2449 (1.1); 4.2365 (1.1); 4.2171 (1.4); 4.2088 (1.3); 4.0416 (1.2); 4.0303 (1.3); 4.0137 (1.1); 4.0026 (1.0); 3.3306 (54.6); 2.8910 (11.8); 2.7328 (9.6); 2.5111 (7.8); 2.5066 (16.5); 2.5021 (22.4); 2.4976 (16.3); 2.4931 (7.8); 2.4727 (1.1); 2.4426 (16.0); −0.0002 (0.3)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.5048 (3.1); 8.5028 (2.8); 8.4989 (2.1); 8.4860 (3.8); 8.4808 (3.3); 8.3084 (1.2); 8.2591 (2.8); 8.1462 (2.4); 8.1419 (3.0); 8.1290 (2.2); 8.1252 (3.2); 8.1230 (3.8); 8.0511 (1.0); 8.0475 (1.3); 8.0342 (2.9); 8.0307 (2.7); 8.0202 (3.9); 8.0147 (5.1); 8.0100 (2.8); 8.0030 (1.6); 7.9998 (3.0); 7.9959 (3.2); 7.9828 (1.3); 7.9789 (1.1); 7.9525 (1.6); 7.8952 (5.2); 7.8607 (2.7); 7.8412 (3.3); 7.7798 (2.4); 7.7602 (3.6); 7.6903 (3.0); 7.6707 (4.3); 7.6512 (1.7); 6.9886 (4.7); 6.9801 (4.9); 6.7143 (3.2); 6.7119 (3.5); 6.7061 (3.3); 6.7036 (3.1); 5.1106 (1.2); 5.1007 (2.5); 5.0919 (2.6); 5.0826 (1.2); 4.2490 (1.1); 4.2267 (1.2); 4.0094 (1.0); 3.9941 (0.9); 3.3358 (100.6); 2.8914 (13.0); 2.7329 (10.7); 2.5251 (0.4); 2.5205 (0.7); 2.5118 (12.1); 2.5074 (25.9); 2.5028 (35.5); 2.4982 (25.6); 2.4938 (12.2); 2.4623 (2.2); 2.4266 (16.0); −0.0002 (0.5)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.4271 (1.6); 8.4076 (1.6); 8.4047 (1.7); 8.2726 (1.4); 8.0911 (1.4); 8.0712 (1.9); 7.9908 (0.7); 7.9739 (1.4); 7.9514 (4.2); 7.9298 (1.5); 7.9270 (1.4); 7.9131 (0.6); 7.9099 (0.6); 7.5388 (1.7); 7.5191 (1.9); 7.3972 (0.6); 7.3823 (3.4); 7.3791 (3.7); 7.3652 (1.7); 7.3630 (1.7); 7.3440 (0.6); 7.2689 (0.8); 7.2635 (0.8); 7.2465 (1.2); 7.2330 (0.6); 7.2278 (0.6); 7.0002 (1.4); 6.9925 (1.6); 6.7179 (1.7); 6.7123 (1.7); 5.1042 (0.5); 5.0951 (1.3); 5.0865 (1.3); 5.0778 (0.6); 4.2362 (0.6); 4.2112 (0.6); 4.0263 (0.6); 4.0174 (0.6); 3.9992 (0.5); 3.9906 (0.4); 3.3414 (45.4); 2.8902 (16.0); 2.7323 (14.0); 2.5061 (9.3); 2.5017 (13.0); 2.4974 (10.2); 2.4706 (0.9); 2.4602 (0.4); 2.4379 (8.6); 2.3577 (13.2); 2.2591 (0.4)
1H-NMR(400.2 MHz, d6-DMSO) δ = 7.9499 (2.5); 7.7371 (2.9); 7.3084 (3.2); 7.2683 (1.2); 7.2461 (2.1); 7.2058 (3.0); 7.1862 (1.6); 4.7348 (1.5); 4.1238 (0.9); 4.1145 (1.0); 4.0964 (1.1); 4.0875 (1.1); 3.7257 (0.6); 3.7054 (0.7); 3.3352 (28.4); 3.3283 (65.5); 2.8900 (16.0); 2.7315 (14.2); 2.5343 (16.0); 2.5046 (15.5); 2.5004 (20.2); 2.4960 (15.9); 2.3617 (14.5); 2.3146 (6.4); 2.2923 (6.7); 2.2496 (14.1); 2.2243 (14.4)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.4828 (2.1); 8.4794 (1.8); 8.4657 (2.1); 8.4611 (2.6); 8.3066 (0.5); 8.2637 (2.3); 8.1314 (1.6); 8.1271 (2.2); 8.1143 (1.3); 8.1075 (2.7); 8.0318 (1.0); 8.0151 (2.2); 8.0048 (2.3); 7.9997 (3.6); 7.9952 (2.5); 7.9843 (1.9); 7.9808 (2.2); 7.9674 (0.8); 7.9636 (0.9); 7.9518 (2.4); 7.6935 (0.6); 7.6858 (6.3); 7.6810 (3.6); 7.6691 (2.2); 7.6639 (8.0); 7.4466 (4.9); 7.4250 (4.2); 6.9858 (2.8); 6.9777 (3.1); 6.7134 (2.7); 6.7082 (2.7); 6.7060 (2.6); 5.1004 (0.8); 5.0905 (2.0); 5.0826 (2.1); 4.2367 (0.9); 4.2119 (1.0); 4.0087 (0.9); 3.9921 (0.8); 3.3515 (124.6); 3.3089 (0.4); 2.8917 (16.0); 2.7334 (13.8); 2.5080 (15.6); 2.5035 (22.3); 2.4991 (18.5); 2.4948 (10.2); 2.4630 (1.3); 2.4312 (12.8)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.4464 (0.5); 8.4418 (0.3); 8.4268 (0.5); 8.4235 (0.5); 8.2575 (0.4); 8.2528 (0.4); 8.1009 (0.4); 8.0974 (0.4); 8.0781 (0.6); 7.9863 (0.4); 7.9835 (0.4); 7.9668 (0.8); 7.9621 (0.7); 7.9499 (0.5); 7.9460 (0.5); 7.9425 (0.4); 7.5130 (0.8); 7.5080 (0.4); 7.4916 (2.1); 7.4656 (2.1); 7.4605 (0.5); 7.4491 (0.3); 7.4441 (0.8); 6.9917 (0.4); 6.9839 (0.5); 6.7169 (0.5); 6.7143 (0.6); 6.7086 (0.5); 6.7060 (0.5); 5.0841 (0.4); 5.0754 (0.4); 3.3359 (19.2); 2.8903 (1.9); 2.7321 (1.6); 2.5101 (1.7); 2.5060 (3.5); 2.5015 (4.7); 2.4970 (3.4); 2.4927 (1.7); 2.4360 (2.7); 1.3045 (16.0)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.0675 (1.7); 8.0611 (1.7); 7.9510 (1.1); 7.6194 (2.0); 7.6161 (2.1); 7.5995 (2.7); 7.5955 (3.7); 7.5905 (2.4); 7.5754 (2.4); 7.5712 (2.5); 7.4820 (1.1); 7.4777 (1.2); 7.4632 (2.2); 7.4589 (2.0); 7.4436 (1.5); 7.4392 (1.3); 7.4054 (1.7); 7.4018 (1.8); 7.3959 (0.4); 7.3864 (2.2); 7.3829 (2.3); 7.3677 (0.9); 7.3642 (0.9); 6.9462 (2.0); 6.9381 (2.1); 6.6988 (2.0); 6.6961 (2.2); 6.6904 (2.1); 6.6876 (2.0); 5.0122 (0.6); 5.0031 (1.4); 4.9945 (1.5); 4.9852 (0.6); 4.1055 (0.9); 4.0967 (0.9); 4.0778 (1.2); 4.0691 (1.1); 3.8936 (0.8); 3.8822 (0.8); 3.8660 (0.7); 3.8547 (0.6); 3.7569 (0.8); 3.3328 (164.0); 3.2841 (0.3); 2.8911 (8.6); 2.7320 (7.0); 2.5571 (18.3); 2.5243 (0.6); 2.5195 (0.8); 2.5109 (14.6); 2.5064 (31.4); 2.5018 (43.1); 2.4973 (31.3); 2.4928 (15.0); 2.4479 (1.4); 2.4160 (12.2); 2.3179 (16.0); 1.0465 (0.8); 1.0312 (0.8); −0.0002 (1.1)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.0292 (1.6); 7.9510 (0.5); 7.6657 (1.5); 7.6631 (2.4); 7.6613 (3.0); 7.6591 (3.1); 7.6548 (1.6); 7.5629 (6.7); 7.5617 (7.5); 7.5586 (6.4); 7.5571 (6.3); 6.9382 (2.3); 6.9298 (2.3); 6.7017 (2.2); 6.6935 (2.0); 5.0112 (0.7); 5.0023 (1.4); 4.9935 (1.4); 4.9841 (0.6); 4.1212 (0.8); 4.1129 (0.8); 4.0937 (1.0); 4.0855 (0.9); 3.8794 (0.7); 3.8675 (0.7); 3.8516 (0.7); 3.8403 (0.6); 3.3341 (123.5); 2.8916 (3.5); 2.7329 (3.2); 2.5973 (16.0); 2.5060 (23.4); 2.5021 (29.1); 2.4445 (1.2); 2.4170 (11.9); 2.3402 (12.3); 1.0466 (0.6); 1.0309 (0.6)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.0613 (1.4); 7.9517 (1.4); 7.6618 (0.5); 7.6545 (4.9); 7.6493 (1.7); 7.6376 (2.0); 7.6324 (6.0); 7.6250 (0.7); 7.4469 (3.4); 7.4261 (2.8); 6.9414 (1.4); 6.9340 (1.4); 6.7028 (2.0); 6.7002 (2.0); 6.6945 (1.9); 6.6918 (1.7); 5.0123 (0.6); 5.0030 (1.3); 4.9943 (1.3); 4.9854 (0.6); 4.1151 (0.7); 4.1061 (0.7); 4.0868 (0.8); 4.0794 (0.8); 3.8899 (0.6); 3.8804 (0.6); 3.8646 (0.5); 3.8535 (0.5); 3.3286 (96.2); 2.8914 (10.9); 2.7330 (9.0); 2.7324 (9.0); 2.5608 (16.0); 2.5106 (11.6); 2.5063 (23.1); 2.5018 (30.4); 2.4972 (21.8); 2.4929 (10.4); 2.4483 (1.1); 2.4189 (10.6); 2.3176 (11.1); 1.0467 (0.5); 1.0314 (0.5); −0.0002 (0.5)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.0485 (1.4); 7.9505 (2.0); 7.5372 (2.5); 7.5297 (2.2); 7.5260 (2.5); 7.5177 (4.3); 7.5131 (3.8); 7.5046 (0.5); 7.4594 (0.4); 7.4558 (0.4); 7.4470 (1.4); 7.4430 (1.0); 7.4363 (4.3); 7.4314 (4.1); 7.4236 (6.5); 7.4189 (6.1); 6.9392 (1.2); 6.7026 (2.2); 6.6998 (2.4); 6.6941 (2.3); 6.6913 (2.2); 5.0100 (0.6); 5.0007 (1.5); 4.9918 (1.5); 4.9826 (0.7); 4.1073 (0.6); 4.0999 (0.7); 4.0785 (0.8); 3.8825 (0.6); 3.8643 (0.5); 3.3709 (0.6); 3.3388 (217.0); 3.2944 (0.4); 2.8906 (16.0); 2.7317 (13.2); 2.5499 (20.0); 2.5241 (0.5); 2.5194 (0.6); 2.5107 (10.9); 2.5063 (23.3); 2.5017 (32.2); 2.4972 (23.5); 2.4927 (11.4); 2.4481 (1.4); 2.4189 (12.4); 2.3283 (0.4); 2.3071 (12.1); 1.0467 (1.0); 1.0314 (1.0); −0.0002 (0.5)
1H-NMR(400.2 MHz, d6-DMSO) δ = 7.9510 (1.0); 7.8005 (2.6); 7.7255 (1.8); 7.7220 (2.1); 7.7054 (2.2); 7.7018 (2.3); 7.5557 (1.8); 7.5521 (2.0); 7.5361 (2.5); 7.5325 (2.4); 7.4250 (2.3); 7.4050 (3.6); 7.3852 (1.6); 6.7788 (2.1); 4.7555 (0.8); 4.7442 (1.3); 4.7392 (1.0); 4.7333 (0.8); 4.7293 (0.8); 4.1368 (1.0); 4.1269 (1.0); 4.1093 (1.2); 4.0995 (1.1); 3.7117 (0.8); 3.6949 (0.8); 3.6846 (0.8); 3.6676 (0.7); 3.3239 (42.9); 2.8910 (7.5); 2.7323 (6.4); 2.5700 (16.0); 2.5099 (5.8); 2.5057 (12.3); 2.5013 (16.8); 2.4968 (12.5); 2.4926 (6.2); 2.3583 (14.0); 2.3270 (12.4); 2.3073 (9.1)
1H-NMR(400.2 MHz, d6-DMSO) δ = 7.9506 (1.9); 7.7732 (2.9); 7.6523 (4.5); 7.6306 (5.8); 7.4469 (3.8); 7.4262 (3.2); 6.7813 (0.9); 4.7388 (1.5); 4.1345 (1.0); 4.1249 (1.1); 4.1071 (1.2); 4.0978 (1.1); 3.7330 (0.7); 3.7166 (0.8); 3.7073 (0.8); 3.6899 (0.6); 3.3498 (74.2); 3.3446 (96.7); 2.8915 (11.8); 2.7329 (10.8); 2.5626 (16.0); 2.5065 (13.9); 2.5028 (19.2); 2.4988 (15.9); 2.3597 (14.9); 2.3198 (8.9); 2.3015 (6.0)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.5473 (0.3); 8.5401 (2.6); 8.5373 (2.1); 8.5308 (1.4); 8.5222 (2.2); 8.5160 (2.8); 8.5077 (0.5); 8.3079 (1.6); 8.2125 (2.6); 8.1613 (2.0); 8.1553 (1.7); 8.1468 (1.5); 8.1371 (3.3); 8.0736 (0.6); 8.0691 (1.0); 8.0567 (2.8); 8.0505 (4.4); 8.0413 (4.8); 8.0310 (3.7); 8.0259 (2.9); 8.0136 (1.0); 8.0090 (0.6); 7.9520 (0.5); 7.6417 (2.8); 7.6371 (6.3); 7.6328 (4.3); 7.5867 (15.1); 7.5821 (13.5); 6.9784 (4.7); 6.9698 (5.0); 6.7110 (3.1); 6.7052 (3.0); 6.7029 (2.9); 5.1033 (1.0); 5.0933 (2.2); 5.0847 (2.2); 5.0757 (1.1); 4.2545 (1.0); 4.2470 (1.1); 4.2259 (1.2); 4.0078 (0.9); 3.9987 (0.9); 3.9824 (0.8); 3.3419 (70.5); 3.3384 (78.2); 3.3350 (70.8); 2.8920 (3.9); 2.7337 (3.4); 2.5121 (9.5); 2.5078 (20.4); 2.5033 (28.0); 2.4988 (20.8); 2.4946 (10.3); 2.4582 (1.5); 2.4283 (16.0); −0.0002 (0.3)
1H-NMR(400.2 MHz, d6-DMSO) δ = 7.9505 (0.4); 7.7749 (2.2); 7.5081 (1.8); 7.4890 (2.0); 7.3776 (3.7); 7.3667 (2.9); 7.2683 (0.7); 7.2557 (0.9); 7.2478 (0.9); 7.2358 (0.7); 7.2268 (0.5); 4.7476 (1.1); 4.7370 (0.7); 4.1407 (0.7); 4.1309 (0.8); 4.1133 (0.9); 4.1037 (0.8); 3.7324 (0.5); 3.7151 (0.6); 3.7066 (0.6); 3.6891 (0.4); 3.3499 (28.4); 3.3439 (56.1); 2.8910 (2.4); 2.7329 (2.2); 2.5264 (13.2); 2.5062 (8.8); 2.5021 (11.8); 2.4979 (8.9); 2.3684 (11.8); 2.3237 (16.0); 2.2966 (5.3)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.1635 (2.4); 8.1606 (2.4); 7.9688 (1.1); 7.9572 (3.4); 7.9509 (3.8); 7.9364 (3.3); 7.9262 (1.2); 7.8032 (2.0); 7.6020 (0.4); 7.5896 (2.1); 7.5851 (1.6); 7.5779 (2.0); 7.5702 (1.4); 7.5662 (2.1); 7.5531 (0.4); 7.5446 (1.5); 7.5403 (1.4); 7.5231 (1.4); 7.5188 (1.3); 4.7577 (0.9); 4.1518 (0.7); 4.1421 (0.7); 4.1243 (0.8); 4.1148 (0.8); 3.7588 (0.5); 3.7417 (0.5); 3.7327 (0.5); 3.7151 (0.4); 3.3357 (33.9); 3.3320 (38.0); 2.8900 (16.0); 2.7328 (13.8); 2.5531 (12.2); 2.5236 (0.3); 2.5103 (4.8); 2.5060 (9.5); 2.5015 (12.5); 2.4970 (9.0); 2.4928 (4.4); 2.3681 (10.5); 2.3325 (5.2); 2.2889 (2.0); 2.0792 (0.4)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.4234 (2.3); 8.4040 (2.6); 8.4018 (2.5); 8.2615 (2.3); 8.0864 (1.9); 8.0839 (2.0); 8.0647 (2.8); 7.9877 (1.0); 7.9851 (1.0); 7.9708 (2.0); 7.9681 (2.1); 7.9509 (3.6); 7.9442 (3.1); 7.9401 (2.5); 7.9230 (2.4); 7.9198 (2.0); 7.9061 (1.1); 7.9028 (0.9); 7.3749 (4.0); 7.2755 (2.4); 7.2562 (3.7); 7.1879 (2.6); 7.1688 (1.7); 7.0008 (2.2); 6.9935 (2.4); 6.7218 (2.6); 6.7191 (2.8); 6.7165 (2.5); 6.7135 (2.9); 6.7109 (2.6); 5.0904 (2.0); 5.0822 (2.1); 4.2331 (0.9); 4.2093 (1.0); 4.0152 (0.9); 3.9976 (0.8); 3.3370 (44.9); 3.3325 (50.6); 2.8899 (13.5); 2.7321 (11.6); 2.5053 (16.3); 2.5011 (21.4); 2.4966 (16.3); 2.4707 (1.3); 2.4399 (13.3); 2.3272 (0.8); 2.3139 (0.9); 2.2982 (16.0); 2.2606 (16.0)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.4933 (2.6); 8.4910 (2.4); 8.4874 (1.8); 8.4744 (2.9); 8.4706 (2.8); 8.2280 (2.9); 8.1295 (2.2); 8.1107 (3.2); 8.0368 (1.1); 8.0232 (2.6); 8.0199 (2.4); 8.0097 (3.2); 8.0044 (4.2); 7.9995 (2.8); 7.9893 (3.0); 7.9857 (2.8); 7.9725 (1.2); 7.9688 (0.9); 7.9524 (1.7); 7.6899 (1.2); 7.6847 (1.3); 7.6709 (1.4); 7.6653 (2.0); 7.6579 (1.6); 7.6440 (1.3); 7.6390 (1.3); 7.5612 (0.9); 7.5397 (2.2); 7.5348 (1.4); 7.5132 (2.3); 7.4922 (1.4); 7.4469 (2.0); 7.4438 (2.0); 7.4332 (1.4); 7.4277 (1.3); 7.4223 (1.2); 6.9868 (3.5); 6.9786 (4.1); 6.7186 (3.1); 6.7160 (3.3); 6.7103 (3.6); 6.7080 (3.1); 5.0939 (2.4); 5.0858 (2.6); 4.2424 (1.2); 4.2156 (1.4); 4.0087 (1.2); 3.9923 (1.0); 3.3392 (99.7); 2.8920 (9.7); 2.7341 (8.6); 2.5028 (25.7); 2.4986 (20.6); 2.4642 (1.4); 2.4347 (16.0)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.0411 (1.2); 7.9511 (1.6); 7.5021 (0.5); 7.4854 (0.9); 7.4813 (1.5); 7.4661 (1.4); 7.4607 (1.1); 7.4459 (1.0); 7.3628 (3.5); 7.3595 (2.8); 7.3530 (1.0); 7.3421 (2.0); 7.3398 (2.2); 7.3336 (1.3); 7.3299 (0.8); 7.2806 (0.7); 7.2774 (0.7); 7.2750 (0.6); 7.2716 (0.6); 7.2575 (1.2); 7.2513 (1.0); 7.2372 (0.5); 7.2350 (0.6); 7.2309 (0.5); 7.2289 (0.5); 6.9372 (1.4); 6.9292 (1.4); 6.7012 (1.7); 6.6985 (1.8); 6.6928 (1.7); 6.6901 (1.6); 5.0090 (0.5); 4.9995 (1.2); 4.9902 (1.2); 4.9810 (0.5); 4.1109 (0.6); 4.1026 (0.6); 4.0832 (0.7); 4.0752 (0.6); 3.8835 (0.5); 3.8727 (0.5); 3.8561 (0.4); 3.8461 (0.4); 3.3348 (108.0); 2.8912 (13.3); 2.7321 (10.7); 2.5755 (16.0); 2.5243 (0.4); 2.5110 (9.4); 2.5065 (19.6); 2.5019 (26.4); 2.4974 (18.7); 2.4928 (8.6); 2.4446 (1.1); 2.4164 (9.5); 2.3247 (10.5); 1.0466 (0.6); 1.0314 (0.6); −0.0002 (0.6)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.0370 (1.2); 7.9507 (2.0); 7.3998 (2.5); 7.3803 (2.9); 7.1890 (2.5); 7.0686 (1.4); 7.0494 (1.2); 6.9493 (0.8); 6.7048 (1.7); 6.7023 (1.8); 6.6966 (1.7); 6.6939 (1.7); 5.0042 (1.1); 4.9958 (1.2); 4.9864 (0.5); 4.1131 (0.6); 4.1057 (0.6); 4.0857 (0.7); 4.0784 (0.6); 3.8824 (0.5); 3.8626 (0.4); 3.3259 (86.1); 2.8905 (16.0); 2.7319 (13.3); 2.5165 (16.4); 2.5099 (9.8); 2.5054 (18.7); 2.5009 (25.0); 2.4964 (18.0); 2.4919 (8.5); 2.4536 (1.1); 2.4213 (10.3); 2.3185 (12.7); 2.2851 (9.6); 2.2647 (13.8); −0.0002 (0.4)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.0086 (0.6); 7.9505 (0.6); 7.6437 (1.4); 7.6243 (2.9); 7.6049 (1.6); 7.1588 (3.1); 7.1398 (2.9); 6.9055 (1.8); 6.8976 (1.9); 6.6781 (1.7); 6.6720 (1.6); 4.9655 (1.3); 4.9569 (1.4); 4.0610 (0.4); 4.0387 (0.5); 3.8428 (0.4); 3.8313 (0.4); 3.3664 (0.4); 3.3342 (129.1); 2.8909 (3.3); 2.7318 (3.0); 2.6180 (14.9); 2.5056 (18.9); 2.5016 (25.6); 2.4974 (19.6); 2.4323 (16.0); 2.4234 (1.8); 2.4029 (7.6); 2.3415 (9.8); 1.0466 (0.8); 1.0314 (0.8)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.3071 (0.3); 8.0667 (1.3); 7.9513 (0.3); 7.7802 (2.9); 7.7593 (4.6); 7.6960 (4.3); 7.6754 (2.7); 6.9314 (1.8); 6.9231 (1.9); 6.6971 (1.7); 6.6946 (1.9); 6.6888 (1.8); 6.6864 (1.7); 5.0077 (0.6); 4.9984 (1.3); 4.9894 (1.3); 4.9799 (0.6); 4.1137 (0.7); 4.1054 (0.7); 4.0855 (0.8); 4.0772 (0.8); 3.8791 (0.6); 3.8694 (0.6); 3.8524 (0.5); 3.8426 (0.4); 3.3286 (130.5); 2.8916 (2.4); 2.7329 (2.1); 2.5879 (16.0); 2.5241 (0.5); 2.5108 (13.1); 2.5065 (27.6); 2.5020 (37.7); 2.4975 (27.7); 2.4932 (13.6); 2.4419 (1.2); 2.4120 (9.6); 2.3372 (11.4); 1.0465 (0.4); 1.0313 (0.4); −0.0002 (0.5)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.2464 (0.5); 8.2398 (4.2); 8.2176 (4.7); 7.9512 (2.4); 7.7798 (2.1); 7.6926 (0.6); 7.6860 (4.8); 7.6686 (1.4); 7.6638 (4.5); 7.6574 (0.5); 6.6970 (2.9); 4.7235 (1.0); 4.1257 (0.8); 4.1160 (0.9); 4.0984 (1.0); 4.0886 (0.9); 3.7122 (0.5); 3.6950 (0.6); 3.6868 (0.6); 3.6692 (0.4); 3.3273 (30.0); 3.3247 (30.2); 2.8917 (16.0); 2.7328 (14.2); 2.6240 (13.7); 2.5061 (11.1); 2.5017 (15.1); 2.4974 (11.2); 2.3624 (6.7); 2.3437 (12.5); 2.2721 (2.5)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.5259 (2.8); 8.5169 (1.6); 8.5082 (2.4); 8.5030 (3.1); 8.3082 (0.4); 8.2685 (2.9); 8.1635 (2.1); 8.1581 (2.1); 8.1494 (1.6); 8.1401 (3.7); 8.0598 (1.1); 8.0471 (3.1); 8.0412 (5.0); 8.0320 (5.4); 8.0220 (4.2); 8.0168 (3.3); 8.0042 (1.0); 7.9521 (2.3); 7.7678 (5.6); 7.7470 (9.4); 7.6880 (8.7); 7.6676 (5.4); 6.9711 (4.8); 6.9626 (5.3); 6.7043 (3.6); 6.6985 (3.6); 5.0946 (1.2); 5.0850 (2.8); 5.0768 (2.8); 4.2340 (1.2); 4.2109 (1.4); 3.9964 (1.1); 3.9805 (1.0); 3.3405 (82.1); 3.3341 (70.3); 2.8911 (14.4); 2.7328 (12.4); 2.5067 (21.8); 2.5024 (30.1); 2.4981 (23.7); 2.4545 (1.8); 2.4224 (16.0)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.5101 (2.2); 8.5004 (1.2); 8.4924 (1.8); 8.4864 (2.3); 8.4770 (0.4); 8.3072 (0.5); 8.2864 (2.4); 8.2818 (2.4); 8.1628 (1.8); 8.1569 (1.6); 8.1482 (1.2); 8.1390 (2.7); 8.0543 (0.7); 8.0501 (0.9); 8.0375 (2.7); 8.0319 (3.8); 8.0222 (4.3); 8.0124 (3.5); 8.0071 (2.2); 7.9945 (0.8); 7.9520 (0.9); 7.6952 (2.6); 7.6919 (2.6); 7.6754 (2.9); 7.6722 (2.9); 7.4463 (1.7); 7.4435 (1.7); 7.4269 (3.2); 7.3875 (3.4); 7.3805 (0.4); 7.3677 (4.6); 7.3479 (1.8); 6.9753 (4.1); 6.9668 (4.2); 6.7076 (2.9); 6.7056 (2.9); 6.6996 (2.8); 5.0976 (1.0); 5.0888 (2.2); 5.0802 (2.2); 5.0709 (0.9); 4.2324 (1.2); 4.2242 (1.1); 4.2047 (1.4); 4.1972 (1.3); 4.0153 (1.2); 4.0041 (1.2); 3.9878 (1.0); 3.9763 (1.0); 3.3372 (88.6); 2.8914 (6.4); 2.7333 (5.5); 2.5068 (21.0); 2.5025 (26.7); 2.4981 (19.0); 2.4592 (1.4); 2.4292 (16.0); −0.0002 (0.4)
1H-NMR(400.2 MHz, d6-DMSO) δ = 7.7605 (0.8); 7.4547 (6.9); 4.7399 (0.4); 3.3387 (12.7); 3.3339 (13.5); 3.3301 (13.1); 2.8904 (1.9); 2.7319 (1.7); 2.5402 (4.6); 2.5054 (3.8); 2.5011 (5.1); 2.4968 (3.8); 2.3612 (4.1); 2.3009 (2.4); 1.3051 (16.0)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.5135 (2.9); 8.5071 (1.8); 8.4954 (3.0); 8.4908 (3.3); 8.3079 (1.9); 8.2438 (2.9); 8.1457 (2.2); 8.1410 (2.6); 8.1294 (1.8); 8.1224 (3.8); 8.0478 (1.2); 8.0343 (2.8); 8.0309 (2.8); 8.0236 (3.5); 8.0170 (5.0); 8.0106 (2.8); 8.0033 (3.2); 7.9994 (3.1); 7.9864 (1.1); 7.9825 (0.9); 7.9524 (0.8); 7.5817 (0.7); 7.5734 (8.0); 7.5716 (8.5); 7.5658 (4.6); 7.5618 (5.5); 7.5590 (6.6); 7.5395 (0.9); 7.5234 (4.8); 7.4083 (2.1); 7.3989 (2.2); 6.9815 (4.5); 6.9731 (4.9); 6.7079 (3.5); 6.7022 (3.5); 5.1032 (1.2); 5.0933 (2.6); 5.0853 (2.7); 5.0762 (1.3); 4.2428 (1.2); 4.2203 (1.4); 4.0015 (1.1); 3.9852 (1.0); 3.3422 (79.1); 3.3383 (94.8); 3.3353 (93.6); 2.8917 (5.7); 2.7338 (4.8); 2.5075 (22.8); 2.5031 (31.4); 2.4987 (24.5); 2.4592 (1.8); 2.4250 (16.0)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.3065 (0.6); 7.9515 (2.5); 7.7578 (3.2); 7.5426 (1.9); 7.5371 (1.1); 7.5207 (9.5); 7.5089 (9.1); 7.4868 (1.9); 7.4623 (0.3); 6.7783 (0.9); 6.5514 (0.5); 4.7312 (1.6); 4.1291 (1.1); 4.1199 (1.2); 4.1022 (1.3); 4.0923 (1.2); 3.7271 (0.7); 3.7102 (0.8); 3.7011 (0.8); 3.6848 (0.6); 3.4110 (0.4); 3.3403 (147.2); 3.3358 (201.9); 3.3303 (273.6); 2.8922 (15.1); 2.7332 (13.6); 2.6716 (0.6); 2.5593 (17.3); 2.5024 (92.1); 2.3590 (16.0); 2.3127 (13.9); −0.0002 (0.9)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.5057 (1.6); 8.4989 (0.9); 8.4872 (1.7); 8.4821 (1.6); 8.2451 (1.6); 8.1396 (1.2); 8.1349 (1.4); 8.1232 (1.1); 8.1165 (2.0); 8.0431 (0.6); 8.0299 (1.6); 8.0263 (1.5); 8.0189 (1.9); 8.0123 (2.8); 8.0059 (1.5); 8.0021 (1.2); 7.9986 (1.7); 7.9947 (1.6); 7.9817 (0.6); 7.9777 (0.5); 7.9518 (2.3); 7.5875 (3.0); 7.5854 (3.1); 7.5378 (0.9); 7.5335 (0.9); 7.5301 (1.1); 7.5235 (1.7); 7.5206 (1.4); 7.5156 (1.7); 7.5114 (1.5); 7.5029 (0.4); 7.5001 (0.4); 7.4791 (0.5); 7.4665 (5.5); 7.4637 (5.5); 7.4594 (2.4); 7.4546 (2.2); 7.4508 (2.4); 6.9840 (2.4); 6.9756 (2.5); 6.7123 (2.0); 6.7066 (1.9); 5.1021 (0.6); 5.0925 (1.4); 5.0844 (1.4); 5.0752 (0.7); 4.2403 (0.6); 4.2175 (0.7); 4.0031 (0.6); 3.9854 (0.5); 3.3413 (66.8); 2.8911 (16.0); 2.7326 (13.8); 2.5070 (12.9); 2.5026 (16.9); 2.4981 (12.5); 2.4614 (1.0); 2.4314 (9.6)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.0723 (2.0); 7.9510 (0.7); 7.7258 (2.1); 7.7222 (2.2); 7.7056 (2.5); 7.7020 (2.4); 7.5543 (1.8); 7.5507 (1.9); 7.5347 (2.5); 7.5312 (2.4); 7.4197 (2.3); 7.4105 (0.4); 7.3998 (3.6); 7.3799 (1.6); 6.9396 (2.5); 6.9314 (2.7); 6.6980 (2.2); 6.6954 (2.4); 6.6897 (2.3); 6.6871 (2.1); 5.0038 (1.6); 4.9955 (1.6); 4.1067 (1.0); 4.0983 (1.0); 4.0789 (1.3); 4.0708 (1.2); 3.8877 (1.0); 3.8764 (1.0); 3.8602 (0.8); 3.8486 (0.8); 3.3241 (122.7); 2.8914 (4.4); 2.7326 (3.8); 2.5708 (16.0); 2.5059 (32.4); 2.5016 (41.3); 2.4973 (31.3); 2.4474 (1.2); 2.4158 (12.5); 2.3294 (15.4); 1.0464 (0.3); 1.0312 (0.3); −0.0002 (0.8)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.0403 (1.3); 7.9514 (2.2); 7.7695 (3.1); 7.7643 (3.0); 7.7107 (2.7); 7.6898 (3.3); 7.5098 (2.2); 7.5046 (2.0); 7.4889 (1.8); 7.4836 (1.7); 6.9389 (1.6); 6.9308 (1.6); 6.7033 (1.7); 6.7007 (1.8); 6.6951 (1.6); 6.6924 (1.5); 5.0107 (0.6); 5.0016 (1.2); 4.9925 (1.2); 4.9830 (0.6); 4.1177 (0.7); 4.1101 (0.7); 4.0898 (0.8); 4.0819 (0.7); 3.8826 (0.6); 3.8719 (0.6); 3.8555 (0.5); 3.8447 (0.5); 3.3248 (103.2); 2.8913 (16.0); 2.7322 (13.2); 2.5781 (13.4); 2.5103 (13.3); 2.5061 (24.4); 2.5016 (30.9); 2.4971 (22.2); 2.4927 (10.9); 2.4462 (1.4); 2.4189 (9.1); 2.3277 (10.0); −0.0002 (0.5)
1H-NMR(400.2 MHz, d6-DMSO) δ = 8.1688 (4.5); 8.1659 (4.5); 8.0915 (1.8); 7.9699 (2.0); 7.9563 (6.5); 7.9460 (3.4); 7.9343 (6.4); 7.8655 (0.4); 7.8472 (0.6); 7.8260 (0.5); 7.7988 (0.3); 7.6055 (0.8); 7.5936 (3.0); 7.5894 (4.0); 7.5802 (4.4); 7.5703 (3.6); 7.5548 (0.6); 7.5498 (0.4); 7.5401 (2.9); 7.5357 (3.0); 7.5186 (2.7); 7.5143 (2.8); 6.9524 (1.5); 6.7080 (2.6); 6.7054 (2.9); 6.6997 (2.7); 6.6970 (2.6); 5.0330 (0.8); 5.0238 (1.8); 5.0150 (1.9); 5.0058 (0.8); 4.1329 (1.0); 4.1251 (1.0); 4.1058 (1.2); 4.0980 (1.1); 3.9134 (0.8); 3.9040 (0.8); 3.8874 (0.7); 3.3212 (105.6); 2.8901 (6.2); 2.7316 (5.2); 2.5495 (24.9); 2.5233 (0.8); 2.5099 (18.0); 2.5055 (37.4); 2.5009 (50.5); 2.4964 (36.1); 2.4919 (17.0); 2.4562 (1.7); 2.4195 (13.4); 2.3279 (16.0); 1.0465 (0.4); 1.0398 (1.3); 1.0313 (0.4); 1.0244 (1.3); −0.0002 (1.4)
The following compounds of formula (I) may be prepared according to the processes disclosed herein:
The intermediates as shown in the tables below were prepared in analogy with the examples provided above or following methods described herein.
1H-NMR Peak List
1H-NMR(400.1 MHz, CDCl3): δ = 7.3676 (1.1); 7.3478 (1.9); 7.3278 (1.5); 7.2626 (4.0); 7.1882 (1.0); 7.1853 (1.4); 7.1827 (1.1); 7.1693 (0.8); 7.1659 (1.1); 7.1637 (0.9); 7.1380 (1.4); 7.1321 (1.8); 7.1280 (1.3); 7.0012 (1.0); 6.9993 (1.0); 6.9949 (0.9); 6.9931 (0.9); 6.9804 (0.9); 6.9784 (0.9); 6.9741 (0.8); 6.9722 (0.8); 4.5836 (1.2); 4.5658 (3.8); 4.5479 (3.9); 4.5301 (1.3); 3.8048 (15.9); 2.8699 (16.0); 1.5777 (1.2); 1.5077 (4.0); 1.4899 (8.2); 1.4720 (4.0); 0.0703 (0.3); −0.0002 (4.6)
1H-NMR Peak List
1H-NMR(300.1 MHz, CDCl3): δ = 7.2641 (9.8); 6.1002 (0.4); 6.0815 (0.8); 6.0633 (0.6); 6.0466 (1.0); 6.0425 (0.6); 6.0279 (0.6); 6.0239 (1.0); 6.0059 (0.7); 5.9891 (1.0); 5.9705 (0.5); 5.3869 (0.6); 5.3816 (1.6); 5.3763 (1.7); 5.3710 (0.7); 5.3293 (0.5); 5.3240 (1.4); 5.3186 (1.5); 5.3134 (0.6); 5.2659 (0.7); 5.2617 (1.6); 5.2568 (1.5); 5.2310 (0.7); 5.2268 (1.4); 5.2218 (1.4); 5.2177 (0.6); 4.9053 (1.4); 4.6012 (2.3); 4.5966 (3.8); 4.5920 (2.5); 4.5827 (2.3); 4.5781 (3.7); 4.5735 (2.3); 2.8040 (0.4); 2.6616 (0.5); 2.6433 (14.2); 2.6053 (0.5); 2.3736 (16.0); 1.7915 (3.0); −0.0002 (8.6); −0.0112 (0.4)
1H-NMR(400.2 MHz, d6-DMSO): δ = 8.5673 (0.6); 8.5619 (0.6); 8.5476 (6.8); 8.5450 (7.5); 8.5288 (5.8); 8.5254 (7.7); 8.5028 (0.4); 8.0698 (2.9); 8.0656 (3.4); 8.0535 (6.1); 8.0493 (7.6); 8.0447 (3.7); 8.0399 (1.7); 8.0331 (6.4); 8.0280 (8.7); 8.0229 (5.2); 8.0172 (2.1); 8.0104 (2.6); 8.0058 (8.5); 8.0024 (9.0); 7.9966 (2.8); 7.9895 (6.1); 7.9862 (5.7); 7.9750 (9.9); 7.9725 (9.1); 7.9701 (7.6); 7.9548 (4.6); 7.9514 (3.5); 6.6590 (15.5); 6.0854 (2.0); 6.0724 (4.1); 6.0592 (4.0); 6.0460 (4.9); 6.0423 (3.2); 6.0328 (3.1); 6.0290 (5.2); 6.0158 (4.6); 6.0027 (5.0); 5.9896 (2.5); 5.4047 (2.7); 5.4004 (6.8); 5.3959 (7.2); 5.3917 (3.2); 5.3613 (2.5); 5.3571 (6.1); 5.3525 (6.4); 5.3483 (2.9); 5.2222 (3.5); 5.2188 (6.5); 5.2142 (6.1); 5.2107 (2.8); 5.1959 (3.4); 5.1924 (6.3); 5.1879 (5.9); 5.1844 (2.7); 4.4935 (10.7); 4.4898 (16.0); 4.4861 (10.2); 4.4804 (11.6); 4.4767 (16.0); 4.4731 (9.2); 3.4072 (9.2); 2.5119 (5.8); 2.5075 (11.5); 2.5031 (15.1); 2.4986 (10.9); 2.4942 (5.3); −0.0001 (6.8); −0.0084 (0.4)
1H-NMR Peak List
1H-NMR(300.1 MHz, d6-DMSO): δ = 9.6348 (2.5); 9.6194 (4.8); 6.5975 (0.4); 6.0924 (1.6); 6.0741 (2.7); 3.3279 (11.8); 2.6798 (1.7); 2.6347 (0.5); 2.6015 (6.0); 2.5945 (2.8); 2.5803 (11.7); 2.5133 (2.9); 2.5075 (5.2); 2.5016 (6.8); 2.4958 (5.1); 2.4570 (0.4); 2.2626 (16.0); 2.2168 (0.3); 1.9251 (0.5); −0.0002 (1.6)
1H-NMR(300.1 MHz, d6-DMSO): δ = 9.9400 (1.2); 9.9102 (16.0); 8.5638 (0.6); 8.5423 (3.6); 8.5382 (4.2); 8.5183 (3.0); 8.5125 (4.3); 8.4534 (0.3); 8.0703 (1.6); 8.0636 (1.8); 8.0495 (3.3); 8.0429 (4.0); 8.0356 (2.0); 8.0237 (4.6); 8.0152 (4.5); 7.9963 (5.5); 7.9918 (5.9); 7.9717 (8.0); 7.9459 (2.0); 7.9394 (1.3); 7.9136 (0.5); 7.8866 (0.4); 6.3387 (9.0); 3.3368 (17.0); 2.5084 (19.0); 2.5027 (23.3); 2.4972 (16.6); −0.0002 (14.3)
B-1. In Vivo Preventive Test on Alternaria brassicae (Leaf Spot on Radish or Cabbage)
The active ingredients were made soluble and homogenized in a mixture of Dimethyl sulfoxide/Acetone//Tween® 80 and then diluted in water to the desired concentration.
The young plants of radish or cabbage were treated by spraying the active ingredient prepared as described above. Control plants were treated only with an aqueous solution of Acetone/Dimethyl sulfoxide/Tween® 80.
After 24 hours, the plants were contaminated by spraying the leaves with an aqueous suspension of Alternaria brassicae spores. The contaminated radish or cabbage plants were incubated for 3 to 4 days at 20° C. and at 100% relative humidity.
The test was evaluated 3 to 4 days after the inoculation. 0% means an efficacy which corresponds to that of the control plants while an efficacy of 100% means that no disease was observed.
In this test the following compounds according to the invention showed efficacy between 70% and 79% at a concentration of 500 ppm of active ingredient: I-030; I-060; I-088; I-089 In this test the following compounds according to the invention showed efficacy between 80% and 89% at a concentration of 500 ppm of active ingredient: I-009; I-010; I-013; I-015; I-022; I-029; I-033; I-066; I-068; I-069; I-091; I-097; I-121; I-124
In this test the following compounds according to the invention showed efficacy between 90% and 100% at a concentration of 500 ppm of active ingredient: I-006; I-017; I-023; I-027; I-031; I-032; I-042; I-050; I-059; I-062; I-067; I-078; I-095; I-100; I-108; I-109; I-110; I-131; I-135.
B-2. in vivo preventive test on Botrytis cinerea (grey mould)
The active ingredients were made soluble and homogenized in a mixture of Dimethyl sulfoxide/Acetone//Tween® 80 and then diluted in water to the desired concentration.
The young plants of gherkin or cabbage were treated by spraying the active ingredient prepared as described above. Control plants were treated only with an aqueous solution of Acetone/Dimethyl sulfoxide/Tween® 80.
After 24 hours, the plants were contaminated by spraying the leaves with an aqueous suspension of Botrytis cinerea spores. The contaminated gherkin plants were incubated for 4 to 5 days at 17° C. and at 90% relative humidity. The contaminated cabbage plants were incubated for 4 to 5 days at 20° C. and at 100% relative humidity.
The test was evaluated 4 to 5 days after the inoculation. 0% means an efficacy which corresponds to that of the control plants while an efficacy of 100% means that no disease was observed.
In this test the following compounds according to the invention showed efficacy between 70% and 79% at a concentration of 500 ppm of active ingredient: I-038; I-055; I-099
In this test the following compounds according to the invention showed efficacy between 80% and 89% at a concentration of 500 ppm of active ingredient: I-009; I-045; I-089; I-111; I-127
In this test the following compounds according to the invention showed efficacy between 90% and 100% at a concentration of 500 ppm of active ingredient: I-003; I-005; I-006; I-007; I-010; I-011; I-013; I-015; I-017; I-022; I-023; I-029; I-030; I-031; I-032; I-033; I-035; I-042; I-044; I-048; I-050; I-059; I-060; I-062; I-066; I-067; I-068; I-069; I-078; I-079; I-080; I-085; I-088; I-090; I-091; I-095; I-097; I-100; I-108; I-109; I-110; I-117; I-121; I-124; I-131; I-133; I-135.
B-3. In Vivo Preventive Test on Sphaerotheca fuliginea (Powdery Mildew on Cucurbits)
The active ingredients were made soluble and homogenized in a mixture of Dimethyl sulfoxide/Acetone//Tween® 80 and then diluted in water to the desired concentration.
The young plants of gherkin were treated by spraying the active ingredient prepared as described above. Control plants were treated only with an aqueous solution of Acetone/Dimethyl sulfoxide/Tween® 80.
After 24 hours, the plants were contaminated by spraying the leaves with an aqueous suspension of Sphaerotheca fuliginea spores. The contaminated gherkin plants were incubated for 8 days at 20° C. and at 70-80% relative humidity.
The test was evaluated 8 days after the inoculation. 0% means an efficacy which corresponds to that of the control plants while an efficacy of 100% means that no disease was observed.
In this test the following compounds according to the invention showed efficacy between 80% and 89% at a concentration of 500 ppm of active ingredient: I-005; I-035
In this test the following compounds according to the invention showed efficacy between 90% and 100% at a concentration of 500 ppm of active ingredient: I-007; I-010; I-013; I-017; I-022; I-031; I-032; I-033.
B-4. In Vivo Preventive Test on Colletotrichum lindemuthianum (Leaf Spot on Bean)
The active ingredients were made soluble and homogenized in a mixture of Dimethyl sulfoxide/Acetone//Tween® 80 and then diluted in water to the desired concentration.
The young plants of bean were treated by spraying the active ingredient prepared as described above. Control plants were treated only with an aqueous solution of Acetone/Dimethyl sulfoxide/Tween® 80.
After 24 hours, the plants were contaminated by spraying the leaves with an aqueous suspension of Colletotrichum lindemuthianum spores. The contaminated bean plants were incubated for 24 hours at 20° C. and at 100% relative humidity and then for 6 days at 20° C. and at 90% relative humidity.
The test was evaluated 7 days after the inoculation. 0% means an efficacy which corresponds to that of the control plants while an efficacy of 100% means that no disease was observed.
In this test the following compounds according to the invention showed efficacy between 70% and 79% at a concentration of 500 ppm of active ingredient: I-003; I-009; I-021; I-023; I-029; I-042; I-066; I-069; I-095; I-110
In this test the following compounds according to the invention showed efficacy between 80% and 89% at a concentration of 500 ppm of active ingredient: I-026; I-079; I-090
In this test the following compounds according to the invention showed efficacy between 90% and 100% at a concentration of 500 ppm of active ingredient: I-007; I-010; I-013; I-017; I-022; I-027; I-030; I-031; I-032; I-033; I-035; I-044; I-062; I-078; I-100; I-108; I-109; I-135.
B-5. Alternaria alternata In Vitro Cell Test
Fungicides were solubilized in DMSO and the solution used to prepare the required range of concentrations. The final concentration of DMSO used in the assay was ≤1%.
A spore suspension of A. alternata was prepared and diluted to the desired spore density.
Fungicides were evaluated for their ability to inhibit spore germination and mycelium growth in liquid culture assay. The compounds were added in the desired concentration to the culture medium with spores. After 5 days incubation, fungi-toxicity of compounds was determined by spectrometric measurement of mycelium growth. Inhibition of fungal growth was determined by comparing the absorbance values in wells containing the fungicides with the absorbance in control wells without fungicides.
In this test the following compounds according to the invention showed efficacy between 70% and 79% at a concentration of 50 μMol/l of active ingredient: I-044; I-049; I-079; I-111; I-122; I-125
In this test the following compounds according to the invention showed efficacy between 80% and 89% at a concentration of 50 μMol/l of active ingredient: I-059; I-069; I-078; I-091; I-097; I-136
In this test the following compounds according to the invention showed efficacy between 90% and 100% at a concentration of 50 μMol/l of active ingredient: I-042; I-050; I-062; I-067; I-071; I-100; I-103; I-104; I-108; I-109; I-118; I-131; I-135
In this test the following compounds according to the invention showed efficacy between 70% and 79% at a concentration of 20 ppm of active ingredient: I-011; I-014; I-031; I-032
In this test the following compounds according to the invention showed efficacy between 80% and 89% at a concentration of 20 ppm of active ingredient: I-008; I-017
In this test the following compounds according to the invention showed efficacy between 90% and 100% at a concentration of 20 ppm of active ingredient: I-023; I-024; I-029; I-030.
Fungicides were solubilized in DMSO and the solution used to prepare the required range of concentrations. The final concentration of DMSO used in the assay was ≤1%.
A spore suspension of P. oryzae was prepared and diluted to the desired spore density.
Fungicides were evaluated for their ability to inhibit spore germination and mycelium growth in liquid culture assay. The compounds were added in the desired concentration to the culture medium with spores. After 5 days incubation, fungi-toxicity of compounds was determined by spectrometric measurement of mycelium growth. Inhibition of fungal growth was determined by comparing the absorbance values in wells containing the fungicides with the absorbance in control wells without fungicides.
In this test the following compounds according to the invention showed efficacy between 70% and 79% at a concentration of 50 μMol/l of active ingredient: I-066; I-067; I-079; I-086; I-095; I-109; I-124; I-133; I-136
In this test the following compounds according to the invention showed efficacy between 80% and 89% at a concentration of 50 μMol/l of active ingredient: I-044; I-062; I-069; I-078; I-080; I-091; I-097; I-118; I-125; I-131
In this test the following compounds according to the invention showed efficacy between 90% and 100% at a concentration of 50 μMol/l of active ingredient: I-042; I-050; I-071; I-100; I-103; I-104; I-108; I-135
In this test the following compounds according to the invention showed efficacy between 70% and 79% at a concentration of 20 ppm of active ingredient: I-002; I-007; I-028; I-032; I-034
In this test the following compounds according to the invention showed efficacy between 80% and 89% at a concentration of 20 ppm of active ingredient: I-016; I-017; I-022
In this test the following compounds according to the invention showed efficacy between 90% and 100% at a concentration of 20 ppm of active ingredient: I-001; I-005; I-008; I-011; I-014; I-015; I-018; I-023; I-024; I-029; I-030; I-03.
B-7. Colletotrichum lindemuthianum In Vitro Cell Test
Fungicides were solubilized in DMSO and the solution used to prepare the required range of concentrations. The final concentration of DMSO used in the assay was ≤1%.
A spore suspension of C. lindemuthianum was prepared and diluted to the desired spore density.
Fungicides were evaluated for their ability to inhibit spores germination and mycelium growth in liquid culture assay. The compounds were added in the desired concentration to the culture medium with spores. After 6 days incubation, fungi-toxicity of compounds was determined by spectrometric measurement of mycelium growth. Inhibition of fungal growth was determined by comparing the absorbance values in wells containing the fungicides with the absorbance in control wells without fungicides.
In this test the following compounds according to the invention showed efficacy between 70% and 79% at a concentration of 50 μMol/l of active ingredient: I-099; I-122; I-124; I-126
In this test the following compounds according to the invention showed efficacy between 80% and 89% at a concentration of 50 μMol/l of active ingredient: I-046; I-067; I-102; I-118
In this test the following compounds according to the invention showed efficacy between 90% and 100% at a concentration of 50 μMol/l of active ingredient: I-036; I-040; I-042; I-044; I-047; I-050; I-055; I-062; I-066; I-068; I-069; I-071; I-074; I-078; I-079; I-083; I-084; I-086; I-088; I-090; I-091; I-095; I-097; I-100; I-103; I-104; I-108; I-109; I-111; I-125; I-129; I-131; I-133; I-135
In this test the following compounds according to the invention showed efficacy between 70% and 79% at a concentration of 20 ppm of active ingredient: I-021; I-026
In this test the following compounds according to the invention showed efficacy between 80% and 89% at a concentration of 20 ppm of active ingredient: I-009; I-018; I-028
In this test the following compounds according to the invention showed efficacy between 90% and 100% at a concentration of 20 ppm of active ingredient: I-002; I-005; I-006; I-007; I-008; I-010; I-011; I-012; I-013; I-014; I-015; I-016; I-017; I-020; I-022; I-023; I-024; I-025; I-029; I-030; I-031; I-032; I-033; I-034.
B-8. Pyrenophora teres In Vitro Cell Test
Fungicides were solubilized in DMSO and the solution used to prepare the required range of concentrations. The final concentration of DMSO used in the assay was ≤1%.
A spore suspension of P. teres was prepared and diluted to the desired spore density.
Fungicides were evaluated for their ability to inhibit spore germination and mycelium growth in liquid culture assay. The compounds were added in the desired concentration to the culture medium with spores. After 6 days incubation, fungi-toxicity of compounds was determined by spectrometric measurement of mycelium growth. Inhibition of fungal growth was determined by comparing the absorbance values in wells containing the fungicides with the absorbance in control wells without fungicides.
In this test the following compounds according to the invention showed efficacy between 70% and 79% at a concentration of 50 μMol/l of active ingredient: I-036; I-049; I-060; I-068
In this test the following compounds according to the invention showed efficacy between 80% and 89% at a concentration of 50 μMol/l of active ingredient: I-079; I-090; I-122; I-125
In this test the following compounds according to the invention showed efficacy between 90% and 100% at a concentration of 50 μMol/l of active ingredient: I-042; I-044; I-050; I-059; I-062; I-067; I-071; I-078; I-086; I-091; I-097; I-100; I-103; I-104; I-108; I-109; I-111; I-118; I-131; I-135; I-136
In this test the following compounds according to the invention showed efficacy between 90% and 100% at a concentration of 20 ppm of active ingredient: I-007; I-008; I-010; I-011; I-012; I-015; I-016; I-022; I-023; I-024; I-028; I-029; I-030; I-031; I-032; I-033.
B-9. Botrytis cinerea In Vitro Cell Test
Fungicides were solubilized in DMSO and the solution used to prepare the required range of concentrations. The final concentration of DMSO used in the assay was ≤1%.
A spore suspension of B. cinerea was prepared and diluted to the desired spore density.
Fungicides were evaluated for their ability to inhibit spore germination and mycelium growth in liquid culture assay. The compounds were added in the desired concentration to the culture medium with spores. After 6 days incubation, fungi-toxicity of compounds was determined by spectrometric measurement of mycelium growth. Inhibition of fungal growth was determined by comparing the absorbance values in wells containing the fungicides with the absorbance in control wells without fungicides.
In this test the following compounds according to the invention showed efficacy between 70% and 79% at a concentration of 50 μMol/l of active ingredient: I-040; I-061; I-063; I-084; I-087; I-089; I-112; I-119; I-130
In this test the following compounds according to the invention showed efficacy between 80% and 89% at a concentration of 50 μMol/l of active ingredient: I-045; I-055; I-073; I-099; I-102; I-107
In this test the following compounds according to the invention showed efficacy between 90% and 100% at a concentration of 50 μMol/l of active ingredient: I-038; I-042; I-044; I-048; I-050; I-059; I-060; I-062; I-066; I-067; I-068; I-069; I-071; I-078; I-079; I-080; I-082; I-083; I-085; I-086; I-088; I-090; I-091; I-093; I-095; I-097; I-100; I-103; I-104; I-108; I-109; I-110; I-111; I-114; I-115; I-117; I-118; I-121; I-124; I-125; I-131; I-133; I-135; I-136; I-137
In this test the following compounds according to the invention showed efficacy between 70% and 79% at a concentration of 20 ppm of active ingredient: I-004
In this test the following compounds according to the invention showed efficacy between 90% and 100% at a concentration of 20 ppm of active ingredient: I-002; I-005; I-006; I-007; I-008; I-009; I-011; I-012; I-013; I-014; I-015; I-016; I-017; I-022; I-023; I-024; I-025; I-028; I-029; I-030; I-031; I-032; I-033; I-034.
B-10. Fusarium culmorum In Vitro Cell Test
Fungicides were solubilized in DMSO and the solution used to prepare the required range of concentrations. The final concentration of DMSO used in the assay was ≤1%.
A spore suspension of F. culmorum was prepared and diluted to the desired spore density.
Fungicides were evaluated for their ability to inhibit spore germination and mycelium growth in liquid culture assay. The compounds were added in the desired concentration to the culture medium with spores. After 5 days incubation, fungi-toxicity of compounds was determined by spectrometric measurement of mycelium growth. Inhibition of fungal growth was determined by comparing the absorbance values in wells containing the fungicides with the absorbance in control wells without fungicides.
In this test the following compounds according to the invention showed efficacy between 70% and 79% at a concentration of 50 μMol/l of active ingredient: I-060; I-066; I-085; I-095; I-133
In this test the following compounds according to the invention showed efficacy between 80% and 89% at a concentration of 50 μMol/l of active ingredient: I-040; I-078; I-097; I-103; I-109; I-117; I-124
In this test the following compounds according to the invention showed efficacy between 90% and 100% at a concentration of 50 μMol/l of active ingredient: I-036; I-042; I-050; I-062; I-069; I-071; I-079; I-080; I-090; I-091; I-100; I-104; I-108; I-111; I-122; I-125; I-135
In this test the following compounds according to the invention showed efficacy between 80% and 89% at a concentration of 20 ppm of active ingredient: I-029; I-032
In this test the following compounds according to the invention showed efficacy between 90% and 100% at a concentration of 20 ppm of active ingredient: I-004; I-008; I-010; I-011; I-022; I-023; I-024; I-030; I-031; I-033.
B-11. Septoria tritici In Vitro Cell Test
Fungicides were solubilized in DMSO and the solution used to prepare the required range of concentrations. The final concentration of DMSO used in the assay was ≤1%.
A spore suspension of S. tritici was prepared and diluted to the desired spore density.
Fungicides were evaluated for their ability to inhibit spore germination and mycelium growth in liquid culture assay. The compounds were added in the desired concentration to the culture medium with spores. After 7 days incubation, fungi-toxicity of compounds was determined by spectrometric measurement of mycelium growth. Inhibition of fungal growth was determined by comparing the absorbance values in wells containing the fungicides with the absorbance in control wells without fungicides.
In this test the following compounds according to the invention showed efficacy between 90% and 100% at a concentration of 50 μMol/l of active ingredient: I-100
In this test the following compounds according to the invention showed efficacy between 70% and 79% at a concentration of 20 ppm of active ingredient: I-009; I-012; I-016; I-030
In this test the following compounds according to the invention showed efficacy between 80% and 89% at a concentration of 20 ppm of active ingredient: I-007; I-022; I-031
In this test the following compounds according to the invention showed efficacy between 90% and 100% at a concentration of 20 ppm of active ingredient: I-008; I-010; I-011; I-013; I-017; I-018; I-023; I-024; I-029; I-032; I-033.
| Number | Date | Country | Kind |
|---|---|---|---|
| 21211348.4 | Nov 2021 | EP | regional |
| Filing Document | Filing Date | Country | Kind |
|---|---|---|---|
| PCT/EP2022/083603 | 11/29/2022 | WO |
